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Liver transplantation has proven to be a successful treatment for patients with end stage 
chronic or acute liver failure. Due to improved surgical techniques, enhanced intensive care, and 
effective immunosuppressant medications, excellent one- and five-year patient (around 90% 
and 80%, respectively) and graft survival rates (around 85% and 75%, respectively) are currently 
achieved (1,2).
Nevertheless, liver transplant waiting lists are increasing more rapidly than the supply of donor 
organs, leaving many patients stranded without access to what is often a life-saving therapy. 
Efforts to increase the donor pool are being made by accepting more donors at the expense 
of diminished quality of their organs (i.e. extended criteria donors). An extended criteria donor 
(ECD) implies a higher donor-related risk in comparison with a standard criteria donor (SCD). This 
risk may manifest as increased incidence of postoperative complications, such as delayed graft 
function, graft failure, biliary complications or transmission of a donor-derived disease (3).
Despite the good overall survival data, biliary complications are a major problem after liver 
transplantation. The incidence of biliary complications varies between 10% and 40% in different 
studies and these types of complications are associated with frequent hospital admissions, and 
high morbidity and mortality rates (4-6). Among the various biliary complications that can occur 
after OLT, bile duct strictures are of the greatest concern. Bile duct strictures can be classified as 
anastomotic strictures (AS) or non-anastomotic strictures (NAS). Solitary strictures at the biliary 
anastomosis have been reported in 9%-12% of the patients (7-9), and NAS have been reported 
in 1%-13% of patients receiving a liver from donation after brain death (DBD) and in 21%-33% 
of patients receiving a liver from donation after cardiac death (DCD) (10-13). NAS may occur in 
the extrahepatic donor bile duct as well as the intrahepatic bile ducts, but they are usually limited 
to the larger bile ducts.
For many years researchers have been trying to understand the underlying mechanisms of AS and 
NAS. Current evidence suggests that AS are mainly related to the surgical technique and local 
ischemia of the distal bile duct stump, leading to fibrotic scarring of the anastomosis (4,9). The 
etiology of NAS is thought to be multifactorial and three relevant types of biliary injury have been 
identified as a potential cause of NAS: ischemia/reperfusion related injury; immune-mediated 
injury; and cytotoxic injury caused by hydrophobic bile salts (4,14). The etiologies of NAS are still 
poorly understood and therapeutic options are limited and often unsuccessful (15,16).
Despite the high numbers of patients on the waiting list for transplantation, many donor livers are 
still declined for transplantation for various reasons. According to the United Network for Organ 
Sharing (UNOS) database, 58.2% of the DCD livers (and 14.4% of livers donated after brain 
death [DBD]) with consent for donation are currently not accepted due to the perceived high risk 
of complications after transplantation (4). In order to expand the donor pool through utilization 
of these livers, research should focus on better defining the mechanism underlying NAS and on 
the development of effective preventive measures. Machine perfusion as an alternative to static 
cold storage (SCS) is increasingly discussed as a promising tool to optimize DCD and other ECD 
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livers before transplantation. However, there are no convincing data as to whether preservation 
related injury of the bile ducts prior to transplantation is a risk factor for the development of 
biliary complications after transplantation. Moreover, there are no studies on machine perfusion 
that have specifically addressed the question whether this preservation method provides better 
protection of the bile ducts, compared to SCS.
Therefore, the aim of this thesis was to gain a better understanding of the etiologies underlying 
NAS and to study the potential protective role of machine perfusion in the prevention of bile duct 
injury before transplantation. In addition, we provide an overview of the literature to understand 
the scope of the problem and the thesis concludes with a study on how to inform and involve 
patients in the decision to accept a liver with increased risk of bile duct complications.
Part a: The Scope of Bile Duct Injury in Liver Transplantation
The aim of this section is to provide an overview of the literature in order to understand the 
scope of bile duct injury in liver transplantation. The different types of biliary complications 
that can occur after liver transplantation are discussed in chapter 2. Surgical aspects of bile 
duct reconstruction that are relevant for the development of biliary complications are covered, 
followed by a discussion of diagnostic and imaging methods and a description of the pathogenesis, 
clinical presentation, and management of the various types of biliary complications after liver 
transplantation.
Chapter 3 focuses on the most prevalent and troublesome of all bile duct complications: non-
anastomotic bile duct strictures (NAS). Current and emerging insight into the pathogenesis of 
NAS, including the lacunae in our current knowledge and potential targets to reduce biliary 
injury and preserve bile ducts are discussed in this chapter.
Part B: Immune and Ischemia-mediated Etiologies of Bile Duct Injury
The aim of this section is to gain better understanding of the etiologies underlying NAS. Despite 
extensive research, the exact etiological mechanisms of NAS remain unclear and improved 
understanding of the pathophysiology of NAS may lead to the development of preventive or 
curative treatments. The aim of the clinical study described in chapter 4 was to determine 
the role of the immune system in the development of NAS. NAS has been associated with 
various immunological processes, such as ABO-incompatible liver transplantation (17), pre-
existing diseases with a presumed autoimmune component (18-20), cytomegalovirus infection 
(18,21) and chronic rejection (17). The exact role of the immune system in the pathogenesis of 
NAS, however, remains unclear. A loss-of-function mutation in the chemokine receptor CCR5 
(CCR5-Δ32) leads to changes in the immune system, including impaired chemotaxis of regulatory 
T-cells (22-24). To determine whether the immune system is involved in the pathogenesis of NAS 
we assessed the impact of the CCR5-Δ32 mutation in liver donors and recipients on outcome, 
and the development of NAS after OLT.
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The aim of chapter 5 is to draw attention to the changing perspective on the pathogenesis 
of biliary strictures after liver transplantation. For decades it was assumed that only few biliary 
epithelial cells are damaged and lost during cold preservation and that most of the biliary 
injury occurs after transplantation during reperfusion injury. Two recently published studies 
provided new perspective from which to view biliary injuries and the development of strictures 
after transplantation (25,26). Subsequently, the new perspective on the pathogenesis of biliary 
strictures is now based on the insufficient regeneration of the biliary epithelium, resulting in the 
development of NAS.
It is conceivable that biliary epithelium of the extrahepatic bile duct has an endogenous 
regenerative capacity, which may be impaired when NAS develops after liver transplantation. 
The aim of chapter 6 is to identify possible site(s) where epithelial regeneration may be initiated 
in the human extrahepatic bile duct and to study the possible role of proliferation of mature 
biliary epithelial cells as well as that of local progenitor cells in this process. We examined 
tissue specimens from normal and diseased human EHBD varying from mild cellular injury (as in 
cholangitis/cholecystitis) to severe epithelial injury with cholangiocyte loss, as can be seen in NAS 
after orthotopic liver transplantation.
In chapter 6 the peribiliary glands of large bile ducts were identified as a local niche of biliary 
progenitor cells that contribute to regeneration of the biliary epithelial lining after major injury. 
However, it is unknown whether injury or loss of the peribiliary glands is a risk factor for the 
development of NAS after transplantation. In chapter 7 we examined biopsies taken during 
128 liver transplant procedures, taken from the distal end of the extrahepatic bile duct. Slides 
were examined by light microscopy, using a systematic injury grading system. Special attention 
was paid to the peribiliary glands and peribiliary vasculature. The aim of this study was to 
determine the impact of injury to the peribiliary glands and the vasculature in the development 
of NAS.
Part C: Machine Perfusion: a Potential Strategy to Prevent Bile Duct Injury
The aim of this section is to study the potentially protective effect of machine perfusion on the 
development of bile duct injury, and to demonstrate feasibility of machine perfusion in human 
livers. Machine perfusion is increasingly discussed as a promising tool to optimize DCD and 
other ECD livers before transplantation. During machine preservation livers are perfused with 
an oxygenated or non-oxygenated perfusion fluid at either low temperature or normal body 
temperature (27-31).
 Thus far, most investigations have focused on hypothermic machine perfusion (HMP; 0-4°C) and 
studies have suggested that HMP results in better preservation of the liver parenchyma, compared 
to the classical method of organ preservation, static cold storage (SCS) (29-31). However, it is 
unknown whether hypothermic oxygenated machine perfusion results in better preservation of 
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biliary epithelium and the peribiliary vasculature. Therefore, the aim of chapter 8 is to study bile 
duct injury and morphology in a porcine DCD model, comparing oxygenated HMP with SCS.
Although hypothermic perfusion has achieved adequate results in near-clinical and clinical setting 
(27,32), its use seems to offer too little protection in suboptimal grafts (33,34). Moreover, HMP 
in porcine livers did not provide protection of the bile duct epithelium, when compared to SCS in 
a porcine DCD model (chapter 8). Normothermic machine perfusion (NMP) of donor livers offers 
potential to meet the higher requirements for DCD graft preservation. An important advantage 
of NMP over conventional static cold storage (SCS) is the delivery of oxygen and nutrients at 
37°C, providing full metabolic support. The aim of chapter 9 is to determine the impact of NMP 
on bile duct preservation in both DCD and non-DCD rat livers.
Although normothermic machine perfusion may provide better viability testing and resuscitation, 
it requires challenging, near-physiological conditions (35). To date, successful normothermic 
perfusion of livers has been reported only in animal models (36-40). Although these results 
are promising, feasibility of normothermic machine perfusion in human livers remains to be 
demonstrated. In chapter 10 we studied the feasibility of normothermic, oxygenated machine 
preservation and ex vivo viability testing of discarded human ECD livers, using a newly developed 
liver perfusion machine. In order to move forward to clinical use of machine perfusion, it is 
necessary to identify markers during machine perfusion that can predict liver function after 
transplantation. In chapter 11 we aimed to identify markers as early as possible during the 
course of machine perfusion that would allow us to predict liver function after 6 hours of NMP, 
as a first step towards using machine perfusion in a clinical setting.
Part D: addendum
DCD and other ECD donor grafts are increasingly used for transplantation, resulting in an 
increased risk of bile duct complications after transplantation. At the time of organ offer for 
transplantation, donor-related risks such as disease transmission and graft failure are weighed 
against the patient’s risk of remaining on the waiting list. The patient’s role in decision-making, 
as well as the timing and extent of donor-specific risk information, has been discussed in the 
medical literature. However, there is very little data on how patients themselves see their role 
in making these complicated decisions. In chapter 12 we describe the first study revealing 
the opinion of liver patients on these issues. Forty patients listed for liver transplantation and 
179 transplanted liver patients participated in an anonymous questionnaire-based survey. The 
aim of this chapter is to investigate how to inform and involve patients in the decision on whether 
or not to accept a liver with an increased risk of complications.
The aim of chapter 13 is to describe the details of a new pressure and temperature controlled 
dual perfusion system that we have developed to perfuse rat livers for the study described 
in chapter 9. In chapter 14 the results of this thesis are summarized, followed by a general 
discussion and future perspectives.
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Biliary complications are a major cause of morbidity and graft failure after liver transplantation. 
Advances in surgical techniques and preservation methods during the last decades have 
led to better results, but biliary complications still occur in 10-40% of the recipients and 
are associated with mortality rates of 8-15%. The use of livers from extended criteria 
donors is inevitable in the attempt to scale down the worldwide shortage of organs for 
transplantation, but these organs carry an increased risk of developing complications of the 
biliary system. The same is true for liver grafts from living donors. Of all biliary complications, 
bile duct strictures and bile leakage are most common after liver transplantation. This 
chapter discusses the pathogenesis, epidemiology and management of these and other less 
frequently occurring biliary complications.
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Biliary complications are a major cause of morbidity and graft failure after liver transplantation. 
Although advances in the surgical technique of liver transplantation have led to a better overall 
outcome and fewer surgical complications, biliary complications still occur in 10-40% of the 
recipients and are associated with mortality rates of 8-15% (1,2). The continuing high biliary 
complication rate in liver transplantation can at least partially be explained by the increasing 
diversity of liver grafts used for transplantation in recent years. Besides livers derived from 
donation after brain death (DBD) donors, livers from DCD donors (donation after cardiac death) 
are increasingly used for transplantation, and these grafts are associated with a higher risk of 
biliary complications (3). The use of these and other extended-criteria donor livers, however, is 
inevitable in an attempt to scale down the worldwide shortage of organs. In order to expand 
the pool of potential donors, split-liver transplantation and living donors have also evolved as 
surgical alternatives and numbers have increased in recent years, providing particularly young 
children opportunity to receive a graft in time. In western countries, both split- and living- donor 
transplantation currently account for about 10% of all liver transplantations, although there are 
large variations among countries. Some countries in Asia might even reach a living donor liver 
transplantation rate of almost 100%. Yet, both surgical variants of liver transplantation carry an 
increased risk of biliary complications. Diversity in the quality and type of transplanted organs, 
variations in recipient risk factors, and variations in the applied surgical technique lead to a 
diversity in biliary complications that may occur after liver transplantation.
Of all biliary complications, bile leaks and bile duct strictures (anastomotic or non-anastomotic) 
are the most common types. These and other less frequent biliary complications are summarized 
in Table 1 and will be discussed in this chapter. First, surgical aspects of bile duct reconstruction 
that are relevant for the development of biliary complications will be covered, followed by 
a discussion of diagnostic and imaging methods and a description of the pathogenesis, 
clinical presentation, and management of the various types of biliary complications after liver 
transplantation.
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Table 1. Biliary complications after liver transplantation
Ischemic biliary complications due to hepatic artery thrombosis or stenosis
– Stricture
– Leak






– Parenchymal cut surface leak1
– Kinking of redundant bile duct
– External compression (cystic duct mucocele or hepatic lymphoma)
Ischemic-type biliary lesions / non-anastomotic strictures
– Ischemia-reperfusion injury
– Immune-mediated injury
– Bile salt cytotoxic injury
Infectious biliary complications / cholangitis
Uncommon biliary complications
– Sphincter of Oddi dysfunction
– Biliary stones, sludge, and casts
1 Living donor or split liver grafts
SuRgICaL TEChnIquE In RELaTIon To BILIaRy CoMPLICaTIonS
Biliary Reconstruction
The two main types of biliary reconstruction used in liver transplantation nowadays are 
1) choledochocholedochostomy, also called the duct-to-duct anastomosis (using either an end-
to-end anastomosis or a side-to-side anastomosis), and 2) a hepatico-jejunostomy using a Roux-Y 
jejunal loop. The use of one type of reconstruction instead of the other largely depends on 
the anatomical situation of the recipient’s extrahepatic bile ducts and sometimes the surgical 
preference.
In case of a duct-to-duct choledochocholedochostomy, an anastomosis is created between 
donor and recipient choledochal ducts (common bile duct). An end-to-end anastomosis is 
generally easier to perform than a side-to-side anastomosis, and the former is therefore used 
more frequently. In a prospective, randomized trial comparing end-to-end anastomosis with 
side-to-side anastomosis, no major differences in outcome between the two techniques were 
found (4). An end-to-end reconstruction restores the physiologic anatomical situation and does 
not carry the risk of bile sludge or cast formation as can occur in the dead ends of a side-to-side 
anastomosis.
In case of a Roux-Y hepatico-jejunostomy, an end-to-side anastomosis is constructed between 
the donor hepatic duct and a Roux-Y jejunal loop created in the recipient. Roux-Y hepatico-
jejunostomy is mainly used in patients whose native extrahepatic bile duct is not suitable for 
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anastomosis with the bile duct of the donor liver. The main indications for using a Roux-Y loop 
for biliary reconstruction are primary sclerosing cholangitis with involvement of the extrahepatic 
bile duct, biliary atresia, significant size discrepancy between the donor and recipient choledochal 
duct, and retransplantation (1,2). Although a hepatico-jejunostomy may be a safe alternative when 
duct-to-duct anastomosis is not feasible, the disadvantage is that it creates an open connection 
between the intrahepatic bile ducts of the graft and the bowel lumen. This may result in reflux 
of small bowel content into the bile ducts and subsequently ascending bacterial migration and 
(recurrent) cholangitis. Additional advantage of using a cholecochocholedochostomy is easier 
access for diagnostics and therapy compared with a Roux-Y hepatico-jejunostomy. It is, therefore, 
generally agreed that the preferred method of biliary reconstruction in liver transplantation 
should be a choledochocholedochostomy whenever possible.
Few centers have advocated and reported on the use of a direct connection between the donor 
bile duct and the recipient duodenum (so called choledochoduodenostomy) as a safe alternative 
to a hepatico-jejunostomy (5).
The use of a Biliary Drain
When reconstructing the biliary system in a liver transplant recipient, this can be done either with 
or without the insertion of a biliary drain. A biliary drain can be either a T-tube or a straight (open 
tip) catheter. A T-tube is a flexible tube that is inserted in the choledochal duct in the proximity 
of the end-to-end anastomosis in case of a choledochocholedochostomy. This tube allows the 
bile to drain in two directions; towards the duodenum and outward of the body. Alternatively, a 
straight catheter can be used, with the advantage of a lower risk of bile leakage upon removal 
of the drain as it results in smaller hole in the bile duct after extraction.
Choledochocholedochostomy reconstructions over T-tubes have been the subject of controversy 
for many years, but it has nevertheless remained common practice in some transplant centers. 
Yet, with increasing surgical experience, many centers have begun to abandon the routine use of 
biliary drains in their liver transplant recipients (6,7).
Benefits of using a biliary drain include direct visual evaluation of the quality of bile produced 
by the recently implanted graft and easy access to the biliary tree for radiological imaging. 
Especially in liver grafts that contain a higher risk of developing biliary complications (e.g. livers 
from DCD donors) this could be an advantage. Some studies have suggested that placement of 
a T-tube may reduce the incidence of anastomotic strictures (8). In addition, a T-tube may result 
in adequate decompression of the biliary tree and a reduction of the intraductal pressure, which 
may subsequently contribute to a lower rate of intrahepatic biliary strictures and leakage.
The main drawback of using T-tubes is their association with an increased rate of biliary 
complications, especially bile leakage at the site of the drain insertion after its removal occurring 
in 5-15% of patients (1). In addition, the use of a T-tube increases the risk of ascending cholangitis 
and peritonitis, due to an open connection of the choledochal duct with the exterior. In a recent 
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systematic review and meta-analysis of studies focusing on the use of biliary drains in liver 
transplantation it was concluded that biliary drains such as T-tubes should be abandoned (6). 
Although this meta-analysis showed lower rates of anastomotic and non-anastomotic strictures 
in patients with a T-tube, the incidence of interventions was not diminished in comparison to 
patients without a T-tube. Patients without a T-tube had fewer episodes of cholangitis and 
fewer episodes of peritonitis. Yet, patients with or without a T-tube had equivalent outcomes 
with respect to anastomotic bile leaks or fistulas, the need for biliary interventions, incidence 
of hepatic artery thrombosis, retransplantation rate, and mortality due to biliary complications.
The use of alternative devices, like internal stents, have been reported by some centers, but these 
stents have been associated with increased rates of serious complications, including obstruction, 
migration, and erosion with hemobilia (9).
The use of biliary drains such as a T-tube in liver transplant recipients, therefore, remains 
controversial. Probably the only remaining argument to use a T-tube is to allow accurate 
monitoring and easy access to the biliary tree in liver grafts that carry an increased risk of biliary 
complications, such as livers from DCD donors.
Relevance of the Donor / Back Table Procedure
Efforts to minimize the risk of biliary complications after liver transplantation should start with 
proper surgical and preservation techniques during the donor procedure. Aspects of liver 
procurement and preservation which have been demonstrated to reduce the risk of biliary 
complications include: 1) efforts to minimize ischemic injury of the bile ducts, 2) preservation of 
the vasculature of the extrahepatic bile duct by avoiding dissection too close to the bile duct, 
3) thorough rinsing of the bile duct lumen to remove toxic bile, and 4) adequate arterial perfusion 
of the liver with preservation fluid to preserve the peribiliary capillary plexus. These aspects 
are relevant as biliary epithelial cells (cholangiocytes) are very sensitive to ischemia/reperfusion 
injury (10). In addition to primary preservation-related ischemic injury, ischemic damage of the 
peribiliary plexus will result in secondary ischemic injury of the biliary epithelium. The strong 
relationship between ischemia and bile duct injury is illustrated by studies demonstrating an 
association between both cold and warm ischemia time and the development of non-anastomotic 
strictures (NAS). As long as the cold ischemia time is kept below 10 h, the incidence of NAS is not 
increased, however more prolonged cold ischemia is clearly associated with a higher risk of such 
strictures (11-13). Warm ischemia time, on the other hand, has been identified as a risk factor 
in several studies. The relevance of warm ischemia is also illustrated by the high incidence of 
NAS after transplantation of livers from DCD donors, which suffer an inevitable period of warm 
ischemia prior to organ procurement (13,14).
During organ procurement, surgeons should avoid “stripping” of the extrahepatic bile duct, 
which will damage its microvascularization. The extrahepatic bile duct should always remain 
surrounded by adequate amount of tissue to ensure sufficient blood supply.
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Preservation injury results in increased arterial resistance and may cause circulatory disturbances 
in small capillaries, such as the biliary plexus. Since the blood supply to the biliary tract is solely 
dependant on arterial inflow, disturbances in the blood flow through the peribiliary plexus may 
result in insufficient oxygenation and subsequent damage of the biliary epithelium.
Gentle retrograde flushing of the bile ducts with preservation fluid is considered an important 
method to remove bile from the bile duct lumen. Bile contains bile salts, which are cytotoxic 
due to their detergent properties. Several studies have shown that bile salts may contribute 
to toxic damage of the biliary epithelium both during liver preservation and after liver 
transplantation (15,16).
University of Wisconsin (UW) solution has been recognized as the gold standard preservation 
solution (17). Although some studies have suggested that highly viscous preservation solutions 
such as the UW solution may result in an incomplete flush out of the small donor peribiliary 
arterial plexus, resulting in a higher incidence of NAS (11,18), this could not always be confirmed 
in other studies (17). Therefore, it remains debatable whether low viscosity preservation fluids 
are associated with a lower incidence of biliary complications. Adequately powered randomized, 
controlled trials with long-term follow up are needed to determine whether the type of 
preservation fluid has an impact on biliary complications after liver transplantation.
One method to overcome inadequate flush-out and preservation of the peribiliary plexus 
is the application of high pressure arterial infusion of preservation fluid either in vivo during 
procurement or immediately afterwards on the back table. Several studies have shown that 
additional flushing of the peribiliary plexus by controlled arterial back-table pressure perfusion 
may result in a considerable reduction in the incidence of NAS (19).
Better flush out and preservation of the peribiliary capillary plexus may also be achieved by 
machine preservation. Although machine preservation of organs for transplantation is receiving 
increasing attention and is subject of intensive research, it remains to be established whether this 
technique will result in a reduction of biliary complications after liver transplantation.
DIagnoSTIC MoDaLITIES
In most cases, the suspicion of a biliary complication will arise after an increase in liver enzymes 
is noted. There is no specific pattern to reliably distinguish a biliary complication from other 
causes of graft dysfunction, although an increase in serum bilirubin, alkaline phosphatase and/
or gamma-glutamyl transferase has been suggested to be most specific. Alternatively, patients 
can present with upper abdominal pain or bacterial cholangitis. In many instances of liver 
enzyme disturbances, a liver biopsy will be performed after gross biliary congestion and bile duct 
dilatation have been excluded by ultrasonography. The presence of specific pathological features 
such as centrilobular cholestasis and portal changes including edema, predominantly neutrophil 
polymorph infiltration, ductular proliferation and cholangiolitis may be indicative of the presence 
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of a biliary complication (20). These findings, however, are not very specific and can be absent. 
In addition, biopsy findings are not informative with regard to the type and severity of biliary 
abnormalities.
The diagnostic work-up of an increase in liver enzymes will always depend on clinical context 
such as primary disease, time after transplantation, local experience and information on the 
biliary anatomy. A general algorithm is provided in figure 1.
DIAGNOSTIC APPROACH TO SUSPECTED BILIARY COMPLICATIONS 
Suspected biliary complication 
No dilated bile ducts Dilated bile ducts 
Consider: 
- time after transplantation 
 - recurrent disease 
 - risk of rejection 
  - clinical presentation 
MRCP Liver Biopsy 






ERCP ERCP or PTCD 
Transabdominal ultrasonography 
figure 1. Schematic presentation of the clinical decisions and diagnostic steps in the work-up of a liver 
transplant recipient with a suspected biliary complication.
Transabdominal ultrasonography
Transabdominal ultrasonography is a useful primary diagnostic tool when a biliary complication 
is suspected. Allograft vascularization can be assessed (especially patency of the hepatic artery), 
fluid collections can be identified, the liver parenchyma can be studied, and dilatation of bile 
ducts can be identified. It should be noted that the transplanted liver behaves differently from 
a normal liver, in that the biliary system does not dilate as easily in the presence of a biliary 
obstruction as in normal livers (21). This leads to a limited sensitivity of approximately 60% 
of transabdominal ultrasonography to detect biliary strictures (21,22). The predictive value 
of transabdominal ultrasonography to detect non-anastomotic biliary strictures is rather low. 
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Therefore, normal ultrasonography of the liver graft in a patient with clinical or biochemical 
evidence of biliary pathology warrants further investigation.
Magnetic Resonance Cholangiography and Computed Tomography
Magnetic resonance cholangiography (MRC) is a rapidly emerging diagnostic tool for the 
detection of biliary abnormalities. It has the strong advantage of providing excellent anatomical 
information without being invasive. In the present era, every transplant centre should be able to 
offer MRC and have an expert radiologist in the transplant team. MRC is useful in the detection 
of both leakages and strictures. Also, the use of an additional magnetic resonance imaging 
or magnetic resonance angiography scanning protocol can provide information about the liver 
parenchyma and vasculature. The reported sensitivity and specificity of MRC for the detection 
of biliary complications is well over 90% (23). After ultrasonography, MRC is the diagnostic 
tool of choice when a biliary complication is suspected. Recently, also computed tomography 
(CT) scanning has been suggested to be of value for the detection of post-transplant biliary 
complications – it has a higher spatial resolution compared to MRC. However, the experience 
with CT cholangiography after liver transplantation is very limited: 1) it can only be performed 
using a contrast medium, 2) it is associated with significant radiation, and 3) it is less reliable in 
the presence of biliary obstruction or high serum bilirubin levels. The use of CT cholangiography 
to detect a biliary complication should still be considered experimental.
Direct Cholangiography
Direct cholangiography, either percutaneously or through endoscopic retrograde cholangio-
pancreaticography (ERCP), is the gold standard for the detection of biliary abnormalities. It has 
the inherent advantage of biliary access to facilitate therapeutic measures. Since the use of a 
biliary drain (e.g. T-tube) is no longer routine practice in most transplant centers, ERCP will be 
the most frequently used method to detect biliary complications. There are no data to suggest 
that ERCP after liver transplantation is associated with more complications than the use of ERCP 
in the general population. Considering the safety, diagnostic yield, and therapeutic potential 
of ERCP, this should be considered the invasive method of choice. In the presence of altered 
biliary anatomy, such as a Roux-Y hepatico-jejunostomy, ERCP is more difficult to perform. 
In these cases, percutaneous transhepatic cholangiography (PTC) or PTC drainage is a good 
alternative method to obtain adequate imaging of the bile ducts. However, in several series 
successful ERCP in the presence of a Roux-Y reconstruction has been reported using either a 
normal duodenoscope or double-balloon endoscopes (24,25). PTC is most easily obtained in the 
presence of dilated bile ducts. In experienced hands, however, this can be a safe procedure also 
with undilated bile ducts (26). It not only allows adequate imaging of the bile ducts, but also 
provides access for therapeutic interventions such as balloon dilatation (see below).




Hepatobiliary scintigraphy can be used as a diagnostic tool to detect post-transplant biliary 
obstruction and leakage. It has a sensitivity of approximately 60% for these indications (27). The 
main advantage is its noninvasive nature; its main disadvantage is low resolution and lack of direct 
visualization of the biliary anatomy. The sensitivity of hepatobiliary scintigraphy to detect NAS 
is not known. With the increasing use and availability of MRC, scintigraphy is nowadays rarely 
used to detect biliary strictures. It could be of value in those patients in whom an obstruction at 
the level of the Roux-Y jejunal loop is suspected or when MRC is not possible (i.e. presence of a 
pacemaker).
other Diagnostic Tools
Endoscopic ultrasonography is an emerging tool for the detection of hepatobiliary diseases. It has 
excellent diagnostic properties for the distal bile duct. Endoscopic intraductal ultrasonography 
can be used for the characterization of intraductal abnormalities. Use of these techniques in liver 
transplant recipients is still anecdotal. A potentially more valuable tool is direct cholangioscopy. 
With this technique, a small endoscope (cholangioscope) can be advanced through a normal 
duodenoscope to directly visualize the bile ducts. This can provide information about the biliary 
epithelium and the presence of stones, sludge and strictures. It can also be a therapeutic tool to 
advance guide wires or to remove bile duct stones. The number of indications for these highly 
specialized techniques, however, is still limited.
PaThogEnESIS, CLInICaL PRESEnTaTIon anD ManagEMEnT
The most common types of biliary complication after liver transplantation are bile duct strictures 
and bile leaks. Strictures at the site of the bile duct anastomosis are often referred to as 
“anastomotic strictures” (AS). Strictures occurring at any other location in the biliary tree of the 
liver are called “non-anastomotic strictures” (NAS).
anastomotic Strictures: Pathogenesis and Clinical Presentation
Isolated strictures at the site of the bile duct anastomosis, so called anastomotic strictures, are 
reported in 4-9% of the patients after liver transplantation (28). In general, anastomotic strictures 
do not remain subclinical and are detected after the occurrence of cholestatic laboratory liver 
function tests, jaundice or cholangitis (28). Anastomotic strictures are thought to result mainly 
from surgical technique and/or local ischemia, leading to fibrotic scarring of the anastomosis. 
Surgical factors include inadequate mucosa-to-mucosa adaptation at the anastomosis and 
damage of microvascularization due to dissection too close to the bile duct (29). To minimize 
the risk of local ischemia at the distal end of the donor choledochal duct, the bile duct should 
therefore remain surrounded by an adequate amount of tissue. Generalized hepatic ischemia due 
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to hepatic artery thrombosis can also result in anastomotic stricturing. Other risk factors for the 
development of anastomotic structures are anastomotic bile leakage after transplantation and a 
sex mismatch between donor and recipient (28,30).
Liver transplantation using a split graft or a liver derived from a living donor is associated with a 
higher risk of developing an anastomotic bile duct stricture, because of the frequent discrepancy 
between the diameter of the hepatic duct of the graft and choledochal duct in the recipient. In 
addition, vascularization of the hepatic duct can be compromised when a partial graft is derived 
from a living donor or split liver.
anastomotic Strictures: Management
The most frequently used therapeutic approach to an anastomotic stricture is endoscopic balloon 
dilatation and stenting of the stenosis. This treatment has been widely studied and is both safe 
and effective. Technical success is obtained in 90-100%, and long-term resolution of the stricture 
in 70-100% of cases (31). Although disputed by some, most centers have best results with 
a protocol of progressive stenting every 8-12 weeks with increasing numbers and diameters 
of stents until resolution of the stenosis is obtained (32). In some cases, the stenosis recurs 
despite effective initial therapy. Some centers have used a covered expandable metal stent to 
treat a refractory biliary stenosis after transplantation. This, however, is not routine practice. 
Presentation of an anastomotic stricture more than 6 months after transplantation and previous 
bile leakage at the site of the anastomosis are risk factors for difficult to manage strictures (28). 
When an anastomotic stenosis does not respond to repeated dilatation and stenting, surgical 
revision or conversion to a Roux-en-Y hepatico-jejunostomy anastomosis is a good alternative 
with excellent long-term success (28). Incidentally, narrowing at the anastomosis can be detected 
while it remains unclear whether this is a clinically relevant stricture. In such cases, a short trial of 
stenting can be of value (33).
In the presence of a hepatico-jejunostomy, where the anastomosis is not accessible by endoscopy, 
percutaneous transhepatic treatment by balloon dilatation and temporary stenting is usually 
successful. This approach can also be used after split liver or living donor liver transplantation, 
although results are not as good, possibly because compromised microvascularization and local 
ischemia are more frequently the underlying cause (31,34).
non-anastomotic Strictures: Pathogenesis and Clinical Presentation
Non-anastomotic biliary strictures are strictures at any location in the biliary system other than the 
anastomosis. Biliary strictures may be confined to the hepatic bifurcation, but may also present 
as a more diffuse type including narrowing of the more peripheral bile ducts in the liver. Non-
anastomotic strictures can be accompanied by intraductal sludge or cast formation. This type of 
bile duct strictures is regarded the most troublesome biliary complication as the strictures are 
often resistant to therapy and one of the most frequent indications for retransplantation (31,35). 
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The clinical presentation of patients with NAS is often not specific; symptoms may include fever 
due to cholangitis, abdominal complaints and increased cholestatic liver function tests, either 
with or without clinical jaundice.
The reported incidence of NAS after liver transplantation varies between different studies, 
ranging from 1-20% (1,2,13), which can partly be explained by variations in the definition of 
non-anastomotic biliary strictures used in different studies. About half of all NAS occur within 
one year after transplantation, and the remainder can be detected up to several years after 
transplantation (31,35). In livers obtained from DCD donors, the incidence of non-anastomotic 
strictures is about 10% higher and they may occur earlier than in livers obtained from DBD 
donors (31,35).
NAS were first described after liver transplantation in association with hepatic artery thrombosis. 
In case of hepatic artery thrombosis occurring early after transplantation, the biliary tree (which 
is entirely dependent on arterial blood supply from the hepatic artery) becomes ischemic and 
eventually necrotic; resulting in a typical cholangiographic image of biliary strictures, dilatations 
and intraductal cast formation. Such cholangiographic abnormalities of strictures and dilatations, 
however, can also be seen in patients who do not have a hepatic artery thrombosis. The name first 
given to this last group of strictures was “ischemic-type biliary lesions”, because the appearance 
was similar to cholangiographic bile duct abnormalities seen in patients with hepatic artery 
thrombosis. Other names used in the literature for this condition are “ischemic cholangiopathy” 
or the more general term NAS. In this chapter the latter will be used.
Knowledge about the pathogenesis of non-anastomotic strictures is slowly emerging from clinical 
and experimental studies. Several risk factors for this type of biliary complication have been 
identified, strongly suggesting a multifactorial origin. In general, the mechanisms underlying 
NAS can be grouped into three categories: 1) preservation or ischemia related, 2) cytotoxic injury 
induced by hydrophobic bile salts, and 3) immune-mediated injury.
In one large clinical study in which patients were grouped based on the time interval between 
transplantation and the occurrence of biliary strictures, it was suggested that ischemia-mediated 
mechanisms are mainly responsible for the development of biliary strictures within the first year 
after transplantation, whereas immune-mediated mechanisms play a more important role in the 
pathogenesis of strictures occurring beyond the first year (11).
The radiological similarities between the abnormalities of NAS and bile duct abnormalities seen 
in the presence of hepatic artery thrombosis strongly suggest an ischemic factor in the origin 
of these strictures. The relevance of adequate blood supply and the impact of ischemia on the 
bile ducts are discussed in more detail above (see paragraph: Relevance of Donor / Back Table 
Procedure).
Another relevant factor in the pathogenesis of bile duct injury after liver transplantation is 
toxicity caused by hydrophobic bile salts. Hydrophobic bile salts have potent detergent properties 
towards cellular membranes of hepatocytes and biliary epithelial cells. Normally, the toxic effects 
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of bile salts are prevented by complex formation with phospholipids and cholesterol (mixed 
micelle). However, early after liver transplantation, the balance in biliary excretion of these three 
components is disturbed, leading to the formation of more toxic bile (15). Evidence for a pivotal 
role of bile salt-mediated toxicity in the pathogenesis of bile duct injury and subsequent bile 
duct stricturing has gradually emerged during the last decade. Both experimental animal studies 
and clinical studies have demonstrated that biliary bile salt toxicity early after transplantation 
is associated with the development of microscopic as well as macroscopic bile duct injury (15). 
Bile salt toxicity acts synergistically to ischemia-mediated injury of the biliary epithelium (16). 
Despite the increasing evidence that bile salts play a role in the pathogenesis of bile duct injury 
and subsequent biliary structuring, it remains to be established whether the administration of 
non-toxic hydrophilic bile salts (e.g. ursodeoxycholic acid) to liver transplant recipients results in 
a reduction of the incidence of this type of biliary complication.
Several studies have provided evidence for an immunological component in the pathogenesis 
of NAS. NAS have been associated with various immunologically mediated processes, such as 
ABO-incompatible liver transplantation, pre-existing diseases with a presumed autoimmune 
component (such as primary sclerosing cholangitis and autoimmune hepatitis), cytomegalovirus 
infection, chronic rejection, and finally with a genetic polymorphism in one of the CC chemokine 
receptors (13). Recurrent primary sclerosing cholangitis may be another cause of NAS occurring 
late (> 6-12 months) after transplantation (11). The true clinical relevance of immune-mediated 
bile duct injury in the pathogenesis of NAS after liver transplantation remains to be established 
and this is an area that requires further research.
non-anastomotic Strictures: Management
Contrary to anastomotic strictures, non-anastomotic structures are much more heterogeneous 
in localization and severity. General recommendations regarding management are hard to make, 
and good quality prospective studies are rare. In every case, adequate vascularization of the biliary 
system of the allograft should be obtained. In the case of diffuse and severe biliary strictures with 
progressive jaundice and bacterial cholangitis or biliary cirrhosis, usually re-transplantation is the 
most favorable option. In most patients, the strictures are more localized and cirrhosis has not 
yet developed. Many cases are amenable to endoscopic therapy. In endoscopic therapy, repeated 
endoscopies with balloon dilatation and multiple stents are used. With this approach, success 
rates are 50-75% (31). As in anastomotic strictures, PTC can be used when endoscopic access is 
not feasible. In case of NAS that are confined to the extrahepatic bile ducts, surgical resection 
of the diseased part and construction of a hepatico-jejunostomy should be considered. In case 
of recurrent cholangitis, maintenance antibiotics may result in long-term relief of symptoms. 
Although widely used, there is no clinical evidence that supports the use of ursodeoxycholic acid.
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Similar approaches can be used with NAS after split- and living-donor liver transplantation, but 
(as with anastomotic structures) with success rates that are significantly lower than after full size 
liver transplantation.
While most types of biliary complications can usually be managed successfully (either surgically 
or by endoscopic techniques) or run a self-limiting course, NAS remain the most challenging type 
of biliary complication as they are frequently therapy resistant and frequently associated with 
long-term sequelae. Up to 50% of patients with non-anastomotic strictures either die or require 
retransplantation. Mortality rates differ markedly among studies (2).
Bile Leakage: Pathogenesis and Clinical Presentation
Bile leakage after liver transplantation is reported in 1-25% of the recipients. The incidence 
of bile leakage is the highest after transplantation of a split liver or a graft from a living donor 
due to presence of the hepatic resection surface (1,2). Bile leakage can either be symptomatic 
or asymptomatic, and may be discovered coincidentally on a postoperative cholangiogram. 
Symptomatic patients may present with abdominal pain, localized or generalized peritonitis, 
fever, and sometimes elevated serum liver enzymes and/or bilirubin.
Biliary leakage can occur at various sites and intervals after transplantation. The majority of 
postoperative leaks occur at the site of anastomosis or the T-tube insertion site, but also the 
resection surface of the graft in case of living donor of split donor transplantation is a common 
site for leakage. Bile leakage early after liver transplantation most likely originates from the 
anastomosis or the T-tube insertion site. Anastomotic leaks are mainly related to errors in surgical 
technique and/or ischemic necrosis at the end of the bile duct. Insufficient blood supply or traction 
of the stitches causes ischemia, which can result in bile leakage. A hepatic artery thrombosis can 
lead to massive biliary necrosis resulting in dehiscence of the biliary anastomosis. Bile leakage 
at the T-tube insertion site can occur immediately after transplantation or after removal of the 
T-tube due to an insufficiently formed fistula around the tract of the bile drain. Occasionally, bile 
leakage occurs after percutaneous liver biopsy or iatrogenic duct damage.
Bile Leakage: Management
The management of bile leaks depends on the type of biliary anastomosis, clinical presentation, 
the severity and the localization of the bile leak. If a leak presents shortly after surgery, the 
abdominal drains should be left in place and opened. Ultrasonography should be made to 
confirm arterial perfusion of the graft. The majority of bile leaks is due to leakage at the site of 
the biliary anastomosis.
A small anastomotic bile leak can usually be managed conservatively, especially when the patient 
is asymptomatic. Symptomatic or infected bile collections should be treated with a radiologically 
placed percutaneous drain. An anastomotic bile leak without disruption of the anastomosis can 
be successfully managed primarily nonsurgically. Stenting of the bile duct, nasobiliary drainage, 
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sphincterotomy and a combination of these have all been used with a success rate of 85-100%. 
Since sphincterotomy may lead to specific complications (bleeding and perforation), it should 
not be routinely performed. The optimal timing of stent removal after resolution of symptoms 
is still unclear, but 8 weeks has been proven successfully (36). In the presence of a hepatico-
jejunostomy, ERCP can be attempted, but is frequently not successful. Alternatively, a PTC drain 
can be placed, even in the presence of non-dilated bile ducts (26).
In the rare case of a complete disruption of the anastomosis, prompt surgery with 
conversion to a hepatico-jejunostomy is most appropriate. In selected cases a redo of the 
choledochocholedochostomy can be considered. In the case of diffuse bilious peritonitis with 
hemodynamic instability or sepsis, direct laparotomy should always be considered.
Leakage after removal of a bile drain can be managed successfully in one-third of cases by 
conservative measure, including intravenous fluids, antibiotics, analgesics and observation (37). 
In the absence of improvement, ERCP with stent placement should be performed. A laparotomy 
is indicated when clinical signs of biliary peritonitis persist despite adequate drainages of the 
biliary system.
other Biliary Complications: Pathogenesis, Clinical Presentation and Management
Sphincter of Oddi dysfunction
The sphincter of Oddi is a small smooth muscle sphincter located at the junction of the bile duct, 
pancreatic duct, and duodenum. The sphincter controls flow of bile and pancreatic juices into 
the duodenum and prevents reflux of duodenal content into the ducts. Disorder in its motility 
is called sphincter of Oddi dysfunction. Clinically sphincter of Oddi dysfunction presents with 
cholestasis, dilatation of the distal extrahepatic bile duct, and cholangiographic absence of any 
anatomic cause for biliary obstruction.
Studies focusing on sphincter of Oddi dysfunction are scarce and often report only very 
few patients. Reported incidence of sphincter of Oddi dysfunction varies from 0-7% (1,2). 
Development of sphincter of Oddi dysfunction after liver transplantation may be imputed 
to operative denervation of the sphincter of Oddi during recipient hepatectomy, leading to 
impairment of ampullary relaxation and increased intraductal biliary pressure (1).
Sphincter of Oddi dysfunction after liver transplantation is an obscure diagnosis. Formal proof 
of this diagnosis will require pressure measurement in the bile duct lumen, which is difficult to 
perform in the absence of a biliary drain. In case of clinical suspicion and exclusion of any other 
possible cause of cholestasis, an endoscopic sphincterotomy or temporary stent placement can 
be performed.
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Biliary casts, sludge and stones
Casts, sludge and stones in the bile ducts are also known as bile duct filling defects. Sludge is 
a viscous collection of mucus, calcium bilirubinate and cholesterol. When left untreated, biliary 
casts can develop. Casts consist of retained lithogenic material morphologically confined to bile 
duct dimensions. Biliary sludge and casts tend to occur within the first year after transplantation, 
and when given enough time they may progress to biliary stones. Bile duct filling defects are 
a relatively rare complication compared with biliary strictures and leaks. A 5.7% incidence of 
bile duct filling defects after transplantation was reported in the largest study so far, including 
1650 transplanted livers (38). Most patients with biliary stones and sludge present with cholangitis 
and only a small percentage present with abdominal pain. Despite the relative infrequency, 
studies have shown an increased morbidity and mortality as a result of biliary sludge and casts 
caused by recurrent cholangitis, repeated need for surgery, graft loss, and death (39).
The exact pathogenesis is yet to be discovered, but multiple factors contribute to bile duct 
filling defect formation, including ischemia, infection, and preservation injury (13). Theoretically, 
anything that increases viscosity of bile or reduces bile flow can predispose to bile duct filling 
defects. It is likely that ischemia contributes to the formation of filling defects both through stasis 
of bile (as a result of strictures) and through its direct injury to the biliary epithelium, resulting in 
the release of cell debris into the bile duct lumen as well as increasing the epithelial susceptibility 
to precipitation of lithogenic materials. Other pathogenic factors thought to be associated with 
filling defects are biliary cholesterol content, bacterial infection in relation to stents, presence of 
a hepatico-jejunostomy, fungal infections and the use of cyclosporine (2).
Stones and sludge of the biliary tree can almost universally be managed successfully by 
endoscopic removal. However, the long-term success of this will depend on the underlying 
cause. If the formation of sludge or casts is caused by a local obstruction such as a biliary drain 
or an anastomotic stricture that can be treated successfully, removal of the obstruction may be 
curative. However, when biliary sludge and casts are a symptom of ischemic bile duct injury, the 
severity of the latter will determine the long-term success of cast removal and will determine the 
fate of the graft.
External compression of the biliary tract
External compression of the biliary tract is a very rare type of biliary complication, characterized 
by extrahepatic cholestasis and jaundice. The main causes of external compression of the bile 
ducts are mucoceles of the cystic duct remnant and periductal lymphoma’s.
Although clinically relevant mucoceles of the cystic duct have been reported in several case 
reports, the exact incidence of this type of complication remains unclear. In one study, non-
obstructive mucoceles of the cystic duct were reported in 4.5% of the liver transplant recipients 
(40). A mucocele of the cystic duct can develop when both ends of donor cystic duct are ligated, 
e.g. due to incorporation into the suture line of the biliary anastomosis. Continued endothelial 
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secretion causes enlargement of the cystic duct and may subsequently cause extrinsic compression 
of the extrahepatic bile duct. External compression of the bile duct by a mucocele can usually be 
treated successfully by surgical excision of the cystic duct remnant.
A lymphoma in the hepatic (neo-)hilum can be caused by post-transplantation lymphoproliferative 
disorder and may result in compression of the extrahepatic bile ducts. While therapy should 
primarily focus on the medical treatment of the underlying lymphomas (2), temporary endoscopic 
stenting of the bile duct may be indicated to restore bile drainage.
Kinking of redundant bile duct
Excessive length of the donor or recipient bile duct can cause kinking of the bile duct, leading 
to bile flow obstruction. This is a rare technical complication that is mainly found after a 
choledochocholedochostomy. Patients may present with cholestatic liver function tests, fever 
due to cholangitis, or bile duct dilatation due to obstruction of the bile flow. The kinked bile duct 
can be repaired in two manners: 1) surgical resection of the redundant part and re-anastomosing 
of the bile ducts, or 2) by an endoscopic approach. The latter involves placement of an endoscopic 
stent to stretch the bile duct at the site of the choledochocholedochostomy. After the repair, scar 
tissue will have formed around the bile duct, which prevents recurrence of kinking. The stent 
can usually be removed safely after 6 weeks. In selected cases, surgical or endoscopic correction 
of the choledochocholedochostomy is not possible and in these cases surgical conversion to a 
Roux-Y hepatico-jejunostomy is indicated.
Bacterial cholangitis
Bacterial cholangitis after liver transplantation usually presents with cholestatic liver function test 
abnormalities in combination with high fever, either with or without chills. The risk of cholangitis 
is increased in patients in whom a T-tube is used, who underwent a hepatico-jejunostomy, and 
in patients complicated by anastomotic or non-anastomotic bile duct strictures. All of these 
conditions may facilitate ascending migration of bacteria into the biliary tree. When a biliary drain 
is present, positive bacterial cultures from the bile may support the diagnosis, although it should 
be noted that colonization of the bile is not infrequent in these patients. In other patients the 
diagnosis cholangitis is rarely supported by positive bile cultures and usually made after exclusion 
of other causes of fever. Management of acute cholangitis after transplantation is similar to that 
recommended to nontransplant patients and should include appropriate antibiotic therapy.




Biliary complications are a frequent cause of morbidity after liver transplantation. Advances in 
surgical techniques and preservation methods during the last decades have led to better results, 
but biliary complications still occur in 10-40% of the recipients and are associated with mortality 
rates of 8-15%. Partial liver grafts (e.g. split livers and livers from living donors) as well as livers 
from extended criteria donors (e.g DCD donors), are associated with a relatively high risk of biliary 
complications. Of all biliary complications, bile duct strictures and bile leakage are most common 
after liver transplantation. While bile leakage and anastomotic bile duct strictures can usually 
be managed successfully without long-term sequelae, non-anastomotic biliary strictures are the 
most troublesome type of biliary complication. NAS are often multifocal and can be difficult to 
treat by endoscopic techniques. When associated with recurrent cholangitis, jaundice or even 
secondary biliary fibrosis, retransplantation may be the only treatment option left over. Future 
studies should focus on better defining the mechanism underlying NAS and on the development 
of effective preventive measures. In this respect it will be interesting to see if the development 
of machine preservation for liver grafts will result in better preservation of the bile ducts and a 
subsequent decrease in the incidence of this type of biliary complications.
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Biliary complications, especially nonanastomotic biliary strictures (NAS), are a major 
cause of morbidity after orthotopic liver transplantation (OLT). Of all donor and recipient 
characteristics known to increase the risk of developing NAS, the role of prolonged ischemia 
times is most extensively described in the literature. However, there is increasing evidence 
that several other, non-ischemia related factors play a critical role in the pathogenesis of 
NAS as well. The clinical presentation of NAS may vary considerably among liver transplant 
recipients, including large variations in time of occurrence, as well as in location and severity 
of the strictures. Additional underlying causes such as bile salt toxicity and immune-mediated 
injury are thought to explain the wide spectrum of biliary strictures after OLT. Current and 
emerging insight in the pathogenesis of NAS and potential targets to reduce biliary injury 
and preserve bile ducts are discussed in this overview.
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BILIaRy CoMPLICaTIonS afTER LIvER TRanSPLanTaTIon
Orthotopic liver transplantation (OLT) has proven to be a successful treatment for patients with 
end stage chronic or acute liver failure. Despite excellent 1-year patient and graft survival rates 
(85-90% and 75-85%, respectively), liver transplantation brings along the risk of complications 
such as infection, rejection of the graft, primary non-function or initial poor function of the 
graft, vascular complications and biliary complications. Of all liver transplant recipients, 10-40% 
develop biliary complications which are associated with mortality rates of 8-15% (1-3). There is 
a variety of biliary complications that can occur after OLT, the most common being bile leakage 
and bile duct strictures.
Bile leakage can occur at various sites and intervals after transplantation. The majority of 
postoperative leaks occur at the site of anastomosis or at the T-tube insertion site. Another 
common site for leakage is the resection surface of the graft in case of living donor or split liver 
transplantation. Depending on the size of the leak, bile leakage can be managed successfully 
conservatively, non-surgically or surgically (4-7).
Bile duct strictures are grouped into anastomotic biliary strictures and nonanastomotic biliary 
strictures (NAS). Anastomotic biliary strictures are isolated strictures at the site of the bile duct 
anastomosis. They result mainly from surgical technique and local ischemia, leading to fibrotic 
scarring of the anastomosis (8). Most anastomotic biliary strictures are treated with dilatation 
and stenting. Sometimes surgical revision or conversion to a Roux-en-Y hepatico-jejunostomy is 
required, all associated with excellent long term results (9-11).
Compared with anastomotic biliary strictures, NAS present much more heterogeneously and 
are regarded the most troublesome biliary complication after OLT. NAS are strictures at any 
location in the biliary system of the transplanted liver (either intrahepatic or extrahepatic). NAS 
were first described after OLT as a cholangiographic image of biliary strictures and dilatations 
caused by ischemia following hepatic artery thrombosis (HAT). However, such cholangiographic 
abnormalities of strictures and dilatations can also be seen in patients who do not have biliary 
ischemia caused by HAT, and the name first given to this last subgroup of strictures was 
“ischemic-type biliary lesions” (figure 1). Alternative names used in the literature are “ischemic 
cholangiopathy” or the more general term “nonanastomotic biliary strictures”, which is used in 
this overview.
The reported incidence of NAS after OLT varies between 1% and 20% (2,3,12,13), which can 
partly be explained by variations in the definition of NAS used. Although most types of biliary 
complications can usually be treated successfully (either surgically or by endoscopic techniques), 
or run a self-limiting course, NAS remain the most challenging type of biliary complication as they 
are frequently therapy resistant and often associated with long-term consequences. Therapeutic 
options are endoscopic dilatation or stenting, percutaneous transhepatic cholangiography (PTC) 
drainage or dilatation, or surgical resection followed by construction of a hepatico-jejunostomy. 
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Because of limited therapeutic options and therapy resistance, up to 50% of patients with NAS 
die or require retransplantation (2). High mortality rates and the impact on the already undersized 
pool of donor organs make NAS a complication in desperate need for better preventive strategies 
and treatment options. Therefore, it is important to understand the pathogenesis of NAS and 
discover ways in which development of NAS after OLT can be prevented.
Knowledge about the pathogenesis of NAS is slowly emerging from clinical and experimental 
studies performed during the last decade. Several risk factors have been identified, strongly 
suggesting a multifactorial origin (12). Although a true causative relationship may not have been 
proven for many putative risk factors, most current evidence is circumstantial and based on 
observational studies. In general, proposed mechanisms underlying the pathogenesis of NAS 
can be divided into three categories: a) ischemia-related injury, b) immune-mediated injury, 
and c) cytotoxic injury induced by hydrophobic bile salts. These mechanisms are summarized in 
Table 1 and are discussed in more detail below.
Table 1. Mechanisms of Biliary Epithelial Injury after Liver Transplantation
A. Ischemia-related injury caused by:
–	 Warm and cold ischemia associated with organ preservation
–	 Warm ischemia in donation after cardiac death donors
–	 Inadequate preservation of the peribiliary capillary plexus
B. Immune-mediated injury due to:
–	 ABO-incompatible transplantation
–	 CMV-infection
–	 Female organs in male recipients
–	 Chemokine receptor CCR5-Δ32 polymorphism
C. Cytotoxic effect of hydrophobic bile salts caused by:
–	 Inadequate flush out of bile from the bile ducts at organ retrieval
–	 High biliary bile salt / phospholipid ratio after transplantation
–	 Impaired cholehepatic shunt with intracellular accumulation of bile salts in cholangiocytes
–	 Impairment of the protective HCO3
- umbrella at the canalicular membrane of cholangiocytes
noT aLL PRESEnTaTIonS of naS aRE EquaL
NAS is a heterogeneous group of bile duct strictures and not all presentations of NAS are equal. 
A large variation is observed in the time interval between liver transplantation and the first 
presentation of NAS, ranging from 0.3-155 months (14,15). Location and severity also differ 
between patients. NAS may be confined to the hepatic bifurcation (large bile ducts), but may also 
present as a more diffuse type, affecting the small peripheral bile ducts of the liver (figure 1).
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figure 1. Contrast cholangiography of the bile ducts in patients after liver transplantation. 
Panel a: radiological example of a patient with predominantly abnormalities in the central bile ducts (arrow). 
Panel B: radiological example of a patient with a diffuse type of nonanastomotic biliary strictures (arrows).
One large clinical study reported differences in anatomical localization and underlying causes 
of NAS presenting early (<1 year) versus late (>1 year) after OLT (15). In the group with early 
presentation of NAS, the vast majority of lesions were found around the bile duct bifurcation 
and the extrahepatic bile duct. On the contrary, biliary abnormalities in the group with late 
presentation of NAS were more frequently located in the periphery of the liver. Moreover, NAS 
presenting within 1 year after OLT were associated with ischemia-related variables, such as a 
longer cold and warm ischemia time, compared to NAS occurring more than 1 year after OLT. The 
latter group was more frequently associated with variables that may explain an immunological 
cause. It has, therefore, been suggested that ischemia-mediated mechanisms are frequently 
responsible for the development of biliary strictures early (<1 year) after transplantation, whereas 
immune-mediated mechanisms play an important role in the pathogenesis of strictures occurring 
beyond the first year (15).
ISChEMIa aS a CauSE of naS
Ischemia-Reperfusion Injury
Bile ducts entirely depend on arterial blood supply for oxygenation. Hepatocytes, on the other 
hand, are supplied by both the hepatic artery and the portal vein. For this reason, HAT is 
specifically detrimental for bile duct epithelial cells (cholangiocytes) and may result in massive 
bile duct necrosis (16). Additionally, cholangiocytes are highly susceptible to reoxygenation 
after anoxia (reperfusion injury) (17). Reoxygenation of anoxic liver cells improves survival of 
hepatocytes, but causes increased cell death of cholangiocytes. The increased susceptibility to 
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reoxygenation injury by cholangiocytes is associated with increased production of toxic reactive 
oxygen species by cholangiocytes during reoxygenation with concomitant low basal levels of the 
antioxidant glutathione in these epithelial cells (17).
Ischemic preconditioning (IPC) has been proposed as an attractive surgical strategy to decrease 
liver ischemia-reperfusion injury. Thus far, there is still significant controversy regarding the use of 
IPC in the liver transplant setting (18). There is currently no evidence to support or refute the use 
of IPC in donor liver procurement (19). However, the effect of IPC on survival of cholangiocytes 
during liver transplantation has not been studied, as outcome parameters used to determine liver 
injury in previous studies were mainly hepatocyte-specific.
Cold Ischemia
The duration of cold ischemic storage of a graft is strongly associated with the development of 
biliary strictures. Prolonged cold ischemia time (>13 hrs) greatly increases the occurrence of NAS 
after transplantation (13). However, with the shorter periods of cold ischemia in OLT these days 
(on average 8-10 hours), the association between cold ischemia time and the development of 
NAS has become less evident (15).
Warm Ischemia
One of the best-known risk factors for NAS is donation after cardiac death (DCD). Warm ischemic 
time in the donor in addition to subsequent cold ischemia-reperfusion injury is thought to result 
in increased damage to biliary epithelial cells. Grafts from DCD donors are used to increase 
the number of organs available for liver transplantation, and about 20% of the livers available 
for transplantation in the US and many European countries is currently derived from a DCD 
donor (20,21). The use of DCD grafts and restrictive criteria can result in patient and graft survival 
rates similar to those of donation after brain death (DBD) liver transplantation; however, this is 
associated with a higher risk of biliary strictures. The incidence of NAS following DCD is 10-30% 
compared with a 1-10% incidence of NAS following donation after brain death (20,22-26).
Preservation
Insufficient flush out of the microvasculature of the liver (peribiliary capillary plexus) is thought 
to play a role in the development of NAS. A sufficient flush out is needed for adequate exposure 
of cholangiocytes and endothelium to preservation fluids. The preservation fluid prevents injury 
of these cells and subsequent formation of microthrombi in the small arteries as a result of cell 
necrosis and local coagulation. With that, it prevents prolonged hypoxia of the bile ducts. The 
use of high-viscosity preservation solution is thought to result in an insufficient flush out of the 
peribiliary capillary plexus, leading to a higher incidence of NAS, compared with low-viscosity 
preservation solutions (27). Lower viscosity could provide a faster initial flush during organ 
retrieval, resulting in faster cooling and improved washout of blood cells. Equally, arterial back-
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table pressure perfusion used to achieve sufficient perfusion of the peribiliary plexus significantly 
decreased the occurrence of NAS after transplantation, compared with standard perfusion 
methods (28). In contrast with the potentially favorable effect of low-viscosity solutions such 
as histidine-tryptophan-ketoglutarate solution on the biliary system, this type of solution has 
recently been associated with reduced graft survival in deceased donor livers, especially those 
from DCD donors (29). The cardiac standstill in DCD donors is not only thought to result in warm 
ischemic injury, but also in the formation of thrombi in the microvasculature of the donor organ. 
Animal studies have shown that the use of a fibrinolytic agent in a preflush before preservation 
of a DCD liver markedly improves flush out of such microthrombi and improves microperfusion 
with University of Wisconsin solution (30).
Potential Targets
An obvious target to reduce ischemia-induced bile duct injury in OLT is keeping ischemic times 
as short as possible. Moreover, low-viscosity organ preservation solution and arterial back-
table pressure perfusion either with or without thrombolysis seem to be beneficial. Adequately 
powered randomized controlled trials (RCTs) with long follow-up periods are required to 
evaluate the long-term effect of histidine-tryptophan-ketoglutarate (HTK) and University of 
Wisconsin (UW) solutions. The safety and side-effects of thrombolysis in DCD donation should 
be studied more extensively and future studies should also focus more on bile duct related 
outcome parameters. (31). In the future, normothermic or hypothermic machine perfusion could 
potentially greatly decrease ischemic injury to the liver graft. Some positive results have been 
shown in this field, however, more research and experience are required (32). In addition, more 
research on the role of IPC in the protection of cholangiocytes against ischemia is warranted.
IMMunoLogICaL faCToRS aS a CauSE of naS
NAS has been associated with various immunological processes. Although the exact role of the 
immune system in the pathogenesis of NAS remains unclear, there are several studies suggesting 
a role for the immune system in the pathogenesis of NAS.
For example, ABO-incompatible liver transplantation has been associated with the development 
of NAS. This may be explained by either a persisting ABH antigen expression in the intrahepatic 
biliary system of the hepatic allograft, resulting in a biliary system more susceptible to immunologic 
injury, or by occlusion and consequent ischemic injury caused by endothelial injury, or both. 
Increased bile duct damage after transplantation across the ABO barrier will eventually result 
in a higher rate of NAS (33-35). Moreover, pre-existing diseases with a presumed autoimmune 
component, such as primary sclerosing cholangitis and autoimmune hepatitis, have been 
associated with a higher incidence of NAS (36-38).
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In one retrospective study, a female to male donor/recipient match was significantly associated 
with late occurrence of NAS (15). It was suggested that the higher incidence of NAS in male 
recipients of a female graft is related to immunological processes.
Biliary complications develop significantly more often in the presence of preceding or concomitant 
cytomegalovirus (CMV) viremia, especially in conjunction with primary CMV infection (38,39). 
CMV inclusions have been detected in a histopathologic specimen of bile duct strictures from a 
liver transplant patient, in whom biliary strictures developed during CMV infection (39). However, 
the exact mechanisms explaining the relationship between CMV infection and NAS are still to be 
elucidated. Thus far it is unclear whether CMV injures the biliary epithelium in a direct manner 
by infecting biliary epithelial cells, or in an indirect manner by immune attack evoked against 
infected biliary epithelial cells. Alternatively, it is potentially possible that CMV infection causes 
ischemic injury of the biliary epithelium via injury of endothelial cells of the peribiliary capillary 
plexus and subsequent formation of microthrombi and inadequate oxygenation of the biliary 
epithelium.
Another line of evidence for an immune-mediated mechanism of bile duct injury and NAS 
formation was provided by a recently described association between a loss-of-function mutation 
in the chemokine receptor CCR5 (CCR5-Δ32) and the development of NAS after OLT. Retrospective 
studies have shown that liver transplant recipients carrying CCR5-Δ32 are at much greater risk 
of developing NAS after transplantation, compared with CCR5 wild-type recipients (40,41). This 
risk is even higher in recipients with CCR5-Δ32 transplanted for primary sclerosing cholangitis 
(PSC). Moreover, late development of NAS is significantly more present in recipients carrying 
CCR5-Δ32 (41). A possible explanation for this may be functional changes in the immune system 
resulting from the CCR5-Δ32 mutation, including impaired attraction of regulatory T cells to the 
site of injury (42-44).
Potential Targets
Because the exact role of the immune system in the pathogenesis of NAS remains unclear, this 
aspect requires further research and is not yet ready for targeted therapy. At this stage, only anti-
CMV prophylaxis to prevent NAS in liver recipients who are seronegative for CMV is supported by 
scientific data, as de novo CMV infections are clearly associated with a higher incidence of NAS.
ThE RoLE of BILE SaLTS In ThE DEvELoPMEnT of naS
Another potential factor in the pathogenesis of bile duct injury after liver transplantation is bile 
salt toxicity. Hydrophobic bile acids can induce damage to hepatocytes and cholangiocytes based 
on either their detergent effects towards lipid cellular membranes or by intracellular cytotoxic 
effects and induction of apoptosis.
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Inadequate flush out of Bile During Cold Ischemia
Experimental studies in pigs have indicated that hydrophobic bile salts are able to induce damage 
to the biliary epithelium of the liver graft during cold ischemia when hydrophobic bile salts 
are added to the preservation solution. This type of injury is characterized by loss of microvilli, 
cell-surface erosions, and cell death (45-47). Based on these observations the importance of 
adequate flush out of the biliary tract, to remove bile during the backtable procedure, has been 
emphasized.
altered Composition of Bile after Liver Transplantation
Hepatic secretion of bile salts, phospholipids and cholesterol is an active process mediated 
by specific hepatobiliary transporter proteins located in the canalicular cell membrane of 
hepatocytes. While the bile salt export pump (BSEP; gene ABCB11) is largely responsible for the 
secretion of bile salts, the multidrug resistance protein 3 (MDR3; gene ABCB4) is responsible for 
the secretion of phospholipids (48).
Experimental and clinical studies have provided increasing evidence that the expression 
and function of these transporters may be impaired after OLT, resulting in an abnormal bile 
composition that has been associated with bile duct injury and NAS after OLT. A well functioning 
graft immediately starts to secrete bile salts upon graft reperfusion, but the overall biliary 
secretion of bile salts remains low within the first week after OLT. Restoration of biliary secretion 
of phospholipids, however, may recover even slower. These differences may be explained by 
differences in the expression and function of the transporters bile salt export pump (BSEP) and 
multidrug resistance protein 3 (MDR3), resulting in a higher bile salt/phospholipid (BS/PL) ratio 
in the bile during the first days after OLT (figure 2a,B). The formation of protective mixed 
micelles is therefore impaired and free hydrophobic bile salts may cause injury of the cellular lipid 
membranes of cholangiocytes via their detergent activities. Compelling evidence that this high 
BS/PL ratio is correlated with the development of biliary injury and NAS has been provided in 
experimental animal studies (46,49,50) and two prospective clinical studies (51,52).
Intracellular accumulation of hydrophobic Bile Salts in Cholangiocytes
At physiological concentrations, a simple detergent-like effect involving disruption of cell 
membranes is likely not the only explanation for bile salt-induced biliary injury after transplantation. 
An alternative mechanism of bile salt-mediated bile duct injury after OLT is the intracellular 
accumulation of hydrophobic bile salts in cholangiocytes. Intracellular accumulation of bile salts 
may occur when the transporters responsible for canalicular uptake and basolateral excretion 
of bile salts by cholangiocytes are no longer in balance (figure 2C). These cholangiocyte 
transporters are, under physiological circumstances, believed to be responsible for the so called 
cholehepatic shunt (53). Bile salt accumulation leading to cellular damage in hepatocytes has 
been described in cholestatic diseases (54), and it is likely that a similar process may occur in 
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cholangiocytes. A recent experimental study in rats has indicated that in addition to the high 
biliary BS/PL ratio, an ischemia related discrepancy may occur in the recovery of the cholangiocyte 
bile acid reuptake transporter apical sodium-dependent bile acid transporter (ASBT) and the 
cholangiocyte basolateral export transporters (organic solute and steroid transporters OSTa and 
OSTb), resulting in the accumulation of toxic bile acids and subsequent injury of cholangiocytes, 
especially in the larger bile ducts (55).
figure 2. Schematic presentation of the hepatobiliary transporter proteins responsible for the uptake 
and secretion of bile components by hepatocytes and cholangiocytes. Panel a: Normal situation. 
Panel  B:  Reduced expression or functional impairment of hepatocellular transporters for bile salts and 
phospholipids (BSEP and MDR3) may result in abnormal bile composition with a relatively high bile 
salt/phospholipid ratio. This has been associated with increased bile duct injury and development of 
nonanastomotic strictures. Panel C: Unbalanced alteration in ASBT, OSTa and OSTb, the main transporters 
involved for the cholehepatic shunt, may result in accumulation of toxic bile salts inside cholangiocytes. 
Panel D: Finally, a functional impairment of the secretion of HCO3
- by cholangiocytes may diminish the 
protective effect of an alkaline environment at the canalicular membrane of cholangiocytes, making them 
more susceptible to uncontrolled membrane permeation of hydrophobic bile salts (full description of this 
hypothesis is provided in ref 56).
abbreviations used: BS, bile salt; PL, phospholipid; BSEP, bile salt export pump; MDR3, multidrug resistance 
protein 3 (phospolipid flippase); ASBT, apical sodium-dependent bile acid transporter; OSTa, organic solute 
and steroid transporter a; OSTb, organic solute and steroid transporter b; AE2, anion exchanger 2; CFTR, 
cystic fibrosis transmembrane conductance regulator.
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- Secretion as a Cause of Biliary Injury
Biliary HCO3
- secretion has been proposed as a mechanism to prevent the uncontrolled membrane 
permeation of hydrophobic bile salts by maintaining an alkaline pH near the apical surface 
of hepatocytes and cholangiocytes (56). An alkaline environment results in deprotonation of 
hydrophobic bile acids, making them less capable of attacking cell membranes (figure 2D). 
Biliary secretion of HCO3
- is largely controlled by the cholangiocyte Cl-/HCO3
- exchanger AE2 
and the transporter cystic fibrosis transmembrane conductance regulator (CTFR), which are 
adenosine triphosphate (ATP) dependent. Ischemia, as inevitably occurs in transplantation, 
will not only result in a reduction of ATP levels, but may also result in altered expression of 
AE2 and CFTR, which will subsequently lead to a diminished function of the “HCO3
- umbrella” 
protecting cholangiocytes (57). Although this mechanism has been hypothesized to contribute 
to the development and progression of NAS after OLT, formal evidence for this is still lacking and 
further research in this area is needed (56).
Potential Targets
The accumulating evidence that hydrophobic bile acids contribute to biliary epithelial injury after 
OLT provides new avenues for possible preventive strategies. Adequate retrograde flushing of 
the bile ducts during organ procurement alone may not be enough to avoid bile salt-mediated 
biliary injury. Additional therapies, such as substitution of hydrophobic bile salts by more 
hydrophilic bile salts, which are thought to exert cytoprotective instead of detrimental effects 
on cholangiocytes (i.e. ursodeoxycholic acid or nor-ursodeoxycholic acid), are an attractive and 
relatively simple option. However, formal evidence that substitution of (nor-)ursodeoxycholic 
acid in liver transplant recipients results in a reduction of the incidence of NAS is still lacking. 
Randomized clinical trails on the efficacy of (nor-)ursodeoxycholic acid in the prevention of NAS 
are needed. In addition, future research should focus on the potentially protective effects of 
stimulating HCO3
- secretion by cholangiocytes after OLT.
ConCLuSIonS
NAS continues to be a serious cause of morbidity and graft loss after OLT. Not all cases of NAS 
are equal. Timing, localization and severity of strictures vary between patients. Differences in 
the pathogenesis of NAS are thought to, at least partly, explain these variations in presentation. 
Although NAS occurring early after OLT are largely associated with an ischemia-related 
pathogenesis, NAS occurring late after OLT are believed to have a more immune-mediated 
origin. Endogenous bile salts may play an additional role in the pathogenesis of bile duct injury 
after OLT. Hydrophobic bile salts have a direct cytotoxic effect on the cholangiocytes and this 
may contribute to the post-ischemic injury of the biliary epithelium. Donor surgeons can help 
prevent NAS by reducing warm and cold ischemia time as much as possible, providing adequate 
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flush out of the liver, the peribiliary plexus, and the bile ducts. Recipient (transplant) surgeons 
can help reducing the incidence of NAS by keeping the cold ischemia time as short as possible 
and by performing arterial back-table pressure perfusion of the liver graft to ensure adequate 
perfusion of the peribiliary capillary plexus. More studies will be needed to provide better insight 
in the immune-mediated mechanisms of NAS that occur late after OLT.
Recent advancements in normothermic and hypothermic machine perfusion could potentially 
have an important impact on incidence of NAS through a reduction of preservation injury of the 
bile ducts and the peribiliary capillary plexus of liver grafts.
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Background: The role of the immune system in the pathogenesis of non-anastomotic 
strictures (NAS) after orthotopic liver transplantation (OLT) is unclear. A loss-of-function 
mutation in the chemokine receptor CCR5 (CCR5-Δ32) leads to changes in the immune 
system, including impaired chemotaxis of regulatory T-cells.
aim: To investigate the impact of the CCR5-Δ32 mutation on the development of NAS. 
Methods: In 384 OLTs we assessed CCR5 genotype in donors and recipients and correlated 
this with the occurrence of NAS.
Results: The CCR5-Δ32 allele was found in 65 (16.9%) patients. Cumulative incidence of NAS 
at 5 years was 6.5% in wild-type (Wt) recipients versus 17.2% for carriers of the CCR5-Δ32 
allele (p < 0.01). In recipients with CCR5-Δ32, 50% of all NAS occurred >2 years after OLT, 
compared to 10% in the Wt group. In multivariate regression analysis, the adjusted risk of 
developing NAS was 4-fold higher in recipients with CCR5-Δ32 (p < 0.01). The highest risk 
of NAS was seen in patients transplanted for primary sclerosing cholangitis (PSC), who also 
carried CCR5-Δ32 (RR 5.4, 95% CI 2.2-12.9; p < 0.01). Donor CCR5 genotype had no impact 
on the occurrence of NAS.
Conclusions: Patients with the CCR5-Δ32 mutation have a 4-fold higher risk of developing 
NAS, compared with Wt recipients. This risk is even higher in patients with CCR5-Δ32 
transplanted for PSC. Late development of NAS is significantly more present in patients with 
CCR5-Δ32. These data suggest that the immune system plays a critical role in development 
of NAS after OLT.
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Combination of Primary Sclerosing Cholangitis and CCR5-D32 in Recipients is Strongly Associated 
with the Development of Non-anastomotic Biliary Strictures after Liver Transplantation
InTRoDuCTIon
Biliary complications are a major cause of morbidity and graft failure following orthotopic liver 
transplantation (OLT) (1,2). Non-anastomotic bile duct strictures (NAS) are regarded the most 
troublesome biliary complication as they are frequently resistant to therapy and one of the 
most frequent indications for retransplantation (2-4). The reported incidence of NAS after OLT 
varies between different studies, ranging from 1-26% (5-10), which can partly be explained 
by variations in the definition of NAS used in different studies. Despite extensive research, the 
exact etiological mechanism of NAS remains unclear. However, several risk factors have been 
identified, strongly suggesting a multifactorial origin.
In general, risk factors for NAS can be divided into three categories: ischemia-related injury to the 
biliary epithelium, cytotoxic injury, and immune-mediated injury (11). NAS has been associated 
with various immunological processes, such as ABO-incompatible liver transplantation (12), 
pre-existing diseases with a presumed autoimmune component (such as primary sclerosing 
cholangitis [PSC] (1,13,14) and autoimmune hepatitis (1)), cytomegalovirus infection (14,15) and 
chronic rejection (12). The role of the immune system in the pathogenesis of NAS, however, 
remains unclear. A loss-of-function mutation in the chemokine receptor CCR5 (CCR5-Δ32) has 
been associated with functional changes in the immune system, including impaired attraction of 
regulatory T cells (16-18).
CC chemokine receptor 5 came into worldwide attention about a decade ago when it 
was identified as one of the major co-receptors for human immunodeficiency virus (HIV) 
infectivity (19). CCR5 is expressed on the cell surface of natural killer T (NKT) cells, CD4+ T cells, 
CD8+ T cells, macrophages, and regulatory T cells. A 32-bp deletion in this gene (CCR5-Δ32 
polymorphism) introduces a premature stop codon into the CCR5 chemokine-receptor locus and 
thus obliterates the receptor (20). About 10-15% of the European population is a heterozygous 
carrier of CCR5-Δ32, and about 1% is homozygous for CCR5-Δ32 (20,21). Homozygous carriers 
do not express CCR5 and heterozygous carriers exhibit a diminished expression of CCR5 on the 
cell surface, in both cases leading to functionally impaired immune cells (20). In the liver, ligands 
of CCR5 (CCL3, CCL4 or CCL5) are expressed by biliary epithelial cells (22).
To determine whether the immune system is involved in the pathogenesis of NAS we assessed 
the impact of the CCR5-Δ32 mutation in liver donors and recipients on outcome and the 
development of NAS after OLT.
PaTIEnTS anD METhoDS
Patients
Between May 1992 and June 2006, a total of 681 liver transplantations were performed at 
the University Medical Center Groningen. Peripheral blood from 568 patients was available for 
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genotyping. After the exclusion of children (age <18) and patients with NAS caused by hepatic 
artery thrombosis, 384 transplant procedures remained for inclusion in this study. In 354 cases, 
splenocytes from the corresponding donors were available for genotyping. The follow-up 
period ended on the 1st of August 2009, which yielded a minimum post-transplant follow-up 
of 4.3 years. Clinical information was obtained from a prospectively collected database. Where 
necessary, missing information was obtained from the original, electronic patient files. Patient 
survival was defined as the time period (in years) between transplantation and death of the 
recipient. Graft survival was defined as the time period (in years) between transplantation and 
retransplantation, or death of the recipient. This study was conducted in accordance with Dutch 
legislation and the local ethical committee guidelines.
Definition of naS
NAS were defined as strictures, dilatations, or irregularities of the intra- or extrahepatic bile ducts 
of the liver graft. Isolated strictures at the bile duct anastomosis were excluded. The diagnosis 
of NAS was based on at least one adequate imaging study of the biliary tree, after exclusion of 
hepatic artery thrombosis by either Doppler ultrasound or conventional angiography. Imaging 
studies of the arterial vasculature were repeated over time if no other explanation for the NAS 
was found and to confirm patency of the hepatic artery. Minor isolated biliary irregularities, 
previously scored by our group as mild NAS, were not defined as NAS in this study (23). The time 
of first presentation of NAS was recorded for all patients.
genotype analysis
The CCR5 gene location is on the short (p) arm at position 21 on chromosome 3. Genotypes 
were determined by polymerase chain reaction (PCR) allelic discrimination. Each essay required 
two unlabeled primers (Life Technologies, Foster City, CA, USA) and two allele-specific probes 
(PE Biosystems, Foster City, CA, USA), and the PCR was accomplished using Taqman universal 
master mix (PE Biosystems). A detailed description has been published previously (24). Patients 
were divided in two groups according to their CCR5 genotype: those homozygous for the major 
allele (non-carriers or wild-type) and those with 1 or 2 deletion alleles (carriers). Patients carrying 
one or two deletion alleles were grouped together, as the number of homozygous CCR5-Δ32 
carriers was too small to be analyzed as a separate group. The same methodology was used to 
group patients based on donor CCR5 genotyping.
Statistical analysis
Continuous variables were presented as median and interquartile range, whereas categorical 
variables were presented as number and percentage. Patient and graft survival curves and the 
cumulative incidence of NAS were calculated using the Kaplan-Meier method and compared 
using the log rank test. Categorical variables were compared with the Pearson chi-square test or 
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Fisher’s exact test where appropriate. Comparison of continuous variables was performed by the 
Mann-Whitney U-test. The level of significance was set at 0.05. A multivariate logistic regression 
analysis was performed to determine independent risk factors and relative risks. Statistical 
analyses were performed using SPSS software version 16.0 for Windows (SPSS, Inc., Chicago, IL).
RESuLTS
Recipient Characteristics
Donor and recipient characteristics, surgical variables, and postoperative outcomes are presented 
in Table 1. Of 384 recipients tested, 2 (0.5%) recipients were homozygous for the CCR5-Δ32 
allele, 63 (16.4%) were heterozygous, and 319 (83.1%) were homozygous for the Wt allele. Of the 
354 donors tested, 1 (0.3%) donor was homozygous for the CCR5-Δ32 allele, 73 (20.6%) were 
heterozygous, and 280 (79.1%) were homozygous for the Wt allele. The median postoperative 
follow-up was 10.7 years (interquartile range, 7.7-13.8 years).
Cumulative Incidence of naS and Impact of Donor and Recipient CCR5 genotype
Non-anastomotic strictures were observed in 28 of 384 (7.3%) transplanted livers at a median 
time interval of 4.1 months (interquartile range, 1.2 - 24.4 months) after transplantation.
Donor CCR5 genotype was not associated with development of NAS (figure 1a). However, 
CCR5 genotype in recipients was strongly associated with development of NAS (figure 1B). 
The cumulative incidence of NAS at 5 years after OLT was 6.5% in recipients with CCR5 Wt 
versus 17.2% for carriers of the CCR5-Δ32 allele. Interestingly, the time interval between OLT 
and the occurrence of NAS was different in recipients with CCR5-Δ32, compared to recipients 
with CCR5 Wt. In recipients with CCR5 Wt, only 10% of all cases of NAS occurred > 2 years after 
OLT. In the recipients with CCR5-Δ32, 50% of the cases of NAS occurred > 2 years after OLT.
Recipient CCR5-Δ32 Is an Independent Risk factor for naS
In a univariate analysis, CCR5-Δ32 was significantly associated with the development of NAS 
(15.4% vs. 5.6% in the CCR5 Wt group; p = 0.006). The following variables, which were 
previously reported in other studies as important risk factors for the development of NAS, were 
subsequently included in a multivariate logistic regression model together with CCR5-Δ32: PSC 
as the indication for transplantation; postoperative CMV infection; type of donor (donation after 
brain death [DBD] versus donation after cardiac death [DCD] and living donor liver grafts); type 
of preservation solution (high-viscosity University of Wisconsin solution versus low-viscosity 
histidine-tryptophan-ketoglutarate solution); and warm and cold ischemia times (1,14,23,25). 
In this multivariate regression analysis, only two variables were identified as independent risk 
factors for NAS: CCR5-Δ32 and postoperative cytomegalovirus infection (Table 2).
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Table 1. Comparison of Donor, Recipient, Surgical, and Postoperative Variables in OLT Recipients With or 
Without the CCR5-Δ32 Polymorphism


















































































































































*) Continuous variables are presented as median and interquartile range, whereas categorical variables are 
presented as number and percentage. Statistical analyses were performed using Mann-Whitney U test 
for continuous variables, Pearson chi-square was used for categorical variables.
**) 63 heterogous for CCR5-Δ32, 2 patients were homozygous for CCR5-Δ32)
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abbreviations table 1: CCR5, CC chemokine receptor 5; AST, aspartate aminotransferase; CMV, 
cytomegalovirus; HTK, histidine-tryptophan-ketoglutarate; ICU, intensive care unit; PBC, primary biliary 
cirrhosis; POD, postoperative day; PSC, primary sclerosing cholangitis; SBC, secondary biliary cirrhosis; UW, 
University of Wisconsin.
figure 1. Cumulative incidence of NAS. (a) CCR5Δ32 in the donor is not associated with development 
of NAS (log-rank, p = 0.82). (B) CCR5Δ32 in recipients is associated with development of NAS (log-
rank, p < 0.01). In patients with CCR5 Wt, only 10% of all cases of NAS occurred late (> 2 years) after 
transplantation. In contrast with this, in patients with CCR5Δ32, 50% of all cases of NAS were detected 
> 2 years after transplantation.
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Table 2. Multivariate Logistic Regression Analysis of Risk Factors for Non-anastomotic Bile Duct Strictures
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abbreviations: CCR5, CC chemokine receptor 5; NAS, non-anastomotic strictures; RR, relative risk; CI, 
confidence interval; PSC, primary sclerosing cholangitis; CMV, cytomegalovirus; UW, University of Wisconsin. 
HTK, histidine-tryptophan-ketoglutarate; DBD, deceased brain death; DCD, donation after cardiac death; 
LD, living donor.
Combination of CCR5-Δ32 and PSC Is highly Predictive for naS
In previous studies, PSC as the indication for transplantation was identified as an independent 
risk factor for NAS (1,14). As described above, PSC was not identified as an independent risk 
factor when CCR5-Δ32 was included in the analysis. However, when CCR5-Δ32 was excluded 
from the multivariate logistic regression, PSC was present as independent risk factor (data not 
shown). We therefore examined the relationship between PSC and CCR5-Δ32. Although there 
were no differences in the distribution of CCR5-Δ32 in patients with or without PSC (Table 1), 
the combination of CCR5-Δ32 and PSC was associated with a significantly higher incidence of 
NAS (figure 2). In patients without CCR5-Δ32 and not transplanted for PSC, 5.8% developed 
NAS. In patients without CCR5-Δ32, but transplanted for PSC, a similar percentage developed 
NAS (4.9%). Patients carrying CCR5-Δ32, but not transplanted for PSC, had a higher incidence 
of NAS (10.2%), but most interestingly, recipients with CCR5-Δ32 and transplanted for PSC 
developed NAS in 31.2% of the cases.
CCR5-Δ32 Is associated with higher Retransplantation Rate
Retransplantation rate within the first year after OLT was significantly higher in recipients carrying 
CCR5-Δ32 compared with recipients with CCR5 Wt (10.8% versus 2.5%; p < 0.01). The most 
frequent indications for retransplantation in recipients carrying CCR5-Δ32 were HAT (4.6% vs 
0.0% in recipients with CCR5 Wt; p < 0.01) and NAS (4.6% vs 0.6% in recipients with CCR5 Wt; 
p = 0.01) (Table 3).
Despite disadvantageous associations between CCR5-Δ32 and the development of NAS and 
a higher retransplantation rate in recipients with CCR5-Δ32, the 5-year patient survival rate 
in recipients carrying CCR5-Δ32 was significantly higher than the 5-year patient survival rate 
in CCR5 Wt recipients (90.8% versus 76.5%; p = 0.01) (figure 3). Analysis of the causes of 
death revealed no major differences between the two groups, apart from a lower incidence of 
infection-related mortality in recipients carrying CCR5-Δ32 (3.1% vs. 9.7%; p = 0.08) (Table 4).
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figure 2. Development of non-anastomotic biliary strictures in recipients with/without PSC and with/
without CCR5-Δ32. The combination of both CCR5-Δ32 and PSC was associated with a significantly higher 
incidence of NAS after OLT (overall Pearson chi-square, p = 0.001).
Table 3. Causes of Graft Loss Leading to Retransplantation Within One-Year After Liver Transplantation in 
Recipients Carrying CCR5-Δ32 vs CCR5 Wild-type






8     2.5%)
0    (0.0%)
0    (0.0%)
2    (0.6%)
6    (1.9%)
7   (10.8%)
3     (4.6%)
1     (1.5%)
3     (4.6%)
0     (0.0%)
   0.002
< 0.001
   0.027
   0.010
   0.265
abbreviations: CCR5, CC chemokine receptor 5; Wt, wild type; HAT, hepatic artery thrombosis; PNF, 
primary non function; NAS, non-anastomotic strictures.
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figure 3. Patient survival after liver transplantation in recipients carrying CCR5-Δ32 versus Wild-type CCR5. 
The 5-year patient survival rate was significantly higher in patients carrying CCR5-Δ32, compared with CCR5 
Wild-type patients (90.8% versus 76.5%; log-rank test p = 0.013).
Table 4. Causes of Death Within Five-Years After Liver Transplantation in Recipients Carrying CCR5-Δ32 vs 
CCR5 Wild-type
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59  (90.8%)
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1      (1.5%)
2      (3.1%)
0      (0.0%)
1      (1.5%)
0      (0.0%)









abbreviations: CCR5, CC chemokine receptor 5; GI, gastro-intestinal.
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DISCuSSIon
The role of the immune system in the pathogenesis of NAS is unclear. In T-cell-mediated liver 
diseases such as autoimmune and viral liver diseases, CCR5 and its respective ligands have been 
implicated in the recruitment of effector T cell subtypes into the liver, as well as their modulation 
of the inflammatory response (22). Recent studies have indicated that CCR5 plays a critical role 
in chemotaxis of regulatory T cells to the site of injury (16-18). In the current study, a functional 
mutation of the CCR5 gene (CCR5-Δ32) was assessed with the aim to find proof for involvement 
of the immune system in the pathogenesis of NAS after OLT.
Patients with the CCR5-Δ32 mutation had a 4-fold higher risk of developing NAS, compared 
with Wt recipients. This risk was even higher in patients with CCR5-Δ32 transplanted for PSC. 
Moreover, late development of NAS was significantly more present in patients with CCR5-Δ32 
compared with Wt patients. Donor CCR5 genotype was not associated with development 
of NAS. These data suggest that the immune system of the recipient plays a critical role in 
development of NAS especially late (> 2 years) after OLT.
The significantly higher incidence of NAS in recipients with CCR5-Δ32 may be explained by 
an immunological imbalance caused by the lack of a functional CCR5 in these patients. CCR5 
deficiency in humans, as well as in experimental animal models of inflammation and infection, 
is associated with significant increases of tissue levels of CCR5 ligand CCL5, which promotes 
enhanced influx of T cells into tissues by binding to one of its alternative receptors, CCR1 
(19,26-28). Moreover, the CCR5-Δ32 mutation has been associated with impaired attraction 
of regulatory T cells to the site of tissue injury (16-18). Regulatory T cells reduce inflammation 
and suppress activation of potentially harmful, self-reactive lymphocytes. The strong association 
between CCR5-Δ32 and NAS observed in the current study could therefore possibly be explained 
by an increased inflammatory response of the host towards the biliary epithelium of the liver 
graft. We speculate that this increased response may subsequently lead to bile duct injury and 
the development of biliary strictures.
Moench et al. first described an association between CCR5-Δ32 in recipients and the occurrence 
of NAS after liver transplantation (6), but these findings were not confirmed by a study 
of Heidenhain et al. Both studies, however, included a relatively small number of transplant 
procedures (146 and 169, respectively), whereas 384 cases were included in the current study. 
Moreover, the minimum post-transplant follow-up in the study of Heidenhain et al. was only 
2 years and 11 patients with established diagnosis of NAS were selectively included into the study 
due to a low incidence of NAS. The minimum post-transplant follow-up in the current study was 
4.3 years.
In addition to a higher incidence of NAS in recipients with CCR5-Δ32, the time of development 
differed from CCR5 Wt recipients. In recipients with CCR5 Wt only 10% of the cases of NAS 
were detected >2 years after transplantation. In contrast, in recipients with CCR5-Δ32 50% of 
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the cases occurred >2 years after OLT. This finding is in accordance with a previously suggested 
hypothesis that the underlying cause of early NAS might be different from the etiology of late 
NAS (23). While NAS occurring early after OLT has been suggested to have a predominant (post-)
ischemia-mediated pathogenesis, NAS occurring late after OLT may be more frequently immune-
mediated in origin (23). The latter is in accordance with the observed higher incidence of late 
NAS in recipients with CCR5-Δ32 in the current study.
Interestingly, the strong association between CCR5-Δ32 and NAS was most pronounced in 
patients transplanted for PSC. In previous studies, PSC has been identified as an important, 
and in some studies even as an independent, risk factor for NAS (1,13,14,29). In the current 
study, we were not able to identify PSC as an independent risk factor for the development 
of NAS when CCR5-Δ32 was included as a co-variable in the multivariate logistic regression 
model. However, in a more detailed analysis of the interaction between PSC and CCR5-Δ32, 
we found that CCR5-Δ32 has a greater impact in patients transplanted for PSC than in patients 
transplanted for other diseases. While PSC alone was not a risk factor for NAS, the combination 
of PSC and CCR5-Δ32 resulted in a dramatically increased incidence of NAS. This finding may 
very well explain the observed correlation between PSC and NAS in previous studies.
Recipients carrying CCR5-Δ32 showed a higher retransplantation rate within the first year after 
OLT, compared with recipients carrying CCR5 Wt. The overall graft survival, however, was similar 
in the two groups. HAT and NAS as a reason for graft loss were significantly more present in the 
CCR5-Δ32 group, but patients survived because they were retransplanted.
The observed positive association between CCR5-Δ32 and excellent long-term patient survival 
after OLT may be explained by a protection against infection-related mortality. Infections as 
cause of death were less prevalent in recipients carrying CCR5-Δ32, compared with CCR5 Wt 
recipients, although this difference did not reach statistical significance. A protective role for 
CCR5-Δ32 in infectious (especially viral) and inflammatory diseases outside the setting of liver 
transplantation is well described in several studies (30-32). The exact mechanisms underlying this 
apparently protective effect of CCR5-Δ32 in infectious diseases remain unclear.
The higher incidence of NAS in recipients carrying CCR5-Δ32 and especially the pronounced 
risk present in recipients with both CCR5-Δ32 and PSC (30% NAS) are of significant clinical 
relevance. The clinical consequences of our findings might involve donor organ selection for these 
recipients. One might want to avoid the use of donor organs with increased risk of NAS such as 
livers derived from DCD donors in recipients with both CCR5-Δ32 and PSC. More research in this 
direction, especially in patients who received a liver from a DCD donor is warranted.
This study is limited by its retrospective design. Imaging of the biliary tree was not performed 
routinely at regular time intervals after OLT and imaging was always guided by clinical symptoms 
or laboratory abnormalities. Therefore, asymptomatic biliary lesions might have been missed. The 
overall incidence of NAS in the current study was 7.3%, which is lower than previously reported 
by our group, but similar to percentages are reported in other studies (5,9,10). This difference 
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can be explained by differences in the definition of NAS. In the current study, minor biliary 
irregularities were not included in the definition of NAS.
In summary, this study provides evidence that the immune system plays a critical role in the 
development of NAS after OLT. A loss-of-function mutation in the chemokine receptor CCR5 
(CCR5-Δ32) leads to changes in the immune system, including impaired chemotaxis of regulatory 
T-cells. Patients with CCR5-Δ32 had a 4-fold higher risk of developing NAS, compared with 
CCR5 Wt recipients. This risk was even higher in CCR5-Δ32 carrying patients transplanted for 
PSC. In addition, retransplantation for NAS was seen more frequently in patients with CCR5-Δ32 
and more late development of NAS occurred in patients with CCR5-Δ32. These data suggest a 
critical role for the immune system in development of NAS after OLT and warrant further clinical 
and experimental studies to define the role of CCR5 in the development of bile duct injury.
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Biliary complications continue to be a major problem after orthotopic liver transplantation (OLT). 
The incidence of biliary complications varies between 10% and 40% in different series and this 
type of complications is associated with frequent hospital admissions and high morbidity and 
mortality rates (1-3). Among the variety of biliary complications that can occur after OLT, bile 
duct strictures are of the most concern. Bile duct strictures can be classified as anastomotic 
strictures (AS) or non-anastomotic strictures (NAS). Solitary strictures at the biliary anastomosis 
have been reported in 9%-12% of the patients (4-6), and NAS have been reported in 1%-20% of 
patients receiving a liver from donation after brain death and in up to 30% of patients receiving 
a liver from donation after cardiac death (DCD) (4,7,8). NAS may occur in the extrahepatic donor 
bile duct as well as the intrahepatic bile ducts, but they are usually limited to the larger bile ducts. 
NAS may be accompanied by intraductal biliary sludge and cast formation.
For many years researchers have been trying to understand the underlying mechanisms of AS and 
NAS. Current evidence suggests that AS are mainly related to the surgical technique and local 
ischemia of the distal bile duct stump, leading to fibrotic scarring of the anastomosis (1,6). The 
etiology of NAS is thought to be multifactorial and three relevant types of biliary injury have been 
identified as a potential cause of NAS: ischemia/reperfusion related injury; immune-mediated 
injury; and cytotoxic injury caused by hydrophobic bile salts (1, 9). Current understanding of the 
occurrence of these types of biliary injury is that they originate mainly after transplantation of the 
liver. Depending on the severity of bile duct injury, the healing process may lead to scar formation 
and subsequent stricturing of the affected bile duct segments. Thus far, it remains unclear as to 
which extend bile ducts of donor livers are injured already before transplantation.
In a recent issue of the Journal of Hepatology, Brunner et al. describe a clinical cohort study including 
79 liver transplant procedures in which biopsies were taken from the distal end of the extrahepatic 
bile duct of the donor liver at the time of organ retrieval and during transplantation (10). Biopsies 
were evaluated by light microscopy and immunofluorescence to determine the amount of biliary 
epithelial injury, using a self-developed semi-quantitative bile duct damage scoring system. The 
investigators subsequently correlated the grade of biliary injury with the occurrence of biliary 
complications after OLT. The most striking finding in this study was the high percentage of donor 
livers with severe injury and loss of biliary epithelium in the distal bile duct before implantation. 
Of all biopsies taken at the end of cold preservation, 86% had signs of bile duct epithelial 
cell loss. The degree of bile duct injury increased only slightly after reperfusion of the graft. 
Few clinicians working in the field of clinical liver transplantation are aware of the fact that the 
vast majority of donor livers have severe bile duct epithelial injury already prior to implantation. 
Interestingly, Brunner and colleagues also found that their histological bile duct damage score 
can be helpful to predict development of bile duct complications after transplantation.
This study is in accordance with another recent clinical study on donor bile duct histology 
published by Hansen et al. (11). In a cohort of 93 liver transplant procedures these investigators 
also performed histological evaluation of donor bile duct biopsies. In this study biopsies were 
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taken after graft reperfusion, before constructing the biliary anastomosis. This research group 
described another histological injury grading system that, in addition to biliary epithelium loss, 
includes the degree of injury of the peribiliary vascular plexus (arteriolonecrosis and thrombosis) 
and necrosis of the bile duct wall stroma. Major bile duct epithelial loss was observed in 88% 
(77/93) of the cases, a percentage that is strikingly similar to the 86% of biliary epithelium loss 
observed by Brunner et al. The results from the study by Hansen and colleagues suggested that 
the presence of arteriolonecrosis in the bile duct wall is strongly associated with the development 
of biliary strictures after transplantation (11).
These two studies not only provide evidence that histological assessment of the donor bile duct 
may help predict the occurrence of biliary strictures after transplantation, they also offer additional 
perspective from which to view the pathogenesis of these strictures. The high percentage of 
donor livers with severe biliary epithelial injury before transplantation is striking. In fact, many 
extrahepatic donor bile ducts appeared to be nothing more than a scaffold of connective tissue 
without any epithelial lining of the lumen. With this knowledge it is a surprise that not every 
donor liver develops biliary strictures after OLT. If the vast majority of donor livers already have 
severe bile duct injury prior to transplantation, yet “only” 10-20% develop NAS or AS, it could 
very well be that the critical factor that determines whether a graft will develop NAS or not is 
insufficient biliary regeneration rather than the initial biliary injury. This new perspective from 
which to view he pathogenesis of biliary strictures is summarized in figure 1.
The study by Brunner et al. (10), as well as the recent paper by Hansen et al. (11) open interesting 
new avenues for further research. Firstly, the studies show that current methods of organ 
preservation are far from sufficient to protect the biliary epithelium and bile duct wall in the 
time period between organ procurement and transplantation. It is possible that current organ 
preservation fluids used to flush the bile ducts during procurement are suboptimal to preserve 
the biliary epithelium. Alternatively, it might be that the current preservation method based 
on cooling is not the best way to protect the biliary epithelium. The only way to eliminate the 
need for cooling down an organ during preservation would be normothermic, oxygenated organ 
perfusion. Our group has recently demonstrated that normothermic, oxygenated perfusion of 
human donor livers is technically feasible; however, more research in this area is needed to 
determine whether this will also result in better preservation of the biliary epithelium (12).
Secondly, the papers by Brunner et al. and Hansen et al. should be seen as a stimulus to study 
in more detail the processes underlying regeneration of the biliary epithelium. Apparently many 
livers have adequate and timely restoration of their biliary epithelium, as these livers do not 
develop biliary strictures despite massive epithelial loss prior to transplantation. Unfortunately, 
the mechanisms of biliary epithelium regeneration in the larger and extrahepatic bile ducts are 
not very well known. Most previous research has focused on the smaller, intrahepatic bile ducts 
and ductules. Studies have suggested a role for the proliferation of remnant biliary epithelial 
cells, but bipotent stem cells in the canals of Herring (oval cells), bone marrow derived stem 
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cells, and peribiliary glands could be involved as well (13,14). If the mechanisms of successful 
reepithelialization of the large and extrahepatic bile ducts are better understood, therapeutic 
strategies to stimulate regeneration in all livers could potentially be developed. For example, 
preconditioning of livers to stimulate regeneration of biliary epithelium before transplantation 
by flushing the bile duct with growth factors or mesenchymal stem cells is an interesting option 
that needs further exploration.
Thirdly, there is a need to develop non-invasive methods that enable assessment of the biliary 
epithelium during organ preservation and before implantation. Histological examinations can 
only be performed by taking biopsies from the distal end of the donor bile duct. It is impossible 
to obtain biopsies from the more proximal or intrahepatic bile ducts without risk for the graft and 
recipients. An attractive alternative could be the development of molecular imaging techniques 
using near-infrared fluorescence that allow a non-invasive assessment of the biliary epithelium. 
If such molecular imaging techniques are combined with visible light cholangioscopy this 
figure 1. Schematic presentation of the changing perspective on the pathogenesis of biliary 
strictures after liver transplantation. Panel a. The “classical” concept based on the degree of biliary 
epithelial injury. Few biliary epithelial cells (BEC) are damaged and lost during cold preservation and most 
part of biliary damage occurs after transplantation due to reperfusion injury, immunological causes and 
hydrophobic bile salt toxicity. Panel B. The “new” concept based on insufficient regeneration of the biliary 
epithelium. Biliary injury and cell loss is almost universally present in all donor livers. Yet only a minority of 
livers develop biliary strictures, suggesting that regeneration of the biliary epithelium is rapid and successful 
in most donors livers. The key question that arises from this novel perspective is “what determines successful 
regeneration of the biliary epithelium and how can we stimulate adequate regeneration in all livers?”
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could provide an intraoperative tool for surgeons to judge viability of the biliary tree prior to 
transplantation (15).
This also touches on a limitation of the study by Brunner et al: specimens were only taken 
from the distal free margin of the extrahepatic bile ducts. It remains unknown whether injury 
detected in these specimens is representative for the epithelial lining higher up in the biliary tree. 
In addition, the series reported by these investigators did not include DCD livers and it would be 
very interesting to know the type and degree of bile duct injury in that type of donor livers prior 
to transplantation.
In conclusion, the study presented by Brunner et al (10), together with the recent data published 
by Hansen et al (11), gives important new information on preservation injury of the bile ducts in 
human liver transplantation. These studies provide new perspective from which to view biliary 
injuries and the development of strictures after transplantation. If loss of the biliary epithelium 
and injury of the bile duct wall is so universally present in human donor livers, yet (fortunately) 
only a minority develops biliary strictures after transplantation, an important new question that 
arises is: ‘Why does regeneration of biliary epithelium fail in certain livers and how can we 
stimulate the regenerative capacity of the biliary epithelium after OLT?’
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Background & aims: Although regeneration of intrahepatic bile ducts has been extensively 
studied and intrahepatic progenitor cells have been identified, few studies have focussed on 
the extrahepatic bile duct (EHBD). We hypothesized that local progenitor cells are present 
within the EHBD of humans. Human EHBD specimens (n=17) were included in this study.
Methods: Specimens of normal EHBD tissue were obtained from healthy donor livers 
(n=6), mildly injured EHBD from patients with cholangitis (n=6) and severely injured EHBD 
from patients with ischemic type biliary lesions (n=5). Double immunostaining for K19 and 
the proliferation marker Ki-67 was performed to identify and localize proliferating cells. 
In addition, immunofluorescent doublestaining using antibodies against K19 and c-Kit was 
performed to identify and localize cholangiocytes co-expressing putative progenitor cell 
markers.
Results: In normal EHBD, few Ki-67+ cells were detected, whereas large numbers of Ki-67+ 
were found in the diseased EHBD. In EHBD affected by cholangitis, Ki-67+ cells were mainly 
located in the basal layer of the lumen. EHBD specimens from patients with ischemic type 
biliary lesions displayed histological signs of epithelial cell loss and large numbers of Ki-67+ 
cells were observed in the peribiliary glands. C-Kit expression was localized throughout the 
EHBD wall and immunofluorescent doublestaining identified a few K19+/c-Kit+ cells in the 
luminal epithelium of the EHBD as well as in the peribiliary glands.
Conclusions: These findings support the hypothesis that progenitor cells exist in the EHBD 
and that the peribiliary glands can be considered a local progenitor cell niche in the human 
EHBD.
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The liver and its various cell types, including hepatocytes and biliary epithelial cells (or 
cholangiocytes), have a well-described regenerative capacity in response to different types of 
injury and cellular loss. While mild to moderate hepatocellular injury or depletion is considered 
a stimulus for the replication of mature hepatic cells, more severe acute and chronic types of 
injury have been associated with a regenerative response that includes the recruitment of hepatic 
progenitor cells (1,2). Accumulating evidence suggests that there are four possible intrahepatic 
stem/progenitor cell niches: the canals of Hering, intralobular bile ducts, periductal mononuclear 
cells, and peribiliary hepatocytes (3,4). Hepatic progenitor cells have been shown to have bi-
potent capacities, allowing them to differentiate into either hepatocytes or cholangiocytes (5).
Most studies on hepatic regeneration alluding to these progenitor cells dealt with replenishment 
of hepatocytes and intrahepatic bile ducts. Data of regeneration of the cholangiocytes lining 
the extrahepatic bile ducts (EHBD) are sparse. The biliary epithelial lining of the EHBD consists of 
simple columnar epithelial cells, which are continuously exposed to bile flow and the cytotoxic 
properties of bile salts. In addition, toxins and pathogens may cause cellular injury in pathological 
situations, such as in ascending bacterial cholangitis. Therefore, it is conceivable that biliary 
epithelium of the EHBD has an endogenous regenerative capacity, which may include a local 
niche of progenitor cells (6). Because the above mentioned intrahepatic progenitor cell niches 
are thought to be closely related to hepatocytes and due to the lack of hepatocytes in the EHBD 
it is conceivable that a different source of progenitor cells exists in the proximity of the EHBD.
The intrahepatic bi-potent progenitor cells have been characterized by the expression of 
hematopoietic markers such as c-Kit (7-10). The expression of these progenitor cell markers in 
combination with the biliary markers keratin 7 (K7) and keratin 19 (K19) has been used to identify 
sub-lineages of the bi-potent progenitor cells differentiating into cholangiocytes. Experiments in 
mice have suggested that the EHBD contains local progenitor cells that are c-Kit positive (11). In 
addition, Cohen et al. and Nakanuma et al. hypothesized that the peribiliary glands of the EHBD 
might be the compartment that harbors regenerative cells, but formal evidence for this is still 
lacking (6,12).
The aim of the current study was to identify possible site(s) where epithelial regeneration may be 
initiated in the human EHBD and to study the possible role of local progenitor cells in this process. 
We have examined tissue specimens from normal and diseased human EHBD varying from mild 
cellular injury (as in cholangitis/cholecystitis) to severe epithelial injury with cholangiocyte loss, 
as can be seen in post-ischemic cholangiopathy, i.e. ischemic type biliary lesions (ITBL), after 
orthotopic liver transplantation.




Source of human EhBD Specimens
All procedures and use of (anonymized) tissue specimens were performed according to recent 
national guidelines. A total of 17 human EHBD specimens were included in this study. Specimens 
of normal EHBD tissue were obtained from six healthy donor livers that had been retrieved from 
DCD (donation after cardiac death) organ donors. These samples were obtained during the 
backtable procedure prior to transplantation of these organs. Specimens of mildly injured EHBD 
were obtained from six patients with cholangitis/cholecystitis who underwent cholecystectomy. 
Specimens of severely injured EHBD were obtained from five patients undergoing a 
retransplantation of the liver due to ITBL, in whom hepatic artery thrombosis was excluded 
by either Doppler ultrasound or CT angiography. All specimens were fixed in 10% buffered 
formalin, embedded in paraffin and 4-mm thick sections were used for immunohistochemical 
analysis.
Immunohistochemistry
To determine the number and location of proliferating cholangiocytes within the EHBD, double 
immunostaining using monoclonal antibodies against keratin 19 (rabbit anti-keratin 19, Abcam, 
Cambridge, United Kingdom, dilution of 1/100) and Ki-67 (mouse anti-Ki-67, DAKO, Glostrup, 
Denmark, dilution of 1/100) were performed. In short, after deparaffinization through a graded 
alcohol series, antigen retrieval was performed with 0.1M Tris/HCL buffer (pH=9) for 15 min at 
98 ºC in a microwave oven. Endogenous peroxidase was blocked with H2O2 for 30 min. Thereafter, 
sections were incubated with Ki-67 for 1 h at room temperature, followed by incubation with 
peroxidase-labeled rabbit anti-mouse antibody (dilution 1/100) and goat anti-rabbit antibody 
(dilution 1/100). The staining reaction was developed using diaminobenzidin (DAB). Sections 
were then washed in a glycin/HCL solution (pH=2) for 45 min, followed by incubation with K19 
for 1 h at room temperature. This was followed by peroxidase-labeled goat anti-rabbit antibody 
(dilution 1/100) and rat anti-goat antibody (1/100) and the staining reaction was developed with 
3-amino-9-ethyl-carbazole (AEC). Sections were counterstained with hematoxylin. Histological 
evaluation was performed by a single pathologist (A.S.H.G).
Immunofluorescent Double Stainings
Immunofluorescent double staining using monoclonal antibodies against K19 (mouse anti-K19, 
Abcam, Cambridge, United Kingdom, dilution of 1/100) and polyclonal antibodies against c-Kit 
(rabbit anti-c-Kit, DAKO, C7244, Glostrup, Denmark) was performed on 4 mm paraffin sections. 
In short, after deparaffinization antigen retrieval was performed with 1 mmol/L ethylene diamine 
tetra acetate (EDTA) buffer (pH=8) for 15 min at 98 ºC in a microwave oven. Thereafter, sections 
were incubated with antibodies against c-Kit for 1 h at room temperature, followed by incubation 
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with antibodies against K19 for 1 h at room temperature. Thereafter, slides were incubated 
in the dark with a mixture of secondary fluorescent antibodies Alexa Fluor 568-conjugated 
goat anti-rabbit IgG antibody (dilution 1/50) and Alexa Fluor 488-conjugated goat anti-mouse 
IgG antibody (dilution 1/50) for 1 h at room temperature. Sections were counterstained with 
4’,6-diaminido-2-phenylindole (DAPI) dilution 1/1000) for 5 minutes at room temperature in the 
dark and then mounted with Vectashield H 1000 (Vector Laboratories, Burlingame, CA, USA). 
Microscopy images were captured using a Leica DMLB microscope (Leica Microsystems, Rijswijk, 
the Netherlands) equipped with a Leica DC300F camera and Leica QWin 2.8 software.
RESuLTS
Cholangiocyte Damage in normal and Diseased EhBD
Examples of the microscopic appearance of healthy and diseased EHBD specimens are presented 
in figure 1. Samples of EHBD obtained from donor livers had a fully preserved epithelial lining, 
without any other histological abnormalities in the bile duct wall. In contrast, specimens from 
patients with cholangitis showed variable grades of inflammation but a preserved epithelial 
lining. EHBD specimens from patients with ITBL showed complete or partial denudation of the 
biliary epithelial lining.
Cholangiocyte Turnover in normal and Diseased EhBD
Healthy and diseased EHBD sections were double stained for the proliferation marker Ki-67 and 
the biliary epithelial marker K19. K19 positive cholangiocytes were detected lining the bile ducts 
and the peribiliary glands. In the healthy EHBD, a few isolated cells expressing both Ki-67 and 
K19 (K19+/Ki-67+ cells) were identified at the basal layer of the lumen and no expression of Ki-67 
was detected in the peribiliary glands (figure 2).
In EHBD from patients with cholangitis, with mild to moderate biliary epithelial injury, the intact 
cholangiocytes were K19 positive and a substantial number of K19+/Ki-67+ cells were detected 
in the basal layer of the lumen of the EHBD, whereas K19+/Ki-67+ cells were detected only 
sporadically in the peribiliary glands (figure 2). In contrast, EHBD of patients with ITBL and 
severe biliary epithelial injury, characterized by a marked loss of lining cholangiocytes on the 
luminal side, exhibited a high number of K19+/Ki-67+ cells in the peribiliary glands, whereas only 
a few double positive cells were observed at the lumen of the bile duct (figure 2).
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figure 1. overview of the different pathological features of the extrahepatic bile ducts (EhBD) 
examined. Representative hematoxylin-eosin staining of surgical specimens of a normal EHBD without 
pathological signs of injury (a), an EHBD from a patient with cholangitis, expressing signs of inflammation 
without disruption of the epithelial layer (B) and an EHBD suffering from ischemic type biliary lesions 
(ITBL) with severe cholangiocyte injury indicated by loss of the continuity of the cholangiocyte layer (C). 
abbreviations: L; lumen, PBG; peribiliary glands.
Cellular Localization of c-Kit
We next examined whether cells expressing c-Kit could be detected in the EHBD specimens. 
Expression of c-Kit was detected in individual cells throughout the bile duct wall. Cells positive 
for c-Kit were located at the basal epithelial layer of the lumen, in the connective tissue of the bile 
duct, and a few positive cells were detected in the peribiliary glands. No differences in number 
and localization between normal, mildly and severely injured EHBDs were present.
To determine if a subpopulation of c-Kit positive cells also express K19, double immunofluorescence 
staining was performed. A few K19+/ c-Kit+ cells were observed at the epithelial lining of the 
lumen (figure 3) of the EHBD as well as in the peribiliary glands (figure 4). The number and 
localization of these cells did not differ between normal and diseased EHBD.
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figure 2. The pattern of cholangiocyte proliferation after different types of biliary injury. 
Immunohistochemical stainings showed that the number of proliferating cholangiocytes is very low 
in normal extrahepatic bile ducts (EHBD) (a). Cholangiocyte proliferation predominantly occurred 
in the luminal lining of the EHBD in the case of cholangitis (B) with low proliferation in the peribiliary 
glands (C). However, in EHBD suffering from ischemic type biliary lesions (severe injury with partial 
denudation of the cholangiocytes lining the lumen), proliferation was mainly located in the peribiliary 
glands with only low numbers of proliferating cholangiocytes within the luminal cholangiocyte 
lining (D). Cholangiocytes are stained in red (keratin 19), proliferating cells are stained in brown (Ki-67). 
abbreviations: L; lumen, PBG; peribiliary glands.
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figure 3. Evaluation of c-Kit expression by cholangiocyte-like cells at the luminal compartment. 
Immunofluorescent double staining with c-Kit (red) and keratin 19 (K19) (green) showed that, although 
in small numbers, K19+/c-Kit+ cells are present in the epithelial lining of the extrahepatic bile ducts (EHBD) 
lumen (indicated by an arrow). These K19+/c-Kit+ were found in normal and diseased states (cholangitis or 
ischemic type biliary lesions) of the EHBD. This population of double positive cells is in contrast with other 
type of cells that are positive for c-Kit but do not express K19 (indicated by arrowheads).
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figure 4. Evaluation of c-Kit expression by cholangiocyte-like cells in the peribiliary glands. 
Immunofluorescent double staining with c-Kit (red) and keratin 19 (K19) (green) showed that, small numbers 
of K19+/ c-Kit+ cells are present in the peribiliary glands of the extrahepatic bile duct (EHBD) wall (indicated by 
an arrow). These K19+/c-Kit+ were found in normal and diseased states (cholangitis or ischemic type biliary 
lesions) of the EHBD. This population of double positive cells is in contrast with other type of cells that are 
positive for c-Kit but do not express K19 (indicated by arrowheads).




In the present study we provide evidence that there are two distinct sites in the human EHBD 
where regeneration of cholangiocytes can be identified. In addition, our data suggest that biliary 
progenitor cells reside within these sites.
In specimens with mild to moderate injury of the EHBD, proliferating cells with cholangiocyte 
characteristics were primarily present in the epithelial lining of the EHBD lumen, whereas 
proliferating cholangiocyte-like cells were primarily present in the peribiliary glands in specimens 
with more severe damage showing loss of cholangiocytes at the luminal side of the EHBD. In line 
with this, we have also demonstrated K19 positive putative progenitor cells within both the lining 
of the bile duct lumen and the peribiliary glands.
Several studies on intrahepatic regeneration of hepatocytes and cholangiocytes have suggested 
c-Kit as a useful marker of biliary progenitor cells (8,13). However, it is also expressed by other cell 
types inside the liver leading to a less unambiguous interpretation of c-Kit stainings. In the current 
study, we found c-Kit expression in small cholangiocytes at the epithelial lining of the lumen as 
well as in the epithelial lining of the peribiliary glands. This finding strongly suggests that both 
the luminal epithelial lining and the peribiliary glands contain cholangiocyte progenitors that are 
involved in repair of the biliary epithelial lining following injury.
We observed only low proliferative activity in the biliary epithelium of normal EHBD. Despite the 
fact that biliary epithelium is continuously exposed to bile flow and the cytotoxic effects of bile 
salts, cellular renewal activity is apparently low under physiological circumstances. In contrast 
with this, substantial proliferative activity was observed in specimens obtained from patients 
with cholangitis and ITBL. We found a striking difference in the pattern of proliferative activity 
between these two disease entities. In cholangitis, the biliary epithelial lining remains largely 
intact and the degree of injury can be graded as mild to moderate. In this situation, proliferating 
cells were observed at the luminal side of the EHBD. In contrast, in patients with ITBL and severe 
EHBD injury, resulting in partial or complete denudation of the epithelial lining, proliferating cells 
were mainly observed in the peribiliary glands and proliferation at the luminal side of the EHBD 
was low. These findings suggest that after relatively mild injury of the epithelium, the necessary 
renewal of cholangiocytes is achieved by replication of neighboring cholangiocytes. This repair 
mechanism may not suffice in the situation of severe epithelial injury when there is partial or 
complete loss of cholangiocytes at the lumen of the bile duct. In this situation, no actual loss 
of cholangiocytes was observed in the inner lining of the peribiliary glands, and recruitment 
seems to occur from these peribiliary glands. Altogether, these findings suggest that replication 
of mature cholangiocytes at the EHBD lumen is a first-line regenerative mechanism of EHBD 
repair. When this first-line mechanism fails, a second-line mechanism is initiated resulting in the 
recruitment of cells from more distant sites such as the peribiliary glands.
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A similar concept is found in hepatocyte regeneration. In massive hepatic necrosis in which 
there is severe loss of parenchymal cells, the progenitor cell compartment is activated whereas 
after partial hepatectomy these progenitor cells remain quiescent and regeneration is mainly 
contributed by adult hepatocytes (4, 5).
Our findings are in agreement with studies performed by Nakanuma et al, who previously 
suggested that the peribiliary glands may be an important reservoir of epithelial regeneration in 
the EHBD. Nakanuma was also the first to describe that there is a micro-structural connection 
between the peribiliary glands and the lumen of the bile duct making it possible for replenishing 
cells to migrate from the peribiliary glands to the site of luminal epithelial injury (6).
To investigate the hypothesis that local progenitor cells are (in part) responsible for cholangiocyte 
repair during mild and more severe injury, we examined the localization of c-Kit positive cells 
within the EHBD. C-Kit is a putative progenitor cell maker, but is also expressed on mature cell 
types such as mast cells and Cajal cells. Indeed, individual c-Kit positive (but K19 negative) cells 
were detected in the wall of the EHBD with morphological characteristics resembling mast cells 
and Cajal cells. However, we found a third population of c-Kit positive/K19 positive cells located 
within the epithelial layer of the lumen and the peribiliary glands. These cells were found in low 
numbers in all sections investigated but no different pattern between normal and diseased EHBD 
was demonstrated. C-Kit expression by biliary epithelial cells of the human intrahepatic bile duct 
has been described previously by Ahmadi et al. but these investigators thought this was due to 
non-specific immunofluorescence staining (14). In contrast, in our study we clearly show these 
c-Kit positive cells are present within the epithelial layer, albeit in very low numbers. Our findings 
that a limited number of K19 positive cells co-expressed c-Kit, is in accordance with findings of 
Crosby et al. who showed similar expression of c-Kit positive/K19 positive cells lining the lumen 
of the intrahepatic bile duct (8,13).
We have demonstrated that a population of cholangiocytes co-expressing c-Kit resides in the 
luminal lining of the human EHBD and the adjacent peribiliary glands. The lack of differences 
between the distribution of c-Kit positive cholangiocytes in different disease states and healthy 
controls is supportive for the hypothesis that these are progenitor cells permanently residing in 
the EHBD. Progenitor cells are responsible for self-renewal instead of being the proliferating cells 
themselves. They give rise to a progeny of proliferating cells as indicated by our Ki-67 stainings.
In summary, in this study we have demonstrated that different patterns of cholangiocyte 
proliferation occur in the human EHBD. Following a mild to moderate type of injury (i.e. cholangitis) 
restoration of the epithelial lining seems predominantly provided by proliferation of (mature) 
cholangiocytes at the luminal lining of the EHBD. In case of severe injury and cholangiocyte loss 
recruitment of cells from the peribiliary glands will add to this. In addition to this, the peribiliary 
glands of the EHBD could be considered as a local niche of biliary progenitor cells. More studies 
will be needed to further identify these progenitor cells and to examine the specific stimuli that 
are involved in the activation of the peribiliary glands.
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Peribiliary glands of large bile ducts have been identified as a niche of progenitor cells that 
contribute to regeneration of biliary epithelium after injury. It is unknown whether injury 
of the peribiliary glands is a risk factor for the development of non-anastomotic biliary 
strictures (NAS) after liver transplantation. Moreover, it is unknown whether pretransplant 
biliary injury is different in livers donated after brain death (DBD) or cardiac death (DCD). 
In 128 liver transplant procedures, biopsies were taken from the extrahepatic bile duct and 
injury was assessed using a systematic histological grading system. Histological injury was 
correlated with the occurrence of posttransplant biliary strictures and a comparison was 
made between DBD (n=97) and DCD livers (n=29). Biliary epithelial loss >50% was observed 
in 91.8% of the grafts before transplantation, yet NAS occurred in 16.4%. Periluminal 
peribiliary glands were more severely injured than the deep peribiliary glands located near 
the fibromuscular layer (>50% loss in 56.9% versus 17.5%, respectively; p<0.001). Injury of 
deep peribiliary glands was more prevalent and more severe in livers that later developed 
NAS, compared to uncomplicated grafts (>50% loss in 50.0% versus 9.8%, respectively; 
p=0.004). In parallel, injury of the peribiliary vascular plexus was more severe in livers that 
developed NAS, compared to uncomplicated grafts (>50% vascular changes in 57.1% versus 
20.3%; p=0.006). Comparison of DBD and DCD livers revealed significantly more vascular 
injury in the latter (p=0.005). Conclusion: Injury of peribiliary glands and vascular plexus 
before transplantation is strongly associated with the occurrence of biliary strictures after 
transplantation. This suggests that insufficient regeneration due to loss of peribiliary glands 
and blood supply may explain the development of biliary strictures.
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InTRoDuCTIon
Biliary complications are a major cause of morbidity and graft failure after orthotopic liver 
transplantation (1-3). Anastomotic and non-anastomotic bile duct strictures (NAS) are the most 
frequent type of biliary complication, with a reported incidence of anastomotic strictures varying 
between 1-15% and of NAS between 5-30% (3-5). The highest incidence of NAS has been 
reported after transplantation of livers donated after cardiac death (DCD) (6-8). In contrast to 
livers obtained from brain death donors (DBD), livers from DCD donors suffer additional warm 
ischemia in the donor during the time interval between cardiac arrest and in situ cold perfusion. 
Duration of warm and cold ischemia during organ retrieval; storage; and transportation have 
been identified as important risk factors for the development of NAS after transplantation (9,10). 
In addition, bile salt induced cellular injury and immune-mediated injury have been shown to play 
a role in the pathogenesis of biliary injury and the subsequent formation of biliary strictures (11-
13). Biliary epithelial cells (or cholangiocytes) are known to be very sensitive to ischemia and 
relatively short periods of ischemia result in a rapid and prolonged depletion of the intracellular 
concentrations of adenosine triphosphate (ATP) (14-16). As a consequence of ATP depletion, biliary 
epithelial cells lose their intercellular connections and detach from the basement membrane, 
resulting in sloughing of the epithelial lining and denudation of the bile duct luminal surface. 
Two independent clinical studies have recently demonstrated that major epithelial cell loss in the 
extrahepatic bile ducts can be observed in more than 80% of DBD donor livers at the time of 
transplantation (17,18). In both studies, histological severity of bile duct injury, including loss of 
epithelial lining and mural necrosis, correlated significantly with the postoperative occurrence of 
biliary strictures. The observation that biliary injury is almost universally (>80%) present at the 
time of transplantation, yet biliary strictures are (fortunately) seen in only a minority of transplant 
recipients, has led to the hypothesis that proliferation and regeneration of the bile duct wall and 
epithelium, rather than the initial injury alone, are important determinants in the pathogenesis 
of biliary strictures (19).
Timely and adequate biliary regeneration requires at least two important preconditions: adequate 
supply of oxygen and nutrients and a vital source from which biliary epithelial cells can proliferate 
and regenerate. Regarding regeneration of the biliary epithelial lining of the larger bile ducts, 
the peribiliary glands have been identified as an important niche of biliary progenitor cells (20-
24). Peribiliary glands are connected to the luminal surface via small canals through which newly 
formed biliary epithelial cells can migrate and contribute to the restoration of the epithelial lining 
of the bile duct lumen (23,24). Progenitor-like cells are mainly found in peribiliary glands that are 
located in the deeper layers of the bile duct wall, near the fibromuscular layer (22,23). Despite 
the presumed critical role of peribiliary glands in the regenerative capacity of large bile ducts, 
there are no studies in which preservation injury of the peribiliary glands has been examined in 
relation to the development of biliary strictures after transplantation. We, therefore, performed a 
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systematic histological analysis of the bile ducts of donor livers at the time of liver transplantation. 
The aim of this study was two-fold: 1) to determine the impact of injury of the peribiliary glands 
in the development of posttransplant biliary strictures, and 2) to determine whether there is 
a difference in severity of pretransplant bile duct injury, including the peribiliary glands and 
vascular plexus, between DBD and DCD livers.
MaTERIaLS anD METhoDS
Donors and Recipients
This study was conducted as a prospective, collaborative research project of the liver transplant 
programs at Massachusetts General Hospital (MGH) in Boston, MA and the University Medical 
Center Groningen (UMCG) in the Netherlands. Between May 1, 2010 and January 1, 2013, 
biopsies from the extrahepatic donor bile duct were collected at the time of transplantation in 
128 liver transplant procedures. Date of last follow-up was June 1, 2013, resulting in a median 
follow-up interval of 17 months (range 5-36 months). Fifty-four transplant procedures were 
included at MGH and 74 at UMCG.
Biopsies were taken from segments of donor extrahepatic bile duct that were excised to adjust its 
length and facilitate adequate positioning of the bile duct and the biliary anastomosis. Specimens 
were cut with either fine Metzenbaum scissors or a surgical scalpel, taking care not to touch the 
inside of the bile ducts. Bile duct biopsies were taken at the end of cold storage, during back 
table preparation of the graft, in 73 cases, after graft reperfusion in 99 cases, and at both time 
points in 44 cases. In both centers, bile duct anastomoses were routinely constructed using 
absorbable monofilament sutures.
Donor and recipient characteristics were collected from the local transplant databases and 
missing data were retrieved from individual electronical patient files. Histological characteristics 
of biliary injury were correlated with biliary outcome parameters after transplantation, as defined 
below.
For the part of the study performed at MGH, local institutional review board approval was 
obtained and for the part performed at the UMCG, collection of data and biopsies was compliant 
with national legislation and the code for usage of human remnant material (Code Goed Gebruik, 
Federation of Medical Scientific Societies in the Netherlands).
histological assessment of Bile Ducts
Bile duct biopsies were immediately preserved in 10% formaldehyde for inclusion in paraffin. 
Paraffin-embedded slides were prepared for hematoxylin and eosin (H&E) staining. In 47 cases, bile 
duct biopsies were embedded in Tissue-Tek® (Sakura Finetek, Alphen aan den Rijn, Netherlands) 
and frozen in isopentane on dry ice (-78 oC) for subsequent preparation as cryostat sections and 
H&E staining. Injury of the biliary epithelium, stromal layer, and peribiliary vascular plexus was 
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graded according to a systematic histological scoring system as described by Hansen et al. (17) 
and summarized in Table 1. In addition, injury of the peribiliary glands was assessed according to 
a self developed scoring system in which the subluminal glands were graded separately from the 
deeper glands located at the junction of bile duct wall stroma and the muscular layer (Table 1). 
Injury of the subluminal and deeper located peribiliary glands was defined as detachment of the 
cells from the basement membrane and/or disappearance of epithelial cells from the glands. The 
degree of injury was graded using the following criteria: grade 0, no signs of injury; grade 1, 
≤50% injury; grade 2, >50% injury. Injury was defined as detachment or loss of epithelial 
cells (figure 1). All bile duct sections were examined in a blinded fashion under supervision 
of an experienced liver pathologist (ASHG) using a Nikon Eclipse 50i light microscope (Nikon 
Instruments Inc, Melville, NY)
Table 1. Overview of the histological characteristics and scoring system used in the assessment of the 
degree of injury of the extrahepatic bile ducts* 
Bile duct wall component
Injury Score
grade 0 grade 1 grade 2 grade 3
Biliary epithelium No loss ≤50% loss >50% loss N/A
Mural stroma No injury ≤25% necrotic 25-50% necrotic >50% necrotic
Peribiliary vascular plexus No injury ≤50% of vessels 
with changes
>50% of vessels 
with changes
Grade 2 + 
arteriolonecrosis
Thrombosis Absent Present N/A N/A
Intramural bleeding None ≤50% of duct wall >50% of duct wall N/A
Periluminal PBG No injury ≤50% loss of cells >50% loss of cells N/A
Deep PBG No injury ≤50% loss of cells >50% loss of cells N/A
Inflammation None At least 10 
leukocytes / HPF
At least 50 
leukocytes / HPF
N/A
*) Modified from Hansen et al (17)
abbreviations used: PBG, peribiliary gland; HPF, high power field; NA, not applicable
outcome Parameters
The primary postoperative outcome parameter of this study was the occurrence of anastomotic 
biliary strictures and NAS. NAS were defined as any irregularities or narrowing of the intra- or 
extrahepatic donor biliary tree in the absence of hepatic artery thrombosis (4). Anastomotic 
strictures were defined as any narrowing of the anastomosis between donor and recipient bile duct, 
requiring an intervention. In all cases of an anastomotic stricture or NAS, the diagnosis was based 
on radiological imaging of the biliary system, including endoscopic retrograde cholangiography, 
magnetic resonance cholangiography, or percutaneous transhepatic cholangiography. In most 
patients, imaging of the bile ducts was indicated based on symptoms (i.e. jaundice, cholangitis) 
or laboratory abnormalities suggesting biliary pathology. Time intervals between transplantation 
and the first diagnosis of an anastomotic stricture or NAS were recorded.
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In addition to biliary complications, graft survival rates were examined as a general outcome 
parameter.
Grade 0
No loss of epithelial cells
Grade 1
Loss of epithelial cells ≤50%
Grade 2
















figure 1. Histological grading system to assess injury of the peribiliary glands of the extrahepatic donor 
bile duct, based on H&E staining. The periluminal glands below the bile duct epithelial lining and the deep 
peribiliary glands located near the fibromuscular layer were scored separately. The following criteria were 
used for determining the degree of injury: grade 0, no signs of injury; grade 1, ≤50% of the glands displayed 
loss or detachment of epithelial cells; grade 2, >50% of the glands displayed loss or detachment of epithelial 
cells. Bile duct lumen is marked by an asterisk, and arrows point at peribiliary glands.
Statistical analysis
Continuous variables are presented as median and interquartile range (IQR). Categorical variables 
are presented as number and percentage. Continuous variables were compared between groups 
using the Mann-Whitney U and categorical variables were compared with the Pearson Chi-
Square test. Survival analysis was performed according to the Kaplan Meier method and groups 
were compared using the log-rank test. The level of significance was set at p-value of 0.05. All 
statistical analyses were performed using SPSS software version 16.0 for Windows (SPSS, Inc., 
Chicago, IL).
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RESuLTS
Donors and Recipients
Demographics of donors and patients, as well as relevant surgical variables are summarized in 
Table 2. In 97 patients (75.7%) the donor liver was derived from a DBD donor, in 29 (22.7%) 
from a DCD donor, and in one case (0.8%) from a living donor (in one patient this information 
was missing). University of Wisconsin (UW) preservation fluid was used in 92 cases (71.9%) and 
histidine-tryptophan-ketoglutarate (HTK) solution in 34 (26.6%). The median duration of cold 
ischemia was 407 min (IQR 341-484 min). Biliary reconstruction was achieved by performing 
a duct-to-duct anastomosis in 108 (84.4%) patients, whereas a hepatico-jejunostomy using a 
Roux-en-Y jejunal loop was constructed in 16 (12.5%) patients (data missing in 4 cases).
Table 2. Demographics of 128 Donors and Patients and Surgical Variables
variable number (%) or Median (IqR)
Donor characteristics
Age (years) 49 (35-56)
Gender (male) 70 (54.7%)
Body Mass Index 25 (23-28)
Cause of death










Full size graft 118 (92.2%)
Reduced size 9 (7.0%)
Split graft 1 (0.8%)
Type of preservation fluid
UW solution 92 (71.9%)
HTK solution 34 (26.6%)
Unknown 2 (1.5%)
Donor warm ischemia time in DCD (minutes) 22 (12-33)
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variable number (%) or Median (IqR)
Recipient characteristics
Age (years) 55 (38-61)
Gender (male) 92 (71.9%)
Indication for transplantation
Post-alcoholic cirrhosis 19 (14.8%)
Hepatocellular carcinoma 18 (14.1%)
Biliary cirrhosis (PSC, PBC or atresia) 17 (13.3%)
Post-viral cirrhosis (hepatitis B or C) 16 (12.5%)
Acute liver failure 10 (7.8%)
Non-alcoholic steatohepatitis 7 (5.5%)
Cryptogenic cirrhosis 5 (3.9%)
Metabolic disease 4 (3.1%)
Auto-immune hepatitis 2 (1.6%)
Retransplantation 20 (15.6%)
Miscellaneous 10 (7.8%)
MELD score 19 (11-31)
Surgical variables
Cold ischemia time (minutes) 407 (341-484)
Warm ischemia time in recipient (minutes) 42 (38-50)
Type of biliary anastomosis
Duct-to-duct 108 (84.4%)
Roux-en-Y hepatico-jejunostomy 16 (12.5%)
Unknown 4 (3.1%)
abbreviations used: DBD, donation after brain death; DCD; donation after cardiac death; HTK; histidine-
tryptophan-ketoglutarate; IQR, interquartile range; MELD, model for end-stage liver disease; UW, University 
of Wisconsin; WIT, warm ischemia time.
histological grading of Bile Duct Injury
Results of the histological grading of bile duct injury at the end of cold storage and after graft 
reperfusion are presented in Table 3. Major loss of biliary epithelium at the luminal surface 
(grade 2 or >50%) was observed in 91.8% of all bile ducts at the end of cold storage, and this did 
not increase further after reperfusion. Signs of >50% bile duct wall stroma necrosis (grade 2 or 
more) were noted in 12.4% of all samples at the end of cold storage, which increased to 42.4% 
after reperfusion. In general, the degree of injury was most severe in the central layers of the 
bile duct wall, including the luminal epithelial lining and subluminal stroma, whereas the outer 
stromal layers were relatively well preserved (figure 2).
Damage to the peribiliary vascular plexus was found in the majority of all bile ducts. Grade 2 
or more vascular lesions (>50% vascular changes) were observed in 27.4% at the end of cold 
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Table 3. Comparison of Histological Grading of Bile Duct Injury Before and After Reperfusion
Bile duct wall component
Injury Score (%)




























































































abbreviations used: PBG, peribiliary glands
storage and in 51.5% after reperfusion (Table 3). Vascular thrombosis and bleeding were rarely 
seen at the end of cold storage, but these abnormalities were noted more frequently after 
reperfusion (Table 3).
Injury of the epithelial cells of the peribiliary glands was much less severe and less frequently 
observed than injury of the biliary epithelial cells at the surface of the bile duct lumen (Table 3). 
In parallel with the gradient of increasing stroma necrosis toward the more superficial layers, the 
deep peribiliary glands were less severely injured than the superficial, periluminal peribiliary glands 
(figure 2a). Overall, grade 2 injury (>50% loss of cells) of the periluminal glands was observed 
in 56.9% of the end of cold storage biopsies, compared to 17.5% of the deep peribiliary glands 
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(p<0.001). Injury of periluminal or deep peribiliary glands did not worsen after graft reperfusion 
(Table 3). A separate analysis of all paraffin embedded slides, after exclusion of frozen sections, 
did not change the results (data not shown).
figure 2. Panel a: Histology (H&E staining) of an extrahepatic donor bile duct, demonstrating a gradient of 
increasing injury from the outer layers toward the more central layers near the bile duct lumen. In 91.8% of 
all patients, there was >50% loss of biliary epithelium at the surface of the bile duct lumen (marked by an 
asterisk). Necrosis of mural stroma was most severe near the lumen (marked by #) and cells of the periluminal 
peribiliary glands (arrows) were generally more detached or lost than the deeper glands located near the 
fibromuscular layer (marked by dashed circle). Panel B and C: Cholangiographic images of a patient after 
liver transplantation with severe non-anastomotic biliary strictures (NAS) (panel B) and a patient without 
NAS (panel C).
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Relation between histology and Postoperative Biliary Complications
We next examined whether the severity of the various components of bile duct injury correlated 
with the occurrence of biliary strictures. The overall incidence of anastomotic strictures was 
20.3% and NAS were seen in 16.4% of the transplant recipients. Median (IQR) time interval 
between transplantation and the diagnosis of an anastomotic stricture or NAS was 40 (9-142) 
days and 104 (47-201) days, respectively. Radiological examples of patients with and without 
NAS are presented in figure 2B and C.
A comparison of bile duct injury at the end of cold storage in livers that developed NAS and 
those that did not develop NAS is presented in Table 4. There was no significant difference 
in the amount of biliary epithelial injury at the luminal surface in livers that developed NAS or 
those that did not develop NAS. However, the degree of mural stroma necrosis, the severity of 
injury to the peribiliary vascular plexus, as well as injury of the deep peribiliary glands was all 
significantly worse in livers that developed NAS (figure 4). The distribution of mild-moderate 
versus severe injury of relevant histological bile duct wall components is summarized in figure 3. 
Mural necrosis of ≥25% of the bile duct stroma (≥ grade 2) was noted in 6.8% of the livers 
that did not develop NAS, compared to 35.7% of the livers that did develop NAS (p=0.007). 
Vascular lesions with >50% vascular abnormalities (grade 2) was 20.7% in livers that did not 
develop NAS, compared to 57.1% of the livers that did develop NAS (p=0.006). Grade 2 injury 
(>50% loss of cells) of the deep peribiliary glands was observed in 9.8% of livers without NAS, 
compared to 50.0% in livers that were complicated by the development of NAS (p=0.004). Injury 
of the superficial, periluminal peribiliary glands was not significantly different between livers with 
or without NAS (Table 4).
Graft survival rates at two years for liver grafts with either severe injury (>50%) of the deep 
peribiliary glands or severe injury (>50%) of the peribiliary vascular plexus versus those without 
these types of bile duct injury were 66.7% and 85.1%, respectively (p=0.205).
There were no significant differences in any of the histological components of bile duct injury at 
the end of cold storage between grafts that developed an anastomotic stricture, compared to 
those without an anastomotic stricture.
Differences in Bile Duct Injury between DBD and DCD Livers
As expected, NAS occurred more frequently after transplantation of DCD livers, compared 
to DBD livers (35.0% and 13.4%, respectively; p=0.165). A comparison of the degree of bile 
duct injury in DBD and DCD livers revealed no statistically significant differences, apart from a 
significantly higher percentage of grafts without any vascular injury in the DBD group versus the 
DCD group (18% versus 0%; p=0.005) (figure 3D).
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Table 4. Histological Grading of Bile Duct Injury Before Transplantation in Donor Livers Which Postoperatively 
Developed Non-anastomotic Biliary Strictures (NAS) or Not
Injury Score (%)




























































































abbreviations used: NAS, non-anastomotic biliary strictures; PBG, peribiliary gland.
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figure 3. Overview of the distribution of mild-moderate versus severe injury of relevant histological bile 
duct wall components. Panel a: Comparison of the percentage of bile ducts with <25% or ≥25% mural 
stroma necrosis before transplantation in livers that developed non-anastomotic biliary strictures (NAS) after 
transplantation and those that remained uncomplicated (no NAS). Panel B: Similar comparison of bile ducts 
displaying <50% or ≥50% loss of the deep peribiliary glands. Panel C: Comparison of bile ducts displaying 
<50% or ≥50% injury of the peribiliary vasculature. Panel D: Comparison of the percentage of bile ducts 
with any vascular injury versus no injury in DBD and DCD liver grafts.






































figure 4. Examples of characteristic histological injury (H&E staining) of the various bile duct wall 
components at the time of transplantation in livers that later developed NAS or remained uncomplicated. 
Panel a and B: Overview demonstrating injury of the biliary epithelial lining of the bile duct lumen (marked 
by an asterisk), various degrees of necrosis of the periluminal stroma (marked by #) and the peribiliary 
glands (arrows). Panel C and D: Higher magnification of the peribiliary glands (arrows). Deep peribiliary 
glands located near the fibromuscular layer displayed significantly worse injury in liver that developed NAS, 
compared to those that did not. Panel E and f: Higher magnification of small arteries of the peribiliary 
vascular plexus (arrowheads). Bile ducts of livers that developed NAS after transplantation displayed 
significantly more vascular injury, including arteriolonecrosis, compared to livers that did not develop biliary 
strictures.
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DISCuSSIon
The peribiliary glands of large intra- and extrahepatic bile ducts have been proposed as a niche of 
progenitor cells that contribute to regeneration of biliary epithelium after injury. Cells expressing 
stem/ progenitor cell markers have been identified mainly in the glands located deep in the duct 
wall, while more mature cells can be found in glands located near the epithelium of the luminal 
surface (22-24). The results of the current study suggest that injury of the deep peribiliary glands 
during cold preservation is a major risk factor for the development of NAS after transplantation. 
Although the vast majority of the biopsies of bile ducts taken before transplantation revealed 
major loss of biliary epithelium at the bile duct lumen, this finding alone did not correlate with 
the development of NAS after transplantation. The only histological characteristics that were 
significantly associated with the postoperative occurrence of NAS were injury of the deep 
peribiliary glands, the peribiliary vascular plexus and mural stroma necrosis. These findings 
suggest that insufficient regeneration due to loss of peribiliary glands and blood supply is a 
critical mechanism underlying the development of biliary strictures after transplantation.
The high percentage of livers with major loss of biliary epithelium from the luminal surface is in 
line with the results of the recent studies by Hansen et al and Brunner et al (17,18). The overall 
rate of bile duct specimens with major biliary epithelial cell loss or detachment from the luminal 
basement membrane was 91.8% in the current study versus 88% and 86% in the previous two 
studies. While the previous two studies included only patients who received a liver from a DBD 
donor, we also included recipients of a DCD liver. Moreover, we have focussed on the role of the 
peribiliary glands, which were not considered in the previous studies. Interestingly, there were no 
major differences in the degree of any of the components of biliary injury in DBD and DCD livers, 
apart from a significantly higher percentage of livers with injury of the peribiliary vascular plexus 
in the DCD group. This finding suggest the higher incidence of biliary complications, especially 
NAS, after transplantation of DCD livers may be explained by more severe injury of the vessels 
and subsequent blood supply to the bile ducts, compared to DBD liver grafts. In fact, all of the 
DCD livers had at least some degree of histological injury of the peribiliary vasculature prior to 
transplantation. The higher rate of vascular injury in bile ducts of DCD livers was accompanied by 
a more than two times higher postoperative rate of NAS, compared to DBD livers (35.0% versus 
13.4%). These percentages of NAS are in accordance with previous reports in the literature (4,7,8).
This study provides important new insight in the pathogenesis of biliary strictures after liver 
transplantation. It has become obvious that almost every donor liver used for transplantation 
has at least some degree of bile duct injury, yet bile duct strictures are seen in only a minority of 
transplant recipients. This suggests that rapid and effective regeneration of the bile ducts occurs 
in most patients after transplantation. The process of biliary regeneration, however, requires 
adequate supply of oxygen and nutrients and preservation of a vital source from which biliary 
epithelial cells can proliferate and regenerate. This may explain why the degree of vascular injury 
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is associated with the development of NAS. Injury of the peribiliary glands is another, hereto 
unrecognized risk factor for the development of NAS after transplantation. The peribiliary glands 
have been identified as a local niche of biliary progenitor cells for the larger bile ducts and, 
therefore, may be a second critical component in the process of biliary regeneration (20-24). The 
observed higher rate of injury of the superficial, periluminal glands compared to glands situated 
deep in the duct wall in the current study is compatible with the fact that blood supply to the 
bile ducts enters from the periphery. This results in the highest oxygen tension in the outer layers 
of the bile ducts, while lower oxygen tension can be anticipated in structures situated near the 
lumen. A similar phenomenon is well described for the bowel and the liver parenchyma where 
hypotension and ischemia typically lead to cell death and necrosis in zone 3 surrounding the 
central vein, which is most remote from the arteries and portal branches in the portal triads. 
For the bile ducts, this differential susceptibility to ischemia is the likely explanation why the 
peripherally located (deep) peribiliary glands were better preserved after cold preservation 
than glands located near the bile duct lumen. Interestingly, detailed histological studies of the 
peribiliary glands have indicated the highest percentage of biliary progenitor-like cells in the 
deeper located glands (23). Descendents from these progenitors undergo maturation while they 
migrate from the interior to the luminal surface of the bile ducts (23,24). The current study 
suggests that adequate preservation of at least the peribiliary glands located deep in the bile 
duct wall, as well the peribiliary plexus to support the supply of oxygen and nutrients, may be 
critical in a timely recovery of the post-ischemic bile duct.
Previous studies have demonstrated that bile salt toxicity may contribute to biliary injury and 
subsequent formation of bile duct strictures after transplantation (11-13). These observations 
become even more interesting in the light of the current knowledge that the biliary epithelial 
lining of the larger bile ducts is absent in a high percentage of donor livers. The lack of epithelial 
lining may result in the leakage of toxic bile salts into the bile duct wall, which may further 
contribute to the injury of stroma, peribiliary glands and vascular plexus.
It is obvious that the current method of liver preservation for transplantation does not provide 
sufficient protection of the bile ducts. Some clinical studies have suggested that inadequate 
wash out and preservation of the peribiliary vascular plexus is risk factor for the development of 
biliary complications (13,25). In addition to suboptimal preservation of the vasculature, it could 
well be that the usage of the current preservation fluids to flush the bile duct lumen during 
procurement provides suboptimal preservation of, or may even be deleterious to, the biliary 
epithelium and stroma. The current preservation fluids were designed to protect hepatocytes 
and sinusoidal endothelial cells and there is surprisingly limited literature on the effects of these 
fluids on the bile duct epithelium. This is an area that requires more research.
Alternatively, it might be that the current preservation method based on cooling is not a good 
method to protect the bile ducts. The high rate a severe histological injury of the bile ducts found 
in the current study, as well as the high incidence of NAS reported after DCD liver transplantation, 
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suggest that the combination of warm and subsequent cold ischemia could be particularly 
detrimental. Reduction, or even elimination, of cold ischemia during organ preservation can only 
be provided by machine perfusion. Machine perfusion is currently receiving increased research 
attention as this technology allows continuous perfusion and oxygenation of a donor organ at 
either hypothermic or (sub)normothermic conditions (26-28). Using a porcine model of DCD livers, 
our group has recently demonstrated that hypothermic oxygenated machine perfusion provides 
better protection of the peribiliary vascular plexus of the extrahepatic bile duct, compared to 
static cold storage (op den Dries et al, unpublished data 2013). However, this technique did not 
result in a reduction of the amount of biliary epithelial cell loss or stroma necrosis, suggesting 
that a more advanced methodology such as normothermic oxygenated perfusion will be needed 
to protect these components of the bile duct wall. Our group has recently reported the first study 
on the technical feasibility of normothermic machine perfusion of human donor livers (29) and in 
an experimental study using pig DCD livers others have suggested that normothermic oxygenated 
perfusion may indeed provide better preservation of bile duct epithelium and stroma (30). More 
research in this area is eagerly awaited to help us define the place of machine perfusion in 
reducing the amount of biliary injury associated with liver transplantation. The current study 
indicates that preservation of the peribiliary glands should be considered as an important target 
in research on machine preservation of donor livers.
The strength of this study is the prospective collection of the bile duct specimens in two 
established liver transplant centers: one in the US and one in Europe.
A limitation of the current study is that we did not obtain paraffin embedded sections in all 
patients. Paraffin embedded sections were available in 81 (64%) of the patients, whereas 
cryostat sections were available in 47 patients (36%). Morphology of the bile duct wall was 
sometimes less well preserved in the cryostat sections, however, we were still able to score the 
various histological characteristics in these biopsies. Moreover, there were no major differences 
in the results when cryostat sections were excluded from the analyses. Finally, imaging of the 
biliary tree after transplantation was only performed when clinically indicated. Subclinical and 
asymptomatic biliary complications, therefore, may have been missed.
In conclusion, this study provides histological evidence for a high incidence of preservation injury 
of the extrahepatic bile ducts of donor livers after cold storage. We have identified injury of the 
deep peribiliary glands and the vascular plexus as significant risk factors for the development 
of biliary strictures after liver transplantation. Injury to the peribiliary vasculature was more 
frequently present in bile ducts of DCD livers compared with DBD livers. These findings suggest 
that preservation of the peribiliary glands and vascular plexus is critical in the timely regeneration 
of the biliary epithelial lining and bile duct wall stroma after liver transplantation. Alternative 
preservation methods such as machine perfusion may not only reduce the incidence of biliary 
complications by lowering the amount of biliary injury prior to transplantation, but also by 
providing better protection of the peribiliary glands and vascular plexus.
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Background: Livers derived from donation after cardiac death (DCD) are increasingly 
accepted for transplantation. However, DCD livers suffer additional donor warm ischemia, 
leading to biliary injury and more biliary complications after transplantation. It is unknown 
whether oxygenated machine perfusion results in better preservation of biliary epithelium 
and the peribiliary vasculature. We compared oxygenated hypothermic machine perfusion 
(HMP) with simple cold storage (SCS) in a porcine DCD model.
Methods: After 30 min of cardiac arrest, livers were perfused in situ with histidine-
tryptophan-ketoglutarate (HTK) solution (4oC) and preserved for 4h by either SCS (n=9) or 
oxygenated HMP (10oC; n=9), using pressure-controlled arterial and portal venous perfusion. 
To simulate transplantation, livers were reperfused ex vivo at 37oC with oxygenated autologous 
blood. Bile duct injury and function were determined by biochemical and molecular markers, 
and a systematic histological scoring system.
Results: After reperfusion, arterial flow was higher in the HMP group, compared to SCS. 
Release of hepatocellular enzymes was significantly higher in the SCS group. Markers of 
biliary epithelial injury (biliary LDH, gamma-GT) and function (biliary pH and bicarbonate, 
and biliary transporter expression) were similar in the two groups. However, histology of bile 
ducts revealed significantly less arteriolonecrosis of the peribiliary vascular plexus in HMP 
preserved livers.
Conclusions: Oxygenated HMP prevents arteriolonecrosis of the peribiliary vascular plexus 
of the bile ducts of DCD pig livers and results in higher arterial flow after reperfusion. 
Together this may contribute to better perfusion of the bile ducts, providing a potential 
advantage in the post-ischemic recovery of bile ducts.
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InTRoDuCTIon
Livers from donation after cardiac death (DCD) donors are increasingly used for transplantation. 
Although this may help to increase the number of donor livers available for transplantation, DCD 
livers are associated with a higher risk of non-anastomotic biliary strictures (NAS), compared 
to livers donated after brain death (DBD (1-4). NAS have been reported in 20-33% of patients 
receiving a DCD liver, compared to 0-13% in patients receiving a DBD liver graft, contributes 
to a higher rate of morbidity and graft failure after DCD liver transplantation (5-7). In contrast 
to DBD liver grafts, livers from DCD donors suffer from warm ischemia in the donor during the 
time period between cardiac arrest and in situ cold perfusion. This donor warm ischemia in 
combination with subsequent cold ischemia during organ preservation is believed to be a main 
cause of bile duct injury leading to NAS after transplantation (8). Biliary epithelial cells have been 
shown to be more susceptible to warm ischemic injury than hepatocytes, which may explain 
the high rate of NAS following otherwise successful DCD liver transplantation (9,10). In a recent 
clinical study, using a standardized histological evaluation of biopsies taken from the extrahepatic 
bile duct at the time of transplantation, arteriolonecrosis of the peribiliary vascular plexus was 
identified as the only independent histological parameter predictive for the development of NAS 
after transplantation (11).
Machine perfusion is increasingly discussed as a promising tool to optimize livers before 
transplantation. During machine preservation livers are perfused with an oxygenated or non-
oxygenated perfusion fluid at either low temperature or normal body temperature (12-16). So 
far, most investigations have focused on hypothermic machine perfusion (HMP) and studies 
have suggested that HMP results in better preservation of the liver parenchyma, compared to 
the classical method of organ preservation, static cold storage (SCS) (14-16). Although machine 
perfusion may be particularly beneficial for preservation of hepatocellular energy status and 
viability of high risk liver grafts, it is still unclear whether it also provides better protection of the 
biliary epithelium and the peribiliary vascular plexus, especially in livers from DCD donors.
We hypothesized that oxygenated HMP leads to reduced injury of the biliary epithelium and 
the bile duct wall, compared to SCS. To test this hypothesis we compared oxygenated HMP 
and SCS in an established DCD model of liver donation in pigs. Outcome parameters were 
selected to assess biliary epithelial injury and function, as well as bile duct morphology after graft 
preservation followed by ex vivo reperfusion using oxygenated autologous blood.




Liver Procurement and Preservation
Experiments were performed in accordance with the Dutch Law on Animal Experiments and 
the study protocol was approved by the Institutional Animal Care and Use Committee of the 
University of Groningen.
Dutch Landrace pigs (n= 18; weight 90-110 kg) were premedicated with atropine, tiletamine/
zolazepam, and Finadyne. General anaesthesia was induced with a 4% sevoflurane mixture with 
air/oxygen and maintained after intubation by mechanical ventilation using 2% sevoflurane. 
After administration of 20,000 U heparin and 4 mg pancuronium iv mechanical ventilation was 
stopped and cardiac arrest was awaited. Animals were subsequently left untouched for 30 min, 
resulting in a mean time interval between cessation of ventilation and in situ cooling of 48 min. 
A midline laparotomy was performed and the distal aorta and inferior vena cava were cannulated 
for rapid in situ flush out with ice-cold histidine-tryptophan-ketoglutarate (HTK) preservation 
solution. The abdominal cavity was filled with slush ice for additional topical cooling. The first 2L 
of blood, drained from the inferior vena cava, was collected in a polyethylene bag with 20.000 IU 
of heparin.
On the backtable, liver grafts were perfused with additional 1L of cold HTK via the portal vein, 
the cystic duct was ligated. After careful flushing of the bile duct with preservation solution, an 
8Fr silicon catheter was inserted and secured in the distal extrahepatic bile duct for collection 
of bile.
Livers were randomly assigned to one of the following two groups: SCS for 4h, followed by 2h 
of ex vivo reperfusion with autologous blood (n= 9) or oxygenated HMP for 4h (n= 9), followed 
by 2h of ex vivo reperfusion with autologous blood at 37 oC.
hypothermic oxygenated Machine Perfusion
HMP was initiated immediately after procurement, using a CE marked device that enables dual 
perfusion via both the hepatic artery and the portal vein in a closed circuit (Liver Assist®, Organ 
Assist, Groningen, Netherlands). Livers were perfused for 4h with Belzer machine perfusion fluid 
(Bridge-to-Life, Ltd., Northbrook, IL), oxygenated with 100% O2. Two rotary pumps provided 
pulsatile flow to the hepatic artery and continuous flow to the portal vein. Two hollow fiber 
membrane oxygenators provided oxygenation of the perfusion solution and removal of CO2. The 
system was both pressure and temperature (10oC) controlled, allowing auto-regulation of the 
blood flow through the liver. Pressure was limited to a mean of 30 mmHg in the hepatic artery 
and 5 mmHg in the portal vein, respectively.
Livers that were preserved by SCS were packed in sterile organ bags with ice-cold HTK 
preservation fluid on melting ice.
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normothermic Reperfusion
To simulate transplantation, liver grafts were reperfused with pig blood, using the same perfusion 
machine as used for HMP. Temperature was kept at 37oC and mean arterial and portal pressure 
were limited to 60 mmHg and 11 mmHg, respectively. Flow was monitored continuously. Sodium 
bicarbonate (8.4% solution) was added to the perfusion fluid to maintain a physiological pH.
assessment of hepatocellular function and Injury
During graft reperfusion, samples were taken from the perfusion fluid every 30 min and analyzed 
immediately for blood gas parameters (pO2, pCO2, sO2, HCO3
- and pH) using an ABL800 FLEX 
analyzer (Radiometer, Brønshøj, Denmark). In addition, plasma from the perfusion fluid was 
collected, frozen and stored at –80oC for determination of alkaline phosphatase, gamma-
glutamyl transferase (gamma-GT), aspartate aminotransferase (AST), lactate dehydrogenase 
(LDH), and total bilirubin, using standard biochemical methods. Total biliary bile salt concentration 
was measured spectrophotometrically using 3-hydroxysteroid dehydrogenase (27). Biliary 
phospholipid concentration was analyzed using a commercially available enzymatic method; the 
Phospholipids FS Kit (DiaSys Diagnostic Systems, Holzheim, Germany).
assessment of Biliary Epithelial Cell function and Injury
After reperfusion, bile production was measured gravimetrically at 30 min intervals. Biliary 
epithelial cell function was assessed by measuring pH, bicarbonate and glucose concentration in 
bile. For this purpose, bile samples were collected under mineral oil and analyzed immediately 
using an ABL800 FLEX analyzer. In addition, biliary concentrations of gamma-GT, alkaline 
phosphatase, and LDH were measured as biomarkers of biliary epithelial injury (28). TBARS 
were measured in bile samples as a marker for oxidative stress in bile ducts. Twenty microliters 
of bile (1:10 diluted with H2O) was mixed with 90mL sodium dodecyl sulfate, 10mL 0.05M 
butylated hydroxytoluene, 400mL 0.1 N HCL, 50mL 10% phosphotungstic acid and 200mL 0.7% 
2-thiobarbituric acid. Samples were kept at 92-97°C for exactly 30 min and the content was 
mixed with 800mL 1-butanol. After centrifugation for 10 min (3,000 rpm/960g), samples from 
the butanol layer were transferred to a 96-well microtitre plate and fluorescence was detected at 
an excitation wavelength of 530nm and emission wavelength of 590nm. TBARS concentrations 
were calculated from a calibration curve of malondialdehyde constructed on the same plate.
gene Expression of hepatobiliary Transporter Proteins
Hepatic mRNA expression of relevant hepatocellular and cholangiocyte transporter proteins 
involved in bile secretion was determined by quantitative real-time PCR. Total RNA was isolated 
from frozen liver tissue using TRIzol (Gibco Life Techologies, Grand Island, NY), and M-MLV 
reverse transcriptase (Invitrogen, Basel, Switzerland) was used to convert RNA into cDNA. 
For quantitative real-time detection, sense and antisense porcine-specific primers (Invitrogen, 
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Paisly, Scotland) were designed for the following genes, using Primer Express software (Applied 
Biosystems, Foster City, CA): the hepatocellular transporters BSEP (bile salt export pump; 
Abcb11) and MDR3 (the phospholipid translocator multidrug resistant protein 3; Abcb4), as 
well as the biliary epithelial transporters involved in biliary bicarbonate secretion CFTR (cystic 
fibrosis transmembrane conductance regulator; Abc35) and AE2 (anion exchanger 2; Slc4a2), 
CK19 (cytokeratin 19; used as internal standard for biliary epithelium) and 18s rRNA (internal 
standard). Amplification and detection were performed with the ABI Prism 7900HT Sequence 
Detection System using emission from SYBR® Green (Applied Biosystems). Copy numbers of 
CK19 and transporter gene mRNA were normalized for 18s rRNA and additionally for CK19 
mRNA if appropriate. Sense and antisense porcine-specific primers used for real-time PCR can 
been found in Table 1.
Table 1. Sequences of primers used for real time RT PCR analysis





DQ530510 U20587 Forward 5’-GCC AAG AAA GGA GCC TAC TAC AAA C-3’ 79
Reverse 5’-CTG TGC ATG AAG TTC TCA AGT CAG AT-3’
MDR3
(Abcb4)
EF067318 Forward 5’-CCA GGA AGC AAA GAA ACT CAA TG-3’ 139
Reverse 5’-CTC CTC CAG GGT CAC AAT GC-3’
CFTR 
(ABc35)




XM_003360081.2 Forward 5’-GATTTTCCTGTACATGGGTGTCAC-3’ 53
Reverse 5’-GCTCGTAGAACTGGATTCCGTTAA-3’
CK19 XM_003131437.1 Forward 5’-TGCCACCATTGAGAACTCCA-3’ 52
Reverse 5’-CAGACGGGCGTTGTCGA-3’
18s NR_46261 Forward 5’-AGTCCCTGCCCTTTGTACACAC-3’ 51
Reverse 5’-AACCATCCAATCGGTAGTAGCG-3’
adenosine-5’-triphosphate (aTP) Extraction and Measurement
Hepatic concentration of ATP was used as an indicator of the energy status of grafts. Liver 
samples were immediately frozen in liquid nitrogen. Frozen tissue was cut into 20mm slices 
and a total amount of ±50mg was homogenized in 1 mL of SONOP (0.372g EDTA in 130mL 
H2O and NaOH (pH 10.9) + 370 mL 96% ethanol) and sonificated. Precipitate was removed by 
centrifugation (13,000 rcf for 10 min). Supernatant was diluted with SONOP to attain a protein 
concentration of 200-300 mg/mL (Pierce BCA Protein Assay Kit, Thermo Scientific, Rockford, 
IL) and mixed with 450mL of 100mM phosphate buffer (Merck; pH 7.6-8.0). Fifty microliters of 
phosphate buffered supernatant was used for ATP measurement using ATP Bioluminescence 
assay kit CLS II (Boehringer, Mannheim, Germany) and a luminometer (Victor3TM 1420 multilabel 
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counter, PerkinElmer). ATP concentrations were calculated from a calibration curve constructed 
on the same plate, corrected for amount of protein, and values were expressed as µmol/g protein.
histological Evaluation of Liver Parenchyma and Bile Ducts
Before and after SCS or HMP, biopsies were taken from liver parenchyma and distal extrahepatic 
bile ducts. After reperfusion, additional biopsies were taken from liver parenchyma, the 
extrahepatic bile duct (proximal from the tip of the biliary catheter), and from the intrahepatic 
bile ducts beyond the level of the first and second bifurcation. Bile ducts were gently grasped 
with fine forceps, taking care not to touch the mucosa and specimens were excised using fine 
Metzenbaum scissors or a scalpel. Biopsies were divided into two sections: one preserved in 
10% formaldehyde for inclusion in paraffin and one snap-frozen in liquid nitrogen and stored at 
-80°C for RNA extraction. Paraffin-embedded slides were prepared for hematoxylin and eosin 
(H&E) staining. Additional slides were prepared for immunohistochemical detection of activated 
caspase-3 (Asp175, Cell Signaling #9661; 1:100), a marker for apoptosis. Injury of bile ducts was 
semiquantified using a systematic scoring system described by Hansen et al. (11). All sections 
were examined in a blind fashion by two independent observers. In the case of discordant 
results, slides were examined by a third investigator.
Statistical analysis
Continuous variables are presented as mean ± standard error (SE). Categorical variables are 
presented as number and percentage. Continuous variables were compared between groups 
using the Student-T test and within groups by a paired T-test. Categorical variables were 
compared with the Pearson chi-square or Fisher’s exact test. The level of significance was set at 
a p-value of 0.05. All statistical analyses were performed using SPSS software version 16.0 for 
Windows (SPSS, Inc., Chicago, IL).
RESuLTS
Reperfusion Characteristics
After 4h of either HMP or SCS livers were reperfused ex vivo for 2h at 37oC using oxygenated 
autologous blood. During the entire reperfusion period hepatic artery flow was higher in the 
HMP group, which was statistically significant at 1h after reperfusion (figure 1a). Portal vein 
flow was similar in the two groups (figure 1B).
Cellular energy status as assessed by hepatic ATP content decreased significantly during SCS, 
but increased during oxygenated HMP. In both groups hepatic ATP content increased after 
normothermic reperfusion (figure 1C).
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Mean weight of livers before and after HMP+ reperfusion was 1427±208 g and 1381±154 g, 
respectively. Liver weight before and after SCS+ reperfusion was 1301±207 g and 1610±161 g, 
respectively. Changes in weight were not significantly different between the two groups.
Impact of hMP on hepatocellular Injury and function
Release of liver enzymes after reperfusion was used to assess the degree of hepatocellular injury. 
To correct for a wash-out effect of machine perfusion, the relative increase in plasma levels of 
AST and LDH during and after the first 15 min of reperfusion was determined. For both time 
intervals increase in serum enzymes was lower in the HMP group, which was significant for the 
first time period (figure 1).
During reperfusion, increasing bile production was observed in both groups, without significant 
differences between the groups (figure 2). There were no significant differences in biliary 
concentrations of bile salts and phospholipids, as well as their ratio at 2h after reperfusion or 
in gene expression levels of the transporter proteins BSEP (bile salt export pump; Abcb11) and 
MDR3 (multidrug resistance protein 3; Abcb4), responsible for the biliary secretion of bile salts 
and phospholipids, respectively (figure 2).
figure 1. Perfusion characteristics during and changes in serum concentrations of AST and LDH after 2h of 
normothermic ex vivo sanguineous reperfusion of DCD livers that were preserved by either 4h of oxygenated 
HMP or SCS. Panel a: Blood flow through the hepatic artery. Panel B: Blood flow through the portal vein. 
Panel C: Changes in hepatic energy content as reflected by hepatic ATP content. Panel D and E: Relative 
increase of liver enzymes was significantly greater for SCS preserved livers, compared to livers preserved by 
oxygenated HMP. * p-value < 0.05.
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figure 2. Parameters of hepatocellular secretory function of DCD livers that were preserved by either 4h 
of oxygenated HMP or SCS and subsequently reperfused for 2h by normothermic ex vivo sanguineous 
perfusion. Panel a: Evolution of bile production in the HMP and SCS group. Panel B and C: Biliary 
concentration of bile salts and phospholipids, respectively. Panel D: Bile salt toxicity, as represented by the 
ratio of biliary bile salt and phospholipid concentrations. There were no statistically significant differences 
between the groups. Panel E-f: Relative mRNA expression of the main hepatocellular bile transporters 
BSEP (bile salt export pump; Abcb11) and MDR3 (multidrug resistance protein 3; Abcb4) after 2h of ex vivo 
sanguineous reperfusion of DCD livers that were preserved by either 4h of oxygenated HMP or SCS. There 
were no significant differences between the two groups.
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Impact of hMP on Biliary Epithelial Injury and function
Biliary concentrations of lactate dehydrogenase (LDH), alkaline phosphatase and gamma-GT at 
2h after reperfusion were similar in the two groups (figure 3a-C). In parallel with this, there was 
no difference in concentration of Thiobarbituric acid reactive substances (TBARS) in bile, a marker 
of oxidative stress in the bile ducts (figure 3D). Moreover, there were no significant differences 
in biliary pH and concentrations of bicarbonate and glucose in bile at 2h after reperfusion or in 
gene expression of the biliary epithelial transporters involved in the secretion of bicarbonate into 
the bile, cystic fibrosis transmembrane conductance regulator (CFTR) and anion exchanger 2 
(AE2) between the two groups (figure 4).
figure 3. Comparison of biochemical parameters of bile duct injury and oxidative stress in DCD livers 
that were preserved by either 4h of oxygenated HMP or 4h of SCS and subsequently reperfused for 2h by 
normothermic ex vivo sanguineous perfusion. Panel a-C: Concentration of LDH, alkaline phosphatase, and 
gamma-GT in bile samples at 2h after reperfusion. Panel D: Comparison of biliary concentration of TBARS, 
a marker for oxidative stress and lipid peroxidation in bile ducts, at 2h after graft reperfusion.
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figure 4. Comparison of functional parameters of biliary epithelial cell function in DCD livers that 
were preserved by either 4h of oxygenated HMP or 4h of SCS and subsequently reperfused for 2h by 
normothermic ex vivo sanguineous perfusion. There were no significant differences in biliary pH (a), biliary 
bicarbonate (B) and glucose concentration (C) at 2h after reperfusion between the two groups. Relative 
mRNA expression of the main cholangiocyte transporter proteins involved in biliary bicarbonate secretion, 
CFTR (cystic fibrosis transmembrane conductance regulator; ABC35) (D) and AE2 (anion exchanger 2; 
SLC4A2) (E) after 2h of ex vivo sanguineous reperfusion of DCD livers that were preserved by either 4h of 
oxygenated HMP or SCS. There were no significant differences between the two groups.
Impact of hMP on Preservation of hepatocellular and Biliary Morphology
Hematoxylin and eosin (H&E) staining and activated caspase-3 immunohistochemistry of liver 
parenchyma revealed less signs of ischemia-reperfusion injury in the HMP group, compared to 
SCS preserved livers (figure 5). H&E staining of bile duct samples was used for semiquantitative 
analysis of bile duct injury, as described by Hansen et al (11). The results of this morphological 
analysis of extrahepatic bile ducts are summarized in Table 2. In this model of DCD livers, we 
observed extensive loss of biliary epithelial lining immediately after organ procurement. The 
underlying mural stroma and peribiliary vascular plexus, however, appeared relatively normal 
(figure 6a). After preservation and reperfusion, bile ducts of both HMP and SCS preserved 
livers displayed signs of increased mural necrosis with loss of cell nuclei in the subepithelial 
stroma (figure 6B). Immunohistochemistry revealed very few activated caspase-3 positive cells, 
suggesting that cells died from necrosis rather than apoptosis (figure 6C). In both groups, the 
degree of bile duct injury was less severe in the more proximal (intrahepatic) biliary branches 
opdendries.indd   119 11-10-2013   9:50:19
Chapter 8
120
(data not shown). Interestingly, the degree of arteriolonecrosis of the peribiliary vascular plexus 
was significantly lower in the HMP group, compared to the SCS group (Table 2 and figure 6D).
Table 2. Histological analysis of bile duct injury according to Hansen et al. (11)
oxygenated hMP group
(n=8)*




Score 0 (no BEC loss)
Score 1 (≤50% BEC loss)









Score 0 (no necrosis)
Score 1 (≤25% necosis)
Score 2 (25-50% necrosis)
Score 3 (50-75% necrosis)













Score 0 (no arteriolonecrosis)
Score 1 (≤50% arteriolonecosis)









Score 0 (no bleeding)
Score 1 (≤50% of the bile duct)









Score 0 (no thrombi)






* Bile duct histology was missing for one pig in the HMP group. 
abbreviations used: BEC, biliary epithelial cells; NA, not assessable
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After oxygenated HMP After SCSAfter procurement
B
A
figure 5. Representative examples of histology of liver parenchyma of DCD liver grafts preserved by either 4h 
of oxygenated HMP or 4h of SCS followed by 2h by normothermic ex vivo sanguineous perfusion. Panel a: 
H&E staining of a central biopsy of the liver parenchyma. Panel B: Caspase-3 immunohistochemistry of 
liver parenchyma showing less intense caspase-3 staining of hepatocytes, sinusoidal endothelial cells, and 
Kupffer cells in the HMP group, compared to the SCS group. Brown color indicates immunopositivity. 
Original magnification 200x
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figure 6. Representative examples of H&E histology of bile ducts of DCD liver grafts preserved by either 
4h of oxygenated HMP or 4h of SCS followed by 2h by normothermic ex vivo sanguineous perfusion. 
Panel a: extrahepatic bile duct immediately after procurement (magnification 200x). The insert represents 
a higher magnification of 400x. Panel B: extrahepatic bile duct after preservation and reperfusion 
(magnification 280x). Panel C: Immunohistochemistry for activated caspase-3 of the same bile ducts as 
presented in panel B (brown color indicates immunopositivity; counterstaining with hematoxylin). Very few 
caspase-3 positive cells were detected in the bile duct wall stroma. Remnant biliary epithelial cells (i.e. in 
the peribiliary glands) were not positive for activated caspase-3. Panel D: higher magnification (400x) of 
extrahepatic bile ducts focusing on the peribiliary plexus. Arrows indicate peribiliary arterioles. Bile ducts of 
livers preserved by oxygenated HMP displayed significantly less signs of arteriolonecrosis, compared to livers 
preserved by SCS (see also Table 1).
DISCuSSIon
Although several authors have proposed machine perfusion as an attractive alternative method 
for preservation of DCD livers, it remains to be established whether this technique will reduce 
the amount of bile duct injury and contributes to a reduction of biliary complications. We here 
report the first study on the impact of oxygenated HMP on the preservation of the bile ducts in 
a porcine DCD model. The most striking histological difference between oxygenated HMP and 
SCS was a lower degree of arteriolonecrosis of the peribiliary plexus in the extrahepatic bile ducts 
of grafts preserved by HMP. In parallel with this we observed a higher arterial blood flow after 
reperfusion of HMP preserved livers, compared to SCS. Although HMP did not result in a lower 
amount of injury of the biliary epithelial lining or underlying stroma, the observed difference 
in preservation of the peribiliary vascular plexus may be clinically relevant as the presence of 
arteriolonecrosis in extrahepatic bile duct biopsies at the time of transplantation was recently 
identified as the only independent histological parameter predictive for the development of 
NAS after human liver transplantation (11). Machine perfusion of liver grafts may enable better 
preservation of the arterial vasculature of the biliary tree by providing a continuous supply of 
oxygen to the endothelium, better distribution of the preservation fluid, and wash-out of waste 
products. Adequate blood supply to the bile ducts is known to be of critical importance in 
maintaining viability. Insufficient arterial perfusion of liver grafts, either due to hepatic artery 
thrombosis or stenosis, leads to ischemic cholangiopathy, characterized by loss of biliary 
epithelium, necrosis of the bile duct wall and subsequent narrowing of the bile duct lumen due 
to sclerosing fibrosis  (9,17). Therefore, better preservation of the peribiliary plexus and higher 
arterial flow after reperfusion as observed in the current study is an important finding.
Apart from the differences in arterial flow after reperfusion and better preservation of the 
peribiliary vascular plexus, we found no histological differences in amount of biliary epithelial 
cell loss or bile duct stroma. In parallel with this, biochemical parameters of biliary epithelial 
cell function (biliary pH and bicarbonate secretion) or biliary injury (concentrations LDH, AF, and 
gamma-GT in bile) did not differ between the two groups. Nevertheless, better of preservation 
and perfusion of the peribiliary vascular plexus as observed in the HMP group may result in 
faster and more efficient regeneration of the biliary epithelium. Two recent clinical studies have 
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demonstrated that biliary epithelial cell loss can be found in more than 80% of all human liver 
grafts before transplantation (11,18). This interesting new finding has changed the perspective 
from which to view the pathogenesis of biliary strictures after transplantation as it suggests 
that the critical factor that determines whether a graft will develop biliary strictures or not, is 
insufficient biliary regeneration rather than the initial biliary injury (19).
In accordance with previous studies (12,16,20,21) we have observed a reduction in biochemical 
histological markers of hepatocellular injury and histological injury of the parenchyma. Release 
of ALT and LDH after graft reperfusion was lower in the HMP group, compared to SCS preserved 
livers. A difference persisted when we corrected for a possible wash-out effect in HMP preserved 
livers by calculating the relative change in concentration of these enzymes after the first 
15 minutes of reperfusion. Although preservation of the liver parenchyma was not the primary 
focus of the current study, these findings confirm previous studies suggesting that HMP provides 
better preservation of the liver parenchyma than SCS.
Although great progress has been made in the development of machine perfusion as an 
alternative to SCS for preservation of donor organs, it remains to be established which method of 
machine perfusion is most effective. Several variations of machine perfusion have been explored, 
including hypothermic oxygenated or non-oxygenated, subnormothemic and normothermic 
perfusion (12,13,21-24). It also remains unclear whether or not machine perfusion should replace 
SCS completely, or whether it is sufficient to provide a short period of machine perfusion at the 
end of cold storage before transplantation (16). The most basic type of machine preservation is 
non-oxygenated hypothermic perfusion, a technique that was first applied in a clinical setting 
by Guarrera et al (12). The advantage of this technique is its relative simplicity and safety, but 
there is doubt whether this method is sufficient to protect high risk grafts such as those from 
DCD donors (20,25). Optimal preservation and protection of the biliary epithelium and bile duct 
wall may require a more advanced technique in which liver grafts are perfused with oxygenated 
perfusion fluid and at body temperature. Using a porcine model of DCD livers, Boehnert et al 
recently reported favourable effects of normothermic acellular machine perfusion of bile duct 
preservation in pig DCD livers (26). Our group previously demonstrated that normothermic, 
oxygenated perfusion of human donor livers is technically feasible. However, more research in 
this area is needed to determine whether this will also result in a reduction of biliary complications 
after transplantation (13).
In conclusion, this study suggests that oxygenated HMP of liver grafts from DCD donors provides 
protection against ischemic injury of the peribiliary vascular plexus, as reflected by a lower 
degree of arteriolonecrosis in the bile duct wall. Moreover, it associated with higher arterial 
flow rates early after reperfusion, compared to SCS. Although, we observed no differences in 
the degree of biliary epithelial cell loss or bile duct necrosis between livers preserved by HMP or 
SCS, the combination of better preservation of the peribiliary plexus and higher arterial flow may 
contribute to a faster recovery of the post ischemic bile ducts. Whether this results in a reduction 
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of the rate of biliary complications after transplantation of DCD livers should be answered in 
clinical trials.
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Injury of bile ducts may occur during liver procurement and transplantation, especially in 
livers donated after cardiac death (DCD). Normothermic machine perfusion (NMP) has 
been shown to reduce hepatic injury, compared to static cold storage (SCS). However, it is 
unknown whether NMP provides better preservation of bile ducts. The aim of this study was 
to determine the impact of NMP on bile duct preservation in both DCD and non-DCD livers. 
DCD and non-DCD livers obtained from Lewis rats were preserved for 3h using either SCS 
or NMP, followed by 2h ex-vivo reperfusion. Biliary epithelial cell injury and function were 
assessed by quantification of biochemical markers and immunohistochemistry. Morphology 
of biliary epithelial cells was analyzed by scanning and transmission electron microscopy. 
Biomarkers of bile duct injury (gamma-GT and LDH in bile) were lower in NMP preserved 
livers, compared to SCS preserved livers. Biliary bicarbonate concentration, reflecting biliary 
epithelial function, was 2-fold higher in NMP preserved livers (p<0.01). In parallel with this, 
the pH of the bile was significantly higher in NMP preserved livers (7.63±0.02 and 7.74±0.05, 
for non-DCD and DCD livers, respectively), compared with SCS (7.46±0.02 and 7.49±0.04, 
for non-DCD and DCD livers, respectively). Scanning and transmission electron microscopy 
of donor extrahepatic bile ducts demonstrated significantly decreased injury of the biliary 
epithelium of NMP preserved donor livers (including loss of lateral interdigitations and 
mitrochondrial injury). Differences between NMP and SCS were most prominent in DCD 
livers.
Conclusion: Compared to conventional SCS, NMP provides superior preservation of bile 
duct epithelial cell function and morphology, especially in DCD donor livers. By reducing 
biliary injury, NMP could have an important impact on the utilization of DCD livers and 
outcome after transplantation.
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Non-anastomotic bile duct strictures are a major cause of morbidity after liver transplantation 
(1-3). These biliary strictures occur more frequently in livers donated after cardiac death (DCD; 
20.5-33.3%), compared to livers donated after brain death (DBD; 0-12.5%) and are notoriously 
therapy resistant (4-7). In an effort to expand the donor pool, DCD donors are increasingly used 
for transplantation. In the US, the percentage of DCD donors increased from 1.1% in 1995 to 
11.2% in 2010 (8). DCD grafts are procured after the donor’s circulation ceases, and are subject 
to a period of warm ischemia in addition to the cold storage period between procurement and 
implantation. The combination of subsequent warm and cold ischemia is thought to lead to 
increased biliary injury, which can explain the increased risk of biliary strictures in DCD donor 
livers (9). Biliary epithelial cells have shown to be more susceptible to ischemic injury than 
hepatocytes, which may explain the high rate of non-anastomotic biliary strictures following 
otherwise successful DCD liver transplantation (10,11). As the discrepancy between available 
donor organs and the number of patients waiting for transplantation increases, more DCD grafts 
will be used, necessitating the development of better preservation methods to minimize bile duct 
injury and the subsequent risk for non-anastomotic strictures.
Normothermic machine perfusion (NMP) of donor livers offers potential to meet the higher 
requirements for DCD graft preservation. An important advantage of NMP over conventional 
static cold storage (SCS) is the delivery of oxygen and nutrients at 37°C, providing full metabolic 
support. NMP can potentially minimize or even eliminate cold ischemia during preservation. 
Animal studies comparing NMP with SCS have demonstrated increased bile production; lower 
levels of hepatocellular enzymes; and decreased parenchymal necrosis after reperfusion of NMP 
preserved livers (12-14). Transplantation of NMP preserved livers in animal models has been 
associated with improved survival (14,15). So far, studies on NMP preservation have focused on 
hepatocellular injury and general viability outcome parameters. It is still unknown whether NMP 
is protective for the bile ducts and whether it results in better preservation of biliary epithelial 
function than SCS.
We hypothesized that NMP provides better preservation of the bile ducts, when compared to 
conventional SCS. To test this hypothesis, we studied the impact of NMP on the preservation of 
biliary epithelium in both DCD and non-DCD rat donor livers.
MaTERIaLS anD METhoDS
animals
Male Lewis rats (LEW/Han®Hsd), weighing 303±4 g (mean±SEM) were obtained from Harlan 
Laboratories (Boxmeer, Netherlands). Animals received care according to the Dutch Law on 
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Animal Experiments, and the study protocol was approved by the Institutional Animal Care and 
Use Committee of the University of Groningen (IACUC-RuG).
Experimental Design
Thirty-eight rat livers were divided into 4 experimental groups and a control group (Table 1). 
Livers were procured from DCD and non-DCD donors and in each group livers were either 
preserved by NMP or SCS (n=7-9 for each group). In the control group, rats (n=6) were used for 
in vivo collection of bile during 30 minutes of anesthesia as described below for liver donation. 
Control rats were supported with mechanical ventilation to maintain a stable arterial blood gas 
(pH 7.35-7.45). After bile collection, the liver and extrahepatic bile duct was excised and tissue 
samples were processed immediately for further analyses.
Table 1. Experimental design
Experimental group: Procurement: Storage: Reperfusion:
Non-DCD+NMP Non-DCD 3h normothermic machine perfusion 2h reperfusion
Non-DCD+SCS Non-DCD 3h static cold storage 2h reperfusion
DCD+NMP DCD 3h normothermic machine perfusion 2h reperfusion
DCD+SCS DCD 3h static cold storage 2h reperfusion
Procurement of DCD and non-DCD Donor Livers
Inhalation anesthesia with isoflurane and oxygen was used before (5% isoflurane) and during the 
procurement (2-3% isoflurane). The extrahepatic bile duct was cannulated and 1 ml 0.9% NaCl 
with 500 IU of heparin was administered via the dorsal penile vein. In case of a DCD donation, 
manual pressure was applied to the heart for 2 minutes until cardiac contractions ceased. The 
aorta and pulmonary artery were clamped close to the heart and the rat was kept at 37°C for 
30 minutes. In case of non-DCD donation, livers were procured immediately after laparotomy. 
In all groups, cannulation of the celiac trunk was followed by clamping the infra-hepatic inferior 
vena cava and the portal vein. The splenic vein, mesenteric artery and mesenteric vein were 
ligated and the portal vein was cannulated. After immediate in situ perfusion of the liver with 
5mL 0.9% NaCl (37°C) via the portal vein cannula, the supra-hepatic inferior vena cava was 
transected, followed by a cold flush out with 5 mL 0.9% NaCl (4°C) via the portal vein cannula. 
The liver was removed and flushed with an additional 20mL of cold (4°C) 0.9% NaCl via the 
portal vein and 5mL of cold (4°C) 0.9% NaCl via the hepatic artery (celiac trunk cannula) before 
preservation by either SCS or NMP.
Static Cold Storage and normothermic Machine Perfusion
In the SCS groups, livers were stored in 0.9% NaCl at 4°C for 3h. In the NMP groups, livers 
were preserved by ex vivo perfusion for 3h, with a perfusion fluid consisting of 20mL human 
red blood cell concentrate (final hematocrit 15-20%), 59mL William’s Medium E solution, 20mL 
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human albumin (200g/L Albuman®, Sanquin, Amsterdam, Netherlands), 1mL insulin (100 IE/mL 
Actrapid®, Novo Nordisk, Alphen aan den Rijn, Netherlands) and 0,1mL unfractionated heparin 
(5000 IE/mL), adding up to a total volume of 100mL. The same fluid was used for two hours of 
reperfusion.
figure 1. Ex vivo rat liver machine perfusion system. Two roller pumps provided a pulsatile flow to 
the hepatic artery (a) and a continuous flow to the portal vein (B), after eliminating pulses with an air 
chamber (C). Two tubular membrane oxygenators provided oxygenation of the perfusion solution, as well 
as removal of CO2 (D). The system was both pressure and temperature controlled. Flow (f), pressure (P) and 
temperature (T) were detected by inline sensors and data were analyzed by and displayed in real-time on 
a connected laptop (E). Heat exchangers (f) and a plexiglass box encapsulating the perfusion system (g), 
ensured temperature control at 37°C. The rat liver was placed into an organ chamber (h), protected with 
a transparent cover to maintain a moist and warm environment. Bile was collected in Eppendorf tubes (I). 
Several three-way connecters were used as bubble traps (J).
For both NMP and ex vivo reperfusion of rat donor livers we developed a liver machine perfusion 
system that enabled dual perfusion via both the hepatic artery and the portal vein in a closed 
circuit (figure 1). Two roller pumps (Ismatec ISM404 + ISM719 and MS-2/6-160; IDEX Health 
& Science, Wertheim-Mondfeld, Germany) provided pulsatile flow to the hepatic artery and 
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continuous flow to the portal vein. Two tubular membrane oxygenators provided oxygenation 
of the perfusion solution and removal of CO2. The system was pressure- and temperature-
controlled, allowing auto regulation of blood flow through the liver, with constant pressure 
at variable flow rates. Inline sensors detected flow, pressure and temperature, and data were 
analyzed by and displayed in real-time on a connected laptop (software kindly provided by 
Organ Assist, Groningen, Netherlands). Pressure was limited to a mean of 110 mmHg in the 
hepatic artery and 11 mmHg in the portal vein and temperature was set to 37°C. After each liver 
perfusion experiment, the system was thoroughly cleaned with biological soap based on active 
enzyme complexes (Biotex Groen, Unilever, Rotterdam, Netherlands), water, ethanol (70%) and 
subsequently dried with compressed air.
Biochemical Markers of function and Injury
During ex vivo reperfusion, flow and temperature were registered every 15 minutes. Before 
reperfusion and 1h after reperfusion, samples were taken from the perfusion fluid. Samples were 
centrifuged (2700 rpm for 5 min at 4°C) and plasma was collected, frozen and stored at -80°C 
for determination of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate 
dehydrogenase (LDH) and albumin, using standard biochemical methods.
Bile production was measured at 30-minute intervals by weighing Eppendorf tubes in which bile 
was collected from the biliary drain. Biliary epithelial cell function was assessed by measuring pH 
and bicarbonate concentration in bile. For this purpose, bile samples were collected under mineral 
oil and analyzed immediately using an ABL800 FLEX analyzer (Radiometer, Brønshøj, Denmark). 
Biliary concentration of gamma-glutamyl transferase (gamma-GT) and LDH were measured as 
biomarkers of biliary epithelial cell injury (17), and biliary bilirubin concentration was measured as 
biomarker of hepatocellular secretory function, using standard biochemical methods.
Immunohistochemistry for activated Caspase-3 of the Extrahepatic Bile Ducts
Immunohistochemistry for activated caspase-3 was performed to detect apoptotic cell death 
in extrahepatic bile ducts. After 2h of reperfusion, a segment of the extrahepatic bile duct 
proximal from the tip of the biliary catheter (and therefore not mechanically injured) was 
dissected free and stored in 10% formaldehyde for inclusion in paraffin. Slides were prepared 
for immunohistochemical detection of activated caspase-3 (Asp175, Cell Signaling #9661; 1:100 
dilution). Antigen retrieval was performed with 1mM EDTA (pH 8.0) and microwave (15 min, 
400W). GaRpo (1:50 dilution; DAKO p0448) and RaGpo (1:50 dilution; DAKO P0449) were used 
as secondary and tertiary antibodies. Slides were counterstained with hematoxylin.
Electron Microscopy of the Extrahepatic Bile Duct Epithelium
Scanning and transmission electron microscopy (EM) were used for ultrastructural assessment of 
morphology of biliary epithelial lining of extrahepatic bile ducts. For this purpose, a segment of 
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the extrahepatic bile duct proximal from the tip of the biliary catheter was excised after 2 hours of 
reperfusion and samples were fixed in 2.5% glutaraldehyde in 0,1M sodiumcacodylate, postfixed 
with osmiumtetroxide, dehydrated through ethanol and critical point dried for scanning EM or 
embedded in EPON before sectioning for transmission EM. Scanning EM (Jeol6301F; 2kV) was 
used for qualitative assessment of the apical surface of the biliary epithelial layer. Transmission EM 
(FEI Cm100; 80kV) was used to assess ultrastructural changes, focusing on cellular attachments 
(including lateral interdigitations, tight-junctions, and cell-basement membrane contact), 
microvilli, and mitochondria. Characteristic ultrastructural mitochondrial changes were assessed, 
using a semi-quantitative scoring system modified from Crouser et al. (18). Ultrastructural 
morphology of mitochondria was graded as normal (grade 0), minimal-moderate swelling 
(grade 1) and severe swelling and/or flocculent condensation (grade 2). Two investigators (SodD 
and NK) examined all mitochondria in a blinded fashion in at least ten epithelial cells per bile 
duct, resulting in 20-40 biliary epithelial cells per group. Mean total number of mitochondria per 
cell and relative distribution of the injury grades were calculated per group.
Statistical analyses
Continuous data are presented as mean ± SEM. Student T-test was used to compare two groups 
of continuous variables. Kruskal-Wallis Test was used for statistical comparison of >2 groups. 
Categorical data are expressed as numbers and percentage and groups were compared using 
Pearson chi-square test or Fischer’s exact test as appropriate. The level of significance was set at 
p-value of 0.05. Analyses were performed using SPSS software version 16.0 for Windows (SPSS 
Inc., Chicago, IL, USA).
RESuLTS
Does nMP Provide Better Protection of hepatic Parenchyma?
In a pressure-controlled perfusion system, blood flow through the liver can be used as an indicator 
of intrahepatic vascular resistance. The average arterial flow at 1h after perfusion was 5.3±0.4 
mL/min and the portal flow was 22.6±0.8 mL/min. Changes in portal flow during reperfusion are 
presented in figure 2a. The lowest initial portal flow was noted in livers preserved by SCS (both 
DCD and non-DCD) and the highest flow in non-DCD livers preserved by NMP. This resulted in a 
significant difference in portal flow between the four groups during the first 1.5h of reperfusion 
(p=0.001 to 0.045 for the various time points). No significant differences in arterial flow were 
observed between the groups (data not shown).
During reperfusion, plasma albumin levels in perfusion fluid decreased in SCS preserved livers, 
whereas no or a minimal decrease was noted in NMP preserved livers, suggesting a greater 
capillary leak in the SCS preserved livers (figure 2B).
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The relative increase of cellular enzymes AST, ALT and LDH in the perfusion fluid after reperfusion 
was used as a biochemical marker of hepatocellular injury. In both non-DCD and DCD donor livers 
the release of hepatocellular enzymes was significantly higher after SCS preservation, compared 
to NMP preservation (figure 3a-C). The highest increase in plasma levels of AST, ALT and LDH 
was noted in the DCD+SCS group and lowest increase in the non-DCD+NMP group.
figure 2. Markers of vascular resistance and integrity during reperfusion. DCD and non-DCD rat livers were 
preserved by normothermic machine perfusion (NMP) or static cold storage (SCS) for 3h and subsequently 
reperfused ex vivo. Panel a: Portal vein flow during reperfusion in the four groups. A significant difference in 
portal flow between the four groups was observed during the first 1.5h of reperfusion. Panel B: Change in 
plasma albumin concentration in the perfusion fluid during the first hour of reperfusion. Data are expressed 
as mean±SEM; * p < 0.05.
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Bile production (an important parameter of hepatocyte function) was significantly higher after 
reperfusion of NMP preserved DCD livers, compared to SCS preserved DCD livers (figure 3D). 
This beneficial effect of NMP was less pronounced in non-DCD donor livers. In all four groups, 
bile flow after ex vivo reperfusion remained lower than in vivo bile flow in control rats.
In NMP preserved livers from both DCD and non-DCD donors, biliary bilirubin concentration 
was not significantly different from that in bile collected in vivo from normal controls. However, 
bilirubin concentration in bile produced by SCS preserved livers (both DCD and non-DCD) were 
about 4-times lower, compared with NMP preserved livers (p<0.05) (figure 3E).
Does nMP Provide Better Protection against Bile Duct Epithelial Cell Injury?
Concentrations of gamma-GT and LDH in bile were used as biomarkers of biliary epithelial 
injury (20). The highest biliary concentrations of enzymes at 1h after reperfusion were found 
in DCD livers preserved by SCS (figure 4a and B). In DCD livers preserved by NMP, the mean 
concentration of gamma-GT in bile was significantly lower compared to SCS. In fact, mean 
biliary gamma-GT concentration in the DCD+NMP group was not different from values in the 
non-DCD groups or in vivo normal controls (figure 4a). A similar pattern was seen for biliary 
LDH concentration. Although the highest biliary concentration of LDH was again found in the 
DCD+SCS group, the differences between the experimental groups did not reach statistical 
significance (figure 4B).
Does nMP Provide Better Preservation of Bile Duct Epithelial Cell function?
Biliary epithelial cells contribute to bile flow and composition by active secretion of bicarbonate 
(HCO3
-) into bile, resulting in an alkalotic pH. Biliary pH and bicarbonate concentration were 
used as markers of epithelial function. Bile collected at 1h of reperfusion of NMP preserved 
livers contained 2-times higher concentration of bicarbonate compared to SCS preserved livers, 
in both DCD and non-DCD groups (p<0.01). The concentration of biliary bicarbonate, however, 
was significantly lower in all experimental groups than in bile collected from in vivo controls 
(figure  4C). In both DCD and non-DCD livers, pH of bile was significantly higher in NMP 
preserved livers (pH 7.63±0.02 and 7.74±0.02, respectively), compared with SCS (pH 7.46±0.02 
and 7.49±0.04, respectively). In fact, the biliary pH of NMP-preserved livers was normal and not 
significantly different from values obtained in in vivo controls (figure 4D).
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figure 3. Biochemical markers of hepatocyte injury and function, measured in the perfusion fluid. DCD and 
non-DCD rat livers were preserved by normothermic machine perfusion (NMP) or static cold storage (SCS) 
for 3h and subsequently reperfused ex vivo. Panel a-C: Relative change in plasma concentration of AST, 
ALT and LDH into the perfusion fluid during the first hour of reperfusion. Panel D and E: Bile production 
and bilirubin concentration in bile at 1 hour after reperfusion. Data are expressed as mean±SEM; * p < 0.05.
opdendries.indd   136 11-10-2013   9:50:27
Normothermic Machine Perfusion Reduces Bile Duct Injury and Improves Biliary Epithelial Function in Rat Donor Livers
137
9figure 4. Biochemical markers of biliary epithelia cell injury and function, detected in bile. Panel a and B: 
Markers of biliary epithelial cell injury: LDH and gGT in bile at 1h after reperfusion. Panel C and D: Markers 
of cholangiocyte function: HCO3
- concentration in bile and pH of bile at 1h after reperfusion. Data are 
expressed as mean±SEM; * p < 0.05.
Does nMP Provide Better Preservation of Bile Duct Epithelial Cell Morphology?
Light microscopy (H&E) did not show obvious injury to the bile duct epithelium. To determine 
whether biliary epithelial cell were apoptotic, immunohistochemistry for activated caspase-3 was 
compared among the groups. In general, there were hardly any caspase-3 positive cells detected 
(figure 5). Only in the group of DCD livers preserved by SCS, caspase-3 positive biliary epithelial 
cells were sporadically noted (figure 5D).
opdendries.indd   137 11-10-2013   9:50:27
Chapter 9
138
figure 5. Immunohistochemistry of activated caspase-3 as marker of apoptosis. Biopsies were taken 2h after 
reperfusion of DCD and non-DCD rat livers preserved by either normothermic machine perfusion (NMP) or 
static cold storage (SCS). Immunoreactivity for caspase-3 (brown color) was only noted sporadically in DCD 
livers preserved by SCS. Panel a: non-DCD liver preserved by NMP. Panel B: non-DCD liver preserved by 
SCS. Panel C: DCD liver preserved by NMP. Panel D: DCD liver preserved by SCS. The insert presents a 
higher magnification with a caspase-3 positive biliary epithelial cell (arrow). Original magnification 200x. 
Counter staining was with hematoxylin (blue color).
Ultrastructural changes in the morphology of extrahepatic bile ducts were assessed by scanning 
and transmission EM. Although the degree of morphological changes varied along the length of 
extrahepatic bile ducts, there were clear differences between the four groups (figures 6 and 7). 
Scanning EM revealed no or only minor changes in bile ducts of non-DCD livers preserved by 
either SCS or NMP (figure 6). The biliary epithelial layer was intact and most cells had normal 
appearing microvilli and cilia on their luminal membrane, except for the non-DCD+SCS group 
where some cells displayed reduced density of microvilli. Scanning EM of bile ducts of DCD livers 
preserved by NMP displayed well-preserved apical surface of the epithelial layer (figure 7B). 
In contrast with this, bile ducts of DCD livers preserved by SCS exhibited signs of severe loss of 
lateral cell-cell contact, loss of microvilli, and sporadic epithelial cell apoptosis (figure 7a).
Loosening of cell-cell contact between biliary epithelial cells of DCD livers preserved by SCS was 
confirmed by transmission EM. Lateral cell contacts at the level of tight junction appeared less 
firm and a loss of intercellular interdigitations was noted along the basolateral membrane of 
biliary epithelial cells in the DCD+SCS group (figure 7a and B). Differences between SCS and 
NMP were much less pronounced for non-DCD livers (figure 6B and C). In addition, transmission 
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EM revealed a significantly reduced number of mitochondria per cell in SCS preserved DCD livers, 
when compared to the other three experimental groups as well as normal controls. The degree 
of mitochondrial injury, as assessed by a semi-quantitative scoring system, was significantly 
higher in SCS preserved DCD livers, compared to the other groups (figure 7C).
figure 6. Non-DCD rat livers: Images of scanning and transmission electron microscopy of biliary epithelium 
of extrahepatic bile ducts. Biopsies were taken 2h after reperfusion of non-DCD rat livers preserved by either 
normothermic machine perfusion (NMP) or static cold storage (SCS). Panel a: Images of normal bile duct 
epithelium. Panel B: Bile duct epithelium of SCS preserved non-DCD livers. Panel C: Bile duct epithelium of 
NMP preserved non-DCD livers. The lumen of the bile duct is marked with an asterisk. Biliary epithelial cells 
with loss of microvilli are marked with white arrows. Scale bars are 1 mm.
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figure 7. DCD rat livers: Images of scanning and transmission electron microscopy of biliary epithelium 
of extrahepatic bile ducts. Biopsies were taken 2h after reperfusion of DCD rat livers preserved by either 
normothermic machine perfusion (NMP) or static cold storage (SCS). Panel a: Bile duct epithelium of SCS 
preserved DCD livers. Panel B: Bile duct epithelium of NMP preserved DCD livers. The lumen of the bile 
duct is marked with an asterisk, the arrows point at widening of tight-junctions (SEM) and loss of lateral 
interdigitations (TEM). White triangles indicate loss of microvilli at the apical membrane. An apoptotic bile 
duct epithelium cell is marked with a pound symbol (#). Panel C: Summary of mitochondrial injury in biliary 
epithelial cells in all four groups, based on a modified semi-quantitative grading system, as described by 
Crouser et al. (19). Scale bars are 1 mm.
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Machine perfusion is receiving increasing attention as an attractive alternative for static cold 
storage of liver grafts before transplantation. Previous animal studies on NMP have shown 
decreased hepatocellular injury and better early posttransplant survival in NMP preserved 
livers, compared to SCS preserved livers (12-15). However, it remains unknown whether NMP 
also provides better protection against biliary injury. In the current study we have performed a 
detailed analysis of bile duct epithelial injury and function in both DCD and non-DCD rat livers 
preserved by either NMP or SCS.
The principal novel finding of our study is that liver graft preservation by NMP provided significantly 
better protection against biliary epithelial cell injury and dysfunction than conventional SCS. In 
addition, NMP resulted in better preservation of the cellular ultrastructural morphology of biliary 
epithelium, compared to SCS. Importantly, the beneficial effects of NMP were most prominent 
in DCD livers.
In both DCD and non-DCD livers, the post-reperfusion release of AST, ALT and LDH was 
significantly lower in NMP preserved livers, compared to SCS preserved livers. These findings 
confirm data from previous studies in rat and porcine livers, which have shown a protective 
effect of NMP against preservation injury of liver parenchyma. (12-15). Based on a porcine model 
of normothermic perfusion, bile output has been suggested as the most relevant parameter of 
liver viability (12,13). In our study we observed both increased bile production and higher levels 
of bilirubin in bile in NMP preserved livers, confirming improved preservation of the donor liver 
parenchyma by NMP.
The highest concentrations of gamma-GT and LDH (established biomarkers of biliary epithelial 
injury [17]) were found in bile samples obtained after reperfusion of DCD livers preserved by SCS. 
On the contrary, biliary gamma-GT concentrations in NMP preserved DCD livers were similar to 
those in bile from normal controls. This indicates that NMP provides important protection of 
biliary epithelium against ischemia-reperfusion injury in DCD livers.
In parallel with this, we observed a significantly better preservation of biliary epithelial cell 
function in NMP preserved livers, as was reflected by increased biliary secretion of bicarbonate 
and higher biliary pH. This functional beneficial effect of NMP was seen in both DCD and non-
DCD livers. Bicarbonate secretion by biliary epithelial cells contributes to bile flow and plays an 
important role in protection of these cells against bile salt toxicity (19). The concept of a ‘biliary 
HCO3
- umbrella’ was recently introduced as a key protective mechanism of biliary epithelium 
against the toxic effects of hydrophobic bile salt monomers in human bile (20). In vitro studies 
have shown that biliary bicarbonate secretion by biliary epithelial cells is critical for their protection 
against bile salt induced injury and apoptosis (19). Secretion of bicarbonate results in elevation 
of the biliary pH, especially near the apical cell membrane. In an alkaline environment, bile salts 
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are deprotonated, which is clinically relevant as protonated bile salts can passively enter cells by 
uncontrolled membrane permeation, causing apoptosis (19,20).
 Several experimental and clinical studies have shown that bile salt toxicity contributes to bile 
duct injury and is associated with the occurrence of non-anastomotic biliary strictures after 
transplantation (16,21,22). The observed increased bicarbonate concentrations in bile samples 
of NMP preserved livers in the current study could, therefore, be an important ancillary factor 
protecting these cells against bile salt-induced injury after transplantation.
Although bicarbonate concentration in post-reperfusion bile samples was twice as high in NMP 
preserved livers compared to SCS preserved livers, absolute values were still lower than in bile 
samples from normal in vivo controls. This suggests that there is still room for improvement by 
further stimulation of biliary bicarbonate secretion during NMP. On the other hand, it should be 
noted that the pH of bile samples obtained from NMP preserved livers was already comparable 
to values in normal in vivo controls. Apparently, bicarbonate-independent mechanisms also play 
a role in the alkalinization of bile.
Although previous studies have suggested that apoptosis is a possible mechanism of biliary cell 
death due to ischemia (23), this is not confirmed by the current study. Morphological changes 
compatible with apoptosis were found only sporadically in the DCD+SCS group. Paucity of 
apoptotic cells was confirmed by scanning EM of the biliary epithelium. The most prominent 
ultrastructural change after reperfusion of SCS preserved DCD livers was loss of cell-cell contact 
and intracellular digitations between biliary epithelial cells. In addition, the number of mitochondria 
per cell was significantly reduced and mitochondria displayed prominent changes compatible 
with ischemia-induced injury (18). These ultrastructural changes were most severe in DCD livers 
preserved by SCS and absent in NMP preserved DCD livers. Intracellular depletion of adenosine 
triphosphate (ATP) in SCS preserved livers is a likely explanation for the observed morphological 
changes. In an in vitro model of cultured normal rat biliary epithelial cells, depletion of ATP 
has been shown to result in substantial morphological changes as detected by EM, including 
extensive loss of basolateral interdigitations and apical microvilli (24,25). Interestingly, several 
hours after restoration of ATP, viable cells still failed to display organized secondary membrane 
structures such as lateral interdigitations, which coincided with a protracted recovery of cellular 
functions. Necrotic or apoptotic cells were noted only occasionally (24,25). The morphological 
changes described in these in vitro cell culture studies are remarkably similar to those observed 
in SCS preserved livers in the current study.
Apart from the remarkably protective effect of NMP on the bile duct epithelium, NMP could 
provide additional clinical opportunities, such as ex vivo selection of donor livers prior to 
implantation (26,27). According to the United Network for Organ Sharing (UNOS) database, 
58.2% of the DCD livers (and 14.4% of the non-DCD livers) with consent for donation, are currently 
not accepted due to the perceived high risk of complications after transplantation  (8). NMP 
could not only provide better preservation of these DCD livers, but also allows pharmacological 
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preconditioning and ex vivo testing of hepatic viability and function prior to transplantation. Our 
group has recently demonstrated that normothermic, oxygenated perfusion of human donor 
livers is technically feasible, which could contribute to a considerable expansion of the number of 
organs available for transplantation (28).
We deliberately did not transplant livers and we performed ex vivo reperfusion to mimic 
transplantation. The limitation of a transplant model would have been the impossibility to take 
biopsies from the extrahepatic bile ducts after graft reperfusion. In addition, transplantation 
would have introduced potentially confounding factors such as immune-mediated bile duct 
injury due to acute rejection. On the other hand, the current model of ex vivo reperfusion did not 
allow us to determine the process of biliary epithelial cell injury more long-term after reperfusion. 
From the current experiments we could not determine whether the observed injury to epithelial 
cells is progressive with time or reversible.
Two recent clinical studies have demonstrated that biliary epithelial cell loss can be found in 
more than 80% of all human liver grafts before transplantation (29,30). In accordance with 
this, our group has recently observed extensive loss of biliary epithelial cells immediately after 
liver procurement in a DCD model of pig livers (op den Dries, unpublished data). Collectively, 
these findings suggest that detachment and loss of the biliary epithelium is a key event in 
ischemia-induced injury of donor livers. In the current study we observed epithelial cell injury 
and detachment, but no complete loss of the epithelial layer. Apparently, biliary epithelial cells of 
rat bile ducts are less susceptible to ischemia or the process of detachment is slower compared 
to human and porcine bile ducts. Alternatively, it could be that the differences between rats, 
pigs and humans are explained by the more hydrophobic, and therefore, more toxic bile salt 
composition in the latter two (31).
In conclusion, this study suggests that NMP provides superior preservation of the bile ducts of 
both DCD and non-DCD liver grafts, compared to conventional SCS. This beneficial effect of 
NMP is most pronounced in DCD livers. By reducing biliary injury, NMP could have an important 
impact on the utilization of DCD livers and may improve outcome after transplantation. These 
findings provide a strong stimulus for a clinical trial of NMP in human DCD liver transplantation.
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In contrast to traditional static cold preservation of donor livers, normothermic machine 
perfusion may reduce preservation injury, improve graft viability, and potentially allows ex-
vivo assessment of graft viability prior to transplantation. We have studied the feasibility of 
normothermic machine perfusion in four discarded human donor livers.
Normothermic machine perfusion consisted of pressure and temperature controlled pulsatile 
perfusion of the hepatic artery and continuous portal perfusion for 6 hours. Two hollow 
fiber membrane oxygenators provided oxygenation of the perfusion fluid. Biochemical 
markers in the perfusion fluid reflected minimal hepatic injury and improving function. 
Lactate levels decreased to normal values, reflecting active metabolism by the liver (mean 
lactate 10.0±2.3 mmol/L at 30 min to 2.3±1.2 mmol/L at 6 h). Bile production was observed 
throughout the 6 h perfusion period (mean rate 8.16±0.65 g/h after the first hour). 
Histological examination before and after 6 h of perfusion showed well-preserved liver 
morphology without signs of additional hepatocellular ischemia, biliary injury, or sinusoidal 
damage.
In conclusion, this study shows that normothermic machine perfusion of human donor livers 
is technically feasible. It allows assessment of graft viability before transplantation, which 
opens new avenues for organ selection, therapeutic interventions and preconditioning.
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Although the traditional organ preservation method of static cold storage is sufficient for 
preserving most livers for transplantation, it fails to maintain viability in part of the grafts of 
suboptimal quality, or so called extended criteria donor (ECD) grafts. Higher rates of delayed graft 
function, primary nonfunction, and cholangiopathies are seen in recipients of donation after 
cardiac death (DCD), older and steatotic grafts (1,2). As the discrepancy between available donor 
organs and the number of patients waiting for transplantation increases, more ECD grafts will 
be used, necessitating the development of new and better preservation and selection methods.
Machine perfusion of donor livers offers potential to meet the requirements to preserve ECD 
grafts. A relatively simple option is hypothermic machine perfusion (0-4°C), offering oxygen 
supply to the liver and the removal of waste products. However, although hypothermic perfusion 
has achieved adequate results in near-clinical and clinical setting (3,4), its use seems to offer too 
little protection in suboptimal grafts (5,6). An important advantage of normothermic perfusion 
(37°C) over static cold preservation and hypothermic perfusion is the full metabolic support 
and the possibility to assess graft viability prior to transplantation. In addition, liver grafts could 
potentially be optimized by pharmacological conditioning during normothermic perfusion. 
However, although normothermic machine perfusion may provide better viability testing and 
resuscitation, it requires challenging, near-physiological conditions (7). To date, successful 
normothermic perfusion of livers has been reported only in animal models (8-12). Although 
these results are promising, feasibility of normothermic machine perfusion in human livers 
remains to be demonstrated. We studied the feasibility of normothermic, oxygenated machine 




Between May 2012 and August 2012, four human livers derived from DCD donors that were 
declined for transplantation by all three transplant centers in the Netherlands were included in 
this study. Characteristics of these four livers are presented in Table 1. In all cases permission 
to use the liver for this study was obtained from the relatives. The study was approved by the 
medical ethical committee of the University Medical Center Groningen and the Nederlandse 
Transplantatie Stichting, the competent authority for organ donation in the Netherlands.
normothermic Machine Perfusion
For normothermic perfusion of the donor livers we used a CE marked (European Union certification 
of safety, health and environmental requirements) device that enables dual perfusion via both 
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the hepatic artery and the portal vein in a closed circuit (Liver Assist®, Organ Assist, Groningen, 
The Netherlands; figure 1). Two rotary pumps provided a pulsatile flow to the hepatic artery 
and a continuous flow to the portal vein. Two hollow fiber membrane oxygenators provided 
oxygenation of the perfusion solution, as well as removal of CO2. The system was both pressure 
and temperature controlled, which allowed auto regulation of the blood flow through the liver, 
with constant pressure at variable flow rates. Flow, pressure and temperature were displayed on 
the device in real-time. Pressure was limited to a mean of 50 mmHg in the hepatic artery and 
11 mmHg in the portal vein. The temperature was set to 37oC and a new sterile disposable set of 
tubing, reservoir and oxygenators was used for each liver.
Table 1. Characteristics of the discarded human donor livers used for normothermic machine perfusion.
Liver no.
Donor characteristics 1 2 3 4
DCD / DBD DCD DCD DCD DCD
Age (years) 66 44 38 64
Sex male female female male
Height (m) 1.85 1.65 1.70 1.80
Weight (kg) 105 92 65 75




Drowning Traumatic brain 
injury
Weight of the liver (kg) 2.06 2.37 2.06 1.75
Reason for rejection for 
transplantation
DCD, age 60+ 
and steatosis
35 minutes of 
O2-saturation 




could not be 
excluded
DCD, age 60+ 
and alcohol 
abuse in medical 
history.
Time between withdrawal of 
life support and cardiac death
17 min 40 min 11 min 24 min
Time between cardiac death 
and cold perfusion
17 min 16 min 12 min 17 min
Cold ischemic preservation 4 h 46 min 6 h 29 min 9 h 28 min 6 h 56 min
Preservation solution during 
initial cold preservation
HTK HTK HTK UW
Normothermic perfusion time 6 h 6 h 6 h 6 h
Histological grade of 
steatosis*
Grade 1 Grade 0 Grade 0 Grade 0
* The grade of steatosis was based on the grading system established by a leading group of expert 
liver pathologists (Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological 
scoring system for non-alcoholic fatty liver disease. Hepatology. 2005; 41: 1313-1321). Grade I translates 
to 5-33% of macrovesicular steatosis. Abbreviations used: DCD, donation after cardiac death; DBD, 
donation after brain death; HTK, histidine-tryptophan-ketoglutarate; UW, university of Wisconsin.
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figure 1. A schematic drawing (a) and a photo (B) of the perfusion machine used for normothermic 
perfusion of human donor livers (Liver Assist®, Organ Assist, Groningen, The Netherlands).
Composition of Perfusion fluid
We aimed for a perfusion fluid containing all nutrients, oxygen and protective substances 
required by a metabolically active liver. Detailed information on the various components and 
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the biochemical characteristics of the perfusion fluid are provided in Table 2 and 3. The base 
of our perfusion fluid was human packed red blood cells and fresh frozen plasma; blood group 
and Rhesus factor identical to the donor liver. These blood products were obtained from the 
local blood bank and derived from third party blood donors. Because of the relatively low 
hematocrit of the perfusion solution (0.23 ± 0.01 at the start of perfusion) the pO2 was targeted 
at supernormal values (60 kPa) in order to provide sufficient oxygen to the liver. Heparin was 
added for anticoagulation, and vitamins, glucose, amino acids and trace elements were added to 
provide sufficient nutrients for the liver. Broad-spectrum antibiotics cefazolin and metronidazole 
were added to prevent bacterial growth and graft infection under normothermic conditions. 
To prevent the development of interstitial edema or intracellular contraction, the oncotic and 
osmotic pressure of the perfusion fluid was adjusted by adding sterile H2O, saline and human 
albumin. The targeted osmolarity of the perfusion fluid was 302 mosmol/L. Sodium bicarbonate 
was added for buffering capacity.
Table 2. Composition of the perfusion fluid used for normothermic machine preservation of human donor 
livers
Component quantity
Red blood cell concentrate (hematocrit 60%) 750 mL





(Clinimix® N17G35E, Baxter international Inc.)
7.35 mL
Multivitamins for infusion
(Cernevit®, Baxter international Inc.)
7 mL
Concentrated trace elements for infusion
(Nutritrace®, B. Braun Melsungen AG)
7.35 mL
Metronidazol for i.v. administration (5 mg/ml)
(Flagyl®, Sanofi-Aventis)
40 mL
Cefazolin 1000 mg flask 5 mL powder for i.v. administration
(Servazolin®, Sandoz )
2 mL
Fast-acting insulin (100 IU/ml)
(Actrapid®, Novo Nordisk)
20 mL
Calcium glubionate, intravenous solution 10%, 137.5 mg/mL
(Sandoz®) 
40 mL
Sterile H2O 51.3 mL
NaCl 0.9% solution 160 mL
Sodium bicarbonate 8.4% solution 31 mL
Heparin 5000 IE/mL for i.v. administration 4 mL
Total volume 2120 mL
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Table 3. Biochemical characteristics of the perfusion fluid before connecting the liver, after 30 min and 6 
hours of normothermic perfusion.
Chemical variable* Before start 
perfusion
at 30 min at 6 h Reference values
in blood
pH 7.59 ± 0.11 7.53 ± 0.09 7.36 ± 0.01 7.35  -  7.45
pCO2 (kPa) 3.5 ± 0.4 1.9 ± 0.8 5.0 ± 1.0 4.6  -  6.0
pO2 (kPa) 74.8 ± 2.4 69.7 ± 3.6 53.1 ± 8.0 9.5  -  13.5
sO2 (%) 100 ± 0.1 100 ± 0.2 100 ± 0.2 96  -  99
HCO3- (mmol/L) 28 ± 10 11 ± 3 21 ± 3 21  -  25
Base excess (mmol/L) 4.9 ± 10.5 -12.6 ± 4.4 -5.1 ± 2.8 -3.0  -  3.0
Na+ (mmol/L) 150 ± 7 139 ± 5 144 ± 4 135  -  145
K+ (mmol/L) 5.3 ± 0.6 4.8 ± 0.9 6.5 ± 1.0 3.5  -  5.0
free Ca2+ (mmol/L) 0.62 ± 0.03 1.47 ± 0.15 1.32 ± 0.14 1.15  -  1.29
Glucose (mmol/L) 13.7 ± 0.6 27.8 ± 6.0 11.3 ± 5.5 4  -  9
Lactate (mmol/L) 6.3 ± 0.5 10.0 ± 2.3 2.3 ± 1.2 0.5  -  2.2
Hemoglobin (mmol/L) 4.7 ± 0.1 3.8 ± 0.1 3.9 ± 0.2 8.7  -  10.6
Hematocrit 0.23 ± 0.01 0.19 ± 0.01 0.20 ± 0.01 0.42  -  0.52 
* To convert values for glucose to mg/dL, multiply by 18.02. To convert values for lactate to mg/dL, 
multiply by 9.01. To convert values for hemoglobin to g/dL, multiply by 1.650. Data are expressed as 
mean ± SEM.
Procurement and Preparation of Donor Livers
All liver procurement procedures were performed by one of the regional multi-organ retrieval 
teams, in the Netherlands, using a standard technique of in situ cooling and flush-out with 
ice cold preservation fluid (University of Wisconsin (UW) or histidine-tryptophan-ketoglutarate 
(HTK) solution). Care was taken to leave a segment of the supratruncal aorta attached. Livers 
were packed and stored in standard sterile donor organ bags and a box with crushed ice, 
and subsequently transported to our center. Immediately upon arrival of the donor liver in 
the operating room, the back table procedure was performed by an experienced transplant 
surgeon. Arteries and the portal vein were dissected free and the arterial cannula was inserted 
and secured in the proximal end of the supratruncal aorta segment. The distal end of the aorta 
was closed below the origin of the celiac trunc, using a prolene 4-0 suture. A second cannula 
was inserted and secured in the distal end of the portal vein. The cannulas for the hepatic artery 
and the portal vein are part of the sterile disposables provided by Organ Assist. The cystic duct 
was ligated to prevent bile flow from the gallbladder into the common bile duct. The gallbladder 
was not removed to avoid continuous bleeding from the gallbladder fossa in a fully heparinized 
system. A Meredith silicon catheter no. 8 was inserted and secured in the distal common bile 
duct. After preparation on the back table, the liver was weighed. Immediately before connecting 
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the liver to the perfusion machine, the liver was rapidly flushed with 1L cold NaCl 0.9% solution 
(only when UW solution was used for preservation), followed by 1L warm NaCl 0.9% solution.
Liver function assessment
During machine perfusion, samples were taken from the perfusion fluid every 30 min and analyzed 
immediately for blood gas parameters (pO2, pCO2, sO2, HCO3
- and pH) and for biochemical 
parameters (glucose, calcium, lactate, potassium, sodium) by an ABL800 FLEX analyzer 
(Radiometer, Brønshøj, Denmark). In addition, plasma from the perfusion fluid was collected 
(after 5 min centrifugation 2700 RPM at 4°C), frozen and stored at -80°C for determination 
of alkaline phosphatase, gamma-glutamyl transferase (gamma-GT), alanine aminotransferase 
(ALT), urea and total bilirubin, using standard biochemical methods. Bile production was 
measured at 30 min intervals by weighing the Eppendorf tubes in which bile was collected from 
the biliary drain. Biliary epithelial cell function was assessed by measuring biliary bicarbonate 
concentration. For this purpose, bile samples were collected under mineral oil and analyzed 
immediately using an ABL800 FLEX analyzer (Radiometer). Biliary concentration of gamma-GT 
and lactate dehydrogenase (LDH) were measured as biomarkers of biliary epithelial cell injury 
(13), and biliary bilirubin concentration was measured as biomarker of hepatocellular secretory 
function, using standard biochemical methods.
histological Evaluation
Biopsies were obtained from the liver parenchyma as well as the extrahepatic bile ducts before 
and after machine perfusion and stored in formalin for histological evaluation. Paraffin-embedded 
slides of liver biopsies were prepared for hematoxylin and eosin (H&E) staining and complementary 
liver staining with periodic acid-Schiff after diastase digestion, Masson’s trichrome, iron and 
reticulin. Additional slides were prepared for immunohistochemical detection of activated 
caspase-3 (Asp175, Cell Signaling #9661; 1:100 dilution), a marker for apoptosis. Paraffin-
embedded slides of extrahepatic bile ducts were prepared for H&E staining and complementary 
staining with periodic acid-Schiff after diastase digestion. Slides of the extrahepatic bile ducts 
were graded according to a systematic scoring system of bile duct injury as first described by 
Hansen et al (14). All liver and bile duct slides were examined by an experienced liver pathologist 
(ASH Gouw) using light microscopy.
RESuLTS
Perfusion Characteristics
Immediately after arrival in our center, donor livers were prepared on the back table and connected 
to the normothermic perfusion system, resulting in a mean cold storage period of 415 ± 58 min. 
Both the arterial and portal flow increased during the first 30 min of normothermic perfusion 
and remained stable thereafter, with a mean arterial flow of 283 ± 29 mL/min and a mean 
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portal flow of 686 ± 25 mL/min at 6 h (figure 2a). The perfusion machine provided adequate 
oxygenation of the perfusion fluid and extraction of carbon dioxide (figure 2B). Macroscopically 
all livers appeared well perfused (figure 3).
assessment of hepatic Injury and function
Changes in the concentration of biochemical markers in the perfusion fluid reflected minimal 
hepatic injury and improving function (figure 2C and D). After a temporary rise in ALT directly 
after the start of perfusion, ALT concentrations remained stable. Other markers of cell injury also 
remained stable (gamma-GT and potassium) or decreased (alkaline phosphatase; figure 2C). 
Lactate concentrations initially increased but subsequently decreased to normal values, reflecting 
active metabolism by the liver (mean lactate 10.0 ± 2.3 mmol/L at 30 min to 2.3 ± 1.2 mmol/L at 
6 h; figure 2D). Similarly, glucose levels decreased to near-normal values (mean 11 ± 5 mmol/L at 
6 h). Bicarbonate levels increased during perfusion to physiological levels (mean 20.7 ± 2.8 mmol/L 
at 6 h). Overall, the pH at the start of perfusion was slightly alkalotic, but in all procedures it 
returned to normal values within the first hour (mean pH 7.40 ± 0.06 at 1 h) (figure 2B). Urea, 
produced by the liver, increased from 5.9 ± 1.0 mmol/L at 30 min to 12.9 ± 2.3 mmol/L at 6 h 
(figure 2D).
Bile production was observed throughout the entire perfusion period (figure 2E). The mean 
rate of bile production after the first hour was 8.16 ± 0.65 g/h. The quality of bile improved 
during perfusion as indicated by a gradual change in color to a darker shade and increasing 
concentrations of biliary bilirubin and bicarbonate (figure 2f). Biliary gamma-GT and LDH 
concentrations decreased after an initial peak at 90 min of perfusion (figure 2g).
Liver and Extrahepatic Bile Duct histology
Histological examination of H&E stained liver biopsies showed no major differences between 
biopsies taken before and after 6 hours of perfusion (figure 4). In general, hepatocytes appeared 
viable without additional ischemic changes and no signs of biliary injury or sinusoidal damage 
were present in the liver biopsies after machine perfusion. Additional liver staining with Masson’s 
trichrome, reticulin, iron, periodic acid-Schiff after diastase digestion and immunohistochemistry 
for caspase-3 confirmed normal liver morphology and provided no evidence of additional 
apoptotic cell death after machine perfusion (data not shown).
Histological examination of biopsies from the distal end of the extrahepatic bile duct taken 
before machine preservation revealed partial loss of the biliary epithelial cell layer similar to 
what has been described by Hansen et al. (14) in human liver transplantation (figure 5). Further 
histological assessment of bile duct wall injury revealed no evidence of major intramural bleeding 
and no microthrombi in the vasculature. The amount of arteriolonecrosis remained stable in 
graft #3 and #4, but increased with one degree in grafts #1 and #2. After perfusion, normal 
morphology of the bile duct wall stroma with presence of cell nuclei was seen in graft #3, but a 
decrease in the number of cell nuclei in the stroma was noted in the other grafts.
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figure 2. Functional parameters of the perfusion machine and markers of liver viability and injury during 
6  hours of normothermic machine perfusion (n=4). Panel a and B: Perfusion characteristics and gas 
exchange parameters. Panel C and D: Concentrations of hepatobiliary injury and function markers in the 
perfusion fluid. Panel E: Bile production during perfusion (n=3). Panel f: Eppendorf tubes containing bile 
from graft #1; demonstrating a gradual change to a darker shade over time, in parallel with increasing biliary 
concentration of bilirubin and bicarbonate. Panel g: Evolution of biliary concentrations of gamma-GT and 
LDH as markers of biliary injury. Data are expressed as mean ± SEM.
figure 3. Photos of liver #1 before and during normothermic machine perfusion. Panel a: Just before 
connecting the liver to the perfusion machine. Panel B: One minute after connecting the liver. Panel C: 
20 minutes after connecting the liver. Panel D: After 6 hours of normothermic machine perfusion. During 
operation the organ chamber is covered by a transparent cover to maintain a moist environment for the liver 
(not shown in these pictures).
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figure 4. Hematoxylin and eosin staining of liver biopsies before (A-D 0 h) and after (A-D 6 h) 6 hours of 
normothermic machine perfusion, showing well preserved microscopic architecture in all four perfused 
livers.
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figure 5. Hematoxylin and eosin stainings of biopsies from the distal end of the extrahepatic bile duct 
(graft #3), taken before and after 6 hours of normothermic machine perfusion. Panel a shows an overview at 
100x magnification, the lumen of the bile duct is marked by the asterisk. Similar to what has been described 
in over 80% of human livers prior to clinical transplantation (14), biopsies taken before machine preservation 
revealed partial loss of the biliary epithelial cell layer. The amount of biliary epithelial cell loss did not increase 
during 6 hours of machine perfusion. Further histological assessment at higher magnification (panel B 
and C) revealed no evidence of major intramural bleeding and no microthrombi in the vasculature. Well-
preserved bile duct wall stroma is marked by # in panel B. Arrows in panel C indicate arteries/arterioles of the 
peribiliary plexus with normal morphology.




In this study we demonstrated feasibility of normothermic machine perfusion of four discarded 
human donor livers. There were no technical failures of the perfusion machine and all livers were 
well perfused and oxygenated. The livers, although discarded for varying reasons, functioned 
well ex vivo. Macroscopically well-perfused livers, continuous bile production (possibly the most 
important outcome parameter for a well-functioning liver (9)) and normalization of various 
biochemical parameters in the perfusion fluid were noted over time in all procedures. Histological 
examinations confirmed adequate preservation of liver morphology.
This is the first description of successful normothermic machine perfusion of human livers, ever 
since the first unsuccessful attempts of hypothermic perfusion of human livers by Starzl et al. in 
1967, after which the clinical use and development of human liver perfusion devices stagnated 
(15). Only recently, renewed clinical application of machine preservation has been reported by 
Guarrera et al (4). The device used by these investigators, however, was based on hypothermic 
perfusion (at 4oC) without oxygenation of the perfusion fluid. In contrast to oxygenated, 
normothermic machine perfusion, hypothermic perfusion does not allow an adequate functional 
assessment of liver viability prior to transplantation. Especially in an era of donor organ shortage, 
normothermic machine preservation has great potential as a tool to increase the number of donor 
livers by enabling pretransplant assessment of ECD livers that would otherwise not have been 
accepted for transplantation because of the presumed too high risk of primary non-function.
Based on a porcine model of normothermic perfusion, bile output has been suggested as the 
most significant parameter of liver viability (9). We observed increasing bile output in all four 
livers tested during 6 h of normothermic machine preservation. Assessment of bile composition 
showed a gradual increase in biliary bilirubin and bicarbonate concentration, reflecting recovery 
of secretory function of hepatocytes and biliary epithelial cells, respectively. In parallel with this, 
biomarkers of biliary epithelial cell injury such as biliary concentrations of gamma-GGT and LDH 
decreased, indicating that there was no ongoing biliary epithelial cell injury during the 6 hours 
of perfusion.
In a recent clinical study in 93 liver transplants, Hansen et al. (14) have observed a >50% loss 
of biliary epithelium in 82.8% of extrahepatic bile duct biopsies taken before transplantation. 
Therefore, it is not surprising that we observed similar changes in our biopsies before machine 
perfusion. Although some signs of bile duct wall injury as described by Hansen et al, such as 
intramural bleeding and microthrombi in the vasculature, could not be detected, other signs 
such as arteriolonecrosis and loss of cell nuclei in the bile duct wall stroma were observed after 
perfusion. Collectively, these histological findings indicate that normothermic machine perfusion 
alone is not sufficient to completely avoid ischemia/reperfusion injury of the extrahepatic bile 
ducts. It needs to be awaited whether modifications of the perfusion fluid, for example by adding 
cytoprotective hydrophilic bile salts, will result in a reduction of the degree of biliary ischemia/
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reperfusion injury and a subsequent lower rate of biliary complications after transplantation. 
Clearly this is an area that still requires intensive further research.
Whether ex vivo bile output and assessment of other viability parameters can be used as 
reliable parameters to discriminate viable from nonviable human donor livers will also require 
confirmation in a larger cohort. This work is in progress in our center and the ultimate goal will 
be to perform a clinical trial. One option would be to apply normothermic machine perfusion in 
ECD livers that have been rejected for transplantation and will otherwise be discarded. This is a 
strategy followed by Guarrera et al. in a clinical trial on hypothermic liver machine perfusion (4). 
Alternatively, one could think of a randomized clinical trial of ECD livers, such as livers obtained 
from DCD donors, using biliary strictures as the primary end-point.
Transplantation of ECD livers, such as steatotic or old livers, results in an increased risk of 
primary non-function or delayed graft function (1). In the case of DCD livers, the most important 
complication is the development of cholangiopathies (2). Although we have been able to 
assess overall viability of the perfused livers by measurement of bile production, serial analysis 
of biochemical markers in the perfusion fluid and bile, as well as histological examination, 
accurate functional assessment of biliary epithelium viability is more difficult. We have used 
biliary secretion of bicarbonate as a biomarker of biliary epithelial function. Biliary epithelial cells 
contribute significantly to bile volume and flow by active secretion of bicarbonate and we have 
observed a recovery of biliary bicarbonate secretion during machine perfusion. The amount of 
bicarbonate secretion in the bile, however, is the result of all biliary epithelial cells present in the 
intra- and extrahepatic bile ducts and it does not necessarily reflect function of the epithelium of 
the larger bile ducts, which are most prone for the development of stricture after transplantation. 
More research in this area is clearly needed (16).
In conclusion, this study shows that normothermic machine perfusion of human donor livers is 
technically feasible. Normothermic perfusion of ECD livers allows assessment of graft viability prior 
to transplantation and opens new avenues for donor organ selection, therapeutic interventions 
and preconditioning. This may not only improve organ quality and function, but will also lead to 
a considerable expansion of the number of organs available for transplantation.
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Although normothermic machine perfusion of donor livers may allow assessment of graft 
viability prior to transplantation, there is currently no data on what would be a good 
parameter of graft viability. To determine whether bile production is a suitable biomarker 
that can be used to discriminate viable from non-viable livers we have studied functional 
performance as well as biochemical and histological evidence of hepatobiliary injury during 
ex vivo normothermic machine perfusion of human donor livers. After a median duration 
of cold storage of 6.5 hours, twelve extended criteria human livers that were declined for 
transplantation were ex vivo perfused for 6 h at 37oC with an oxygenated solution based 
on red blood cells and plasma, using pressure controlled pulsatile perfusion of the hepatic 
artery and continuous portal perfusion. During perfusion, two patterns of bile flow could be 
identified: 1) steadily increasing bile production, resulting in a cumulative output of ≥30 g 
after 6 h (high bile output group), and 2) a cumulative bile production <20 g in 6h (low bile 
output group). Concentrations of transaminases and potassium in the perfusion fluid were 
significantly higher in the low bile output group, compared to the high bile output group. 
Biliary concentrations of bilirubin and bicarbonate were 4-times and 2-times higher in the 
high bile output group. Livers in the low bile output group displayed more signs of hepatic 
necrosis and venous congestion, compared to the high bile output group.
In conclusion, bile production is an easy assessable biomarker of hepatic viability during 
ex vivo machine perfusion of human donor livers. It could potentially be used to identify 
extended criteria livers that are suitable for transplantation.
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Donor liver shortage remains a limiting factor in liver transplant programs in most parts of the 
world. In an attempt to reduce the discrepancy between donor liver availability and demand, 
criteria for organ acceptance have gradually widened with increasing acceptance of livers that 
carry a higher risk of early graft failure or transmission of an infectious or malignant disease (so 
called extended criteria donor (ECD) livers). The types of ECD livers most frequently considered 
for transplantation, despite a higher risk of early dysfunction, are livers with mild-moderate 
steatosis, livers from older donors or donor with a high body mass index, and livers from donation 
after cardiac death (DCD) (1-3). Although livers from ECD donors are increasingly considered 
for transplantation, many of them are still declined. A recent study in the US has shown that 
the proportion of donor livers not used for transplantation is increasing since 2004 (4). The 
proportion of nonuse attributable to DCD increased from 9% in 2004 to 28% in 2010, probably 
because in many cases the risk of early graft failure after transplantation is considered to be too 
high (4).
The decision to either accept or decline a potential donor liver for transplantation is currently 
based on the interpretation of the physician before or during procurement and is primarily based 
on parameters such as donor past medical history, last known laboratory values, findings during 
liver procurement, and other procurement variables such as expected ischemia times. Once a 
donor liver is retrieved and stored in an organ box for transportation functional assessment is no 
longer possible until after transplantation. The uncertainty about how much additional damage 
a liver will sustain during the hours of cold storage poses an important hurdle for accepting many 
ECD livers.
During the past decade, machine perfusion of donor livers has received increasing research 
attention as a tool to improve organ preservation and improve outcome after transplantation (5-
9). Several experimental studies have shown superiority of machine perfusion compared to static 
cold storage with respect to reduction of ischemia/reperfusion (IR) injury (10-12). Apart from 
providing better graft protection against IR injury, machine perfusion provides the possibility of 
functional assessment of a liver graft short before implantation in a recipient. Although machine 
perfusion can be performed at various temperatures, only normothermic oxygenated machine 
perfusion (NMP) may allow a full functional assessment of an organ prior to transplantation. 
During NMP the liver is offered physiological amounts of oxygen and nutrients supporting a full 
functional metabolic activity (13). The possibility of functional assessment of an ECD liver after 
static cold storage and transportation would be of great importance in the judgment of livers 
that would otherwise be declined for transplantation based on the current criteria.
Despite the growing amount of literature on the role of machine perfusion as an alternative and 
better preservation method compared to static cold storage, there is no data on what would be 
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reliable parameters for functional assessment of human donor livers during NMP. Based on a 
porcine model of normothermic liver perfusion, Imber et al have suggested that bile production 
is directly attributed to liver viability and could therefore be used as a predictive marker of liver 
function (11). In addition, bile production has long been recognized as an important clinical 
parameter to predict early graft dysfunction (including primary non-function and delayed graft 
function) after liver transplantation (14). We, therefore, hypothesized that bile production during 
NMP of human donor livers is a suitable and easy to assess biomarker of hepatic viability that 
can be used to discriminate a potentially transplantable from a non-transplantable graft. To test 
this hypothesis we have studied functional performance as well as biochemical and histological 
signs of hepatobiliary injury during ex vivo NMP of human donor livers that were declined for 
transplantation. Secondary aim of this study was to determine the minimal duration of NMP 
needed to discriminate viable and potentially transplantable livers from non-viable livers.
MaTERIaLS anD METhoDS
Liver Donors
Between May 2012 and May 2013 twelve human livers that were declined for transplantation 
by all three liver transplant centers in The Netherlands were included in this study. Of these, ten 
were obtained from a DCD donor and two were obtained from donors after brain death (DBD). 
Livers were retrieved using a standard surgical technique of in situ cooling and flush-out with 
ice cold preservation fluid (University of Wisconsin [UW] or histidine–tryptophan–ketoglutarate 
[HTK] solution). Livers were subsequently packed and stored on ice and transported to our center. 
In all cases, permission to use a donor liver for this study was obtained from the relatives. The 
study protocol was approved by the medical ethical committee of the University Medical Center 
Groningen and the Nederlandse Transplantatie Stichting, the competent authority for organ 
donation in the Netherlands.
normothermic oxygenated Machine Perfusion
Upon arrival at center, cold preserved livers were prepared on the back table for normothermic 
oxygenated machine perfusion as described previously (13). NMP was initiated using a CE marked 
(European Union certification of safety, health and environmental requirements) device that 
enables dual perfusion via both the hepatic artery and the portal vein in a closed circuit (Liver 
Assist® Organ Assist, Groningen, Netherlands). Livers were perfused for 6h with a perfusion 
solution based on heparinized human plasma and red blood cells fortified with nutrients, trace 
elements and antibiotics as described previously (13). Two rotary pumps provided pulsatile flow 
to the hepatic artery and a continuous flow to the portal vein. Two hollow fiber membrane 
oxygenators provided oxygenation of the perfusion solution, as well as removal of CO2. The 
system was temperature and pressure controlled, allowing auto-regulation of the blood flow 
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through the liver. Pressure was limited to a mean of 60 mmHg in the hepatic artery and 11 mmHg 
in the portal vein. The temperature was set to 37ºC and a new sterile disposable set of tubing, 
reservoir and oxygenators was used for each liver. Before connecting the liver to the device, the 
perfusion fluid was primed with the addition of sodium bicarbonate 8.4% solution to obtain a 
stable physiological pH. A summary of the composition of perfusion fluid prior to initiation of 
NMP is provided in Table 1.
assessment of hepatobiliary function and Injury
Bile samples were collected from a catheter in the donor common bile duct and bile production 
was measured gravimetrically at 30 min intervals. Bile production was expressed as g/30 min. 
Concentration of bilirubin in bile was determined as a marker of hepatic secretory function, 
using a standard biochemical method. Biliary concentration of bicarbonate and glucose were 
determined as markers of biliary epithelial cell (cholangiocyte) function. For this purpose, bile 
samples were collected under mineral oil and analyzed immediately using an ABL800 FLEX 
analyzer (Radiometer, Brønhøj, Denmark).
During NMP, samples were taken from the perfusion fluid at 30 min intervals and analyzed 
immediately for blood gas parameters (pO2, pCO2, sO2, HCO
3- and pH) and for biochemical 
parameters (glucose, calcium, lactate, potassium, sodium, and hemoglobin) by an ABL800 FLEX 
analyzer (Radiometer, Brønhøj, Denmark).
In addition, plasma from the perfusion fluid was collected (after 5 min centrifugation at 2700 rpm 
at 4ºC), frozen and stored at -80ºC for determination of alkaline phosphatase (ALP), gamma-
glutamyl transferase (gamma-GT), alanine aminotransferase (ALT), urea, lactate dehydrogenase 
(LDH), total bilirubin, and albumin, using standard biochemical methods.
histological Evaluation
Biopsies were obtained from the liver grafts before and after 6h of machine perfusion and stored 
in formalin for histological evaluation. Paraffin-embedded slides of liver biopsies were prepared 
for hematoxylin and eosine (H&E) staining, and assessed for the degree of steatosis, parenchymal 
necrosis, hepatic congestion, and biliary injury. All liver and slides were examined in a blinded 
fashion by an experienced liver pathologist (ASH Gouw) using light microscopy.
Statistical analysis
Continuous variables are presented as medians and interquartile range (IQR). Categorical variables 
are presented as number and percentage. Continuous variables were compared between groups 
using the Mann-Whitney U test. Categorical variables were compared with the Pearson chi-
square. A p-value <0.05 was considered to indicate statistical significance. All statistical analyses 
were performed using SPSS software version 16.0 for Windows (SPSS, Inc., Chicago, IL).
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Table 1. Biochemical composition of perfusion fluid used from normothermic machine perfusion of donor 
livers
variable Median IqR Reference values in blood
pH 7.40 7.34 – 7.45 7.35 – 7.45
pCO2 (kPa) 4.1 3.5 – 4.6 4.6 – 6.0
pO2 (kPa) 71 65 – 75 9.5 – 13.5
sO2 (%) 100 99 – 100 96 – 99
HCO3- (mmol/L) 19 17 – 21 21 – 25
Base Excess (mmol/L) -4.6 -6.7 – -3.5 -3 to 3.0
Na+ (mmol/L) 150 145 – 154 135 – 145
K+ (mmol/L) 4.4 3.8 – 5.6 3.5 – 5.0
Free Ca2+ (mmol/L) 0.67 0.61 – 0.72 1.15 – 1.29
Glucose (mmol/L)* 14 13 – 15 4 – 9
Lactate (mmol/L)* 6 6 – 7 0.5 – 2.2
Hemoglobin (mmol/L) *4.7 4.6 – 4.9 8.7 – 10.6
Albumin (mmol/L) 31 29 – 33 35 – 50
Chloride (mmol/L) 97 91 – 98 97 – 107
Urea (mmol/L) 3.5 2.9 – 3.6 2.5 – 7.5
Phosphate (mmol/L) 1.8 1.5 – 2.2 0.7 – 1.5
Magnesium (mmol/L) 0.55 0.51 – 0.63 0.70 – 1.00
Alanine-aminotransferase (U/L) 9 8 – 11  0 – 45
Aspartate-aminotransferase (U/L) 13 13 – 17 0 – 40
Alkaline phosphatase (U/L) 24 23 – 28 0 – 120
Gamma-glutamyltransferase (U/L ) 9 7 – 16 0 – 40
Lactate dehydrogenase (U/L) 101 93 – 114 0 – 250
Total bilirubin (umol/L) 2 2 – 3 0 – 17
*) To convert values for glucose to mg/dL, multiply by 18.02. To convert values for lactate to mg/dL, 
multiply by 9.01. To convert values for hemoglobin to g/dL, multiply by 1.650.
RESuLTS
Bile Production as Discriminating variable during Machine Perfusion
First aim of this study was to determine whether bile production is a suitable marker of hepatic 
viability that can be used to during NMP to discriminate a potentially transplantable from a 
non-transplantable graft. Therefore, we determined the evolution of bile production during 6h 
of NMP for all twelve livers. Two distinct patterns of bile flow could be identified: 1) a steadily 
increasing bile production, resulting in a cumulative bile output of ≥30 g during the 6 h of 
perfusion, and 2) an initially increasing bile production during the first 2-3 hours, followed by a 
diminishing production, resulting in a cumulative bile production in 6h <20 g (figure 1). Based 
on these observations, a cutoff value of 20 g cumulative bile production during 6 h of NMP was 
chosen to separate high from low bile output. There were six livers in each group and these two 
groups were used for further analyses.
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figure 1. Cumulative bile production during ex vivo normothermic machine perfusion of human donor 
livers. Presented are individual values for 12 livers that were declined for transplantation. Ex vivo machine 
perfusion and viability testing was started after a median cold storage of 6.5 hours. Two distinct patterns 
of bile flow could be identified: 1) a steadily increasing bile production, resulting in a cumulative bile output 
of ≥30 g during the 6 h of perfusion (dotted lines), and 2) an initially increasing bile production during the 
first 2-3 hours, followed by a diminishing production, resulting in a cumulative bile production in 6h <20 g 
(continuous lines).
A comparison of donor characteristics between livers with a high bile output versus livers 
with a low bile output during ex vivo machine perfusion is provided in Table 2. There were 
no statistically significant differences for any of these variables. Most livers were declined for 
transplantation because of a combination of DCD and age (>60 years) or DCD and high BMI. 
Two livers were declined because of macrovesicular steatosis >30% and both livers were in the 
low bile output group. It was obvious from this comparison that one would not have been able 
to identify livers with a high versus low bile output before organ procurement based on these 
conventional donor characteristics alone.
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Type of donor 0.12
DCD 10 (83 %) 4 (67%) 6 (100%)
DBD 2 (17%) 2 (33%) 0 -
Age (years) 61 (50-64) 55 (48-65) 63 (51-65) 0.47
Gender 0.22
Male 8 (67%) 3 (50%) 1 (17%)
Female 4 (33%) 3 (50%) 5 (83%)
Height (m) 1.77 (1.67-1.80) 1.77 (1.64-1.81) 1.78 (1.71-1.81) 0.69
Weight (kg) 88 (76-98) 90 (85-100)       78 (75-95) 0.20
Reason for rejection 0.25
DCD + age >60 years 5 (41%) 1 (17%) 4 (67%)
DCD + high BMI 3 (25%)        2 (33%) 1 (17%)
DCD + other reason** 2 (17%) 1 (17%) 1 (17%)
Severe steatosis 2 (17%) 2 (33%) 0 -
Preservation Solution 1.00
UW solution 6 (50%) 3 (50%) 3 (50%)
HTK solution 6 (50%) 3 (50%) 3 (50%)
Time between switch-off
and cardiac death (min) 23 (8-51)          18 (0-23)                24 (17-53) 0.36
Donor warm ischemia 
time (min)
14 (17-20)     8 (0-52) 17 (15-18) 0.75
Cold ischemia time (min) 389 (458-585) 530 (431-750) 409 (363-473) 0.11
Liver weight (kg) 2.09 (1.6-2.24)       2.17 (1.60-2.31) 2.03 (1.71-2.18) 0.63
*) continuous variables are presented as median and interquartile range, categorical variables are presented 
as numbers and percentage.
**) One DCD donor with history of iv drug abuse (low bile output group) and one donor with prolonged 
sO2 <30% after withdrawal of life support (high bile output group).
abbreviations used: DCD, donation after cardiac death; DBD, donation after brain death; UW, university 
of Wisconsin; HTK, Histidine tryptophan-ketoglutarate
Comparison of hepatic function and Injury
We next examined whether the differences in bile production correlated with other markers 
of hepatobiliary function and injury during NMP. First, we compared perfusion characteristics 
between the two groups. During NMP the flow in the portal vein and hepatic artery increased 
rapidly during the first 30 min and flows remained stable thereafter for the entire 6h perfusion 
period (figure 2). There were no significant differences in portal flow and although median 
arterial flow was constantly lower in livers with a low bile output, compared to the high bile 
output group, this did not reach statistical significance.
Biochemical markers of hepatobiliary function and injury after 6 h of ex vivo perfusion are 
presented in Table 3. Most striking differences were significantly higher concentrations of 
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figure 2. Changes in portal flow (panel a) and arterial flow (panel B) during ex vivo normothermic 
machine perfusion of human donor livers, using a pressure controlled device. Flow in the portal vein and 
hepatic artery increased rapidly during the first 30 min and flows remained stable thereafter for the entire 
6h perfusion period. There were no significant differences in portal flow and although median arterial flow 
was constantly lower in livers with a low bile output, compared to the high bile output group, this did not 
reach statistical significance.
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transaminases and a higher potassium level in the perfusion fluid of the low bile output group, 
compared to the high bile output group. These findings are compatible with a higher degree 
of IR injury and hepatocellular lysis in the former group. Bicarbonate concentration in perfusion 
fluid of livers with high bile output was 26 mmol/L (22-28 mmol/L), compared to 18 mmol/L (13-
29 mmol/L) in the group of low bile output livers. Although this difference was not statistically 
different, it should be noted that about 4-times more sodium bicarbonate solution (8.4%) 
had been added during perfusion in the low bile out put group to maintain a physiologic pH. 
After initiation of machine perfusion, glucose and lactate concentrations in the perfusion fluid 
initially increased in all cases. In the group of livers with high bile output glucose and lactate 
levels subsequently decreased rapidly and levels were normal at 6 h of NMP. In contrast with 
this, glucose and lactate levels in the low bile output group did not normalize during machine 
perfusion (Table 3).
Biochemical analysis of bile samples during 6 h of NMP revealed a 4-times higher concentration 
of bilirubin and a 2-times higher biliary concentration of bicarbonate in the high bile output 
group, compared to the low bile output group (Table 3). These findings indicate that a better 
secretory function of hepatocytes (bilirubin) coincides with that of cholangiocytes (bicarbonate).
histological Comparison
Finally, we compared histology of liver grafts after 6 h of NMP between the two groups. In 
accordance with the observed differences in biochemical markers of hepatic injury, livers in 
the low bile output group displayed more signs of hepatic necrosis and venous congestion, 
compared to the high bile output group (figure 3 a-D). Despite these differences in hepatic 
parenchymal damage between the two groups, there were no major differences in the degree 
of biliary damage (figure 3 E-f).
Minimal Duration of nMP needed for viability assessment
Secondary aim of this study was to determine the minimal duration of NMP needed to discriminate 
viable and potentially transplantable livers from non-viable livers. For this, we used the individual 
data on cumulative bile production as depicted in figure 1. It can be deducted from this figure 
that livers in the low and high bile output groups can be discriminated from each other as early 
as 150 min after ex vivo machine perfusion. The combination of a cumulative bile production 
of ≥10 grams at 150 min and a bile production of ≥4 grams in the preceding hour identified 
100% of the livers that would be considered as a high bile output liver after 6 h (Table 4). This 
finding indicates that after cold storage of a donor liver, a short period of 2.5 hours of ex vivo 
assessment during NMP is sufficient to identify a liver that may been preserved well enough to 
be transplanted successfully.
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Table 3. Biochemical Composition of Perfusion Fluid and Bile after 6 hour of Ex Vivo Normothermic Machine 
Perfusion
high Bile output (n=6) Low Bile output (n=6) p- value
Blood gas variables
pH 7.36 (7.25 – 7.40) 7.34 (7.29 – 7.40) 1.00
pCO2 (kPa) 6.7 (5.9 – 7.8) 5.0 (3.4 – 6.3) 0.08
pO2 (kPa) 64 (54 – 65) 35 (10 – 67) 0.42
sO2 (%) 100 (99 – 100) 98 (94 – 99) 0.04
HCO3- (mmol/L) 26 (22 – 28) 18 (13 – 29) 0.20
Added HCO3- 8.4 %  (mL) 8 (0 – 20) 25 (4 – 86) 0.24
Base excess (mmol/L) +0.1 (-3.6 – +3.6) -6.8 (-12.0 – -4.0) 0.34
Hemoglobin (mmol/L)* 4.2 (3.7 – 4.3) 4.3 (4.1 – 4.6) 0.26
Electrolytes and Metabolites
Na+ (mmol/L) 154 (143 – 155) 142 (139 – 151) 0.26
K+ (mmol/L) 4 (2 – 8) 13 (8 – 18) 0.01
Urea (mmol/L) 14 (11 - 16) 15 (12 – 22) 0.63
Glucose (mmol/L)* 10 (8 - 19) 23 (16-32) 0.07
Lactate (mmol/L)* 2 (1 - 4) 6 (3-11) 0.03
Injury markers
ALT (U/L) 2795 (1761 – 3972) 11074 (6144 – 16050) 0.04
ALP (U/L) 36 (25 – 44) 154 (82 – 258) 0.01
GGT (U/L) 35 (20 – 55) 124 (107 – 187) 0.06
LDH (U/L) 6227 (5151 – 6703) 22119  (9584 – 34558) 0.06
Total bilirubin (mmol/L) 3 (3 – 3) 5 (3 – 7) 0.20
Variables measured in bile*
Biliary pH 7.58 (7.56 – 7.70) 7.37 (7.05 – 7.71) 0.10
Biliary HCO3
-
 (mmol/L) 44 (35 – 50) 20 (7 – 41) 0.09
Bilirubin in bile (mmol/L) 1100 (968 – 1398) 270 (215 – 525) 0.02
*) To convert values for glucose to mg/dL, multiply by 18.02. To convert values for lactate to mg/dL, 
multiply by 9.01. To convert values for hemoglobin to g/dL, multiply by 1.650. To convert the value for 
bilirubin to mg/dL, divide by 17.1. 
**) Peak values during 6 h of machine perfusion.
abbreviations used: ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamate 
transferase; LDH, lactate dehydrogenase.
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figure 3. Histology of livers after 6 hours of normothermic machine perfusion. In comparison to livers with 
high bile output, livers in the low bile output group displayed more signs of hepatic necrosis (panels a 
and B) and venous congestion (panels C en D). Despite these differences in hepatic parenchymal damage 
between the two groups, there were no major differences in the degree of biliary damage (panels E and f).
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output after 2.5 h (g)
Bile output Between 




1   6.54 2.52 No
2 12.53 3.14 No
3   1.86 0.37 No
4   4.66 2.19 No
5   0.00 0.00 No
6   8.14 2.36 No
High-bile output
7 18.77 7.22 Yes
8 12.93 7.33 Yes
9 14.92 8.50 Yes
10 10.55 5.00 Yes
11 15.72 4.66 Yes
12 25.35 8.85 Yes
*) Criteria are: 1) Cumulative bile production of ≥10 grams after 2.5 h and 2) a bile production of ≥4 grams 
in the preceding hour (1.5 - 2.5 h of perfusion)
DISCuSSIon
Machine perfusion of donor livers is receiving increased attention as experimental studies have 
suggested that this method can provide better protection during storage and transportation, 
compared to static cold storage (10-12). Especially ECD livers have been shown to be more 
susceptible to IR injury, requiring the introduction of novel and more complex preservation 
techniques (7,15). Besides the potential benefits of machine perfusion in providing better 
protection against preservation injury, this technique also provides the possibility of viability 
testing of a donor organ prior to transplantation. Pretransplant viability testing may become an 
important new tool to compensate for the increasing proportion of ECD livers (i.e. livers from 
donors with advanced age, elevated body mass index, diabetes, or livers from DCD donors), which 
has resulted in an increasing proportion of non-use of donor livers during the last decade (4).
The main finding in this study is that bile production can be used as an easy assessable marker 
of liver graft viability during ex vivo NMP. Cumulative bile production of ≥30 g during 6 h of 
NMP was associated with significantly lower release of transaminases and potassium into the 
perfusion fluid and better hepatobiliary function as reflected by a normalization of glucose and 
lactate levels and higher biliary secretion of bilirubin. In addition, histology of grafts with a 
high bile output showed less signs of venous congestion and hepatocellular necrosis, compared 
to livers with a low cumulative bile output. The second novel finding of this study is that the 
minimal duration of NMP needed to discriminate viable and potentially transplantable livers from 
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non-viable livers is 2.5 hours. This relatively short time period facilitates a timely selection and 
preparation of a potential recipient, making this new selection method clinically applicable.
The results of this study open interesting new avenues for the clinical application of ex vivo viability 
testing of ECD livers that, based on conventional criteria, are declined for transplantation. This 
method has the potential to have a significant impact on the number of donor liver available for 
transplantation. Of the twelve discarded livers included in this study, 6 (50%) displayed improving 
function and normalization of hepatobiliary metabolism. Although all livers were declined for 
transplantation because they were considered ECD livers with a too high risk of primary non-
function after transplantation, 50% of these may have functioned well after transplantation. 
All livers were retrieved from a donor outside our hospital and the median duration of cold 
storage prior to initiation of ex vivo viability testing was 6.5 hours. This time sequence can also 
be expected when this technique is introduced in clinical practice.
In an experimental study using pig livers, Imber et al have previously suggested that bile production 
is probably the most important parameter of liver function (11). The amount of bile production 
correlated strongly with the degree of hepatic IR injury. Our experience with discarded human 
donor livers is in line with this experimental study.
The significant higher release of potassium and ALT in low-bile output livers reflects a higher 
degree of hepatocellular injury. The absolute concentrations of ALT measured in the perfusion 
fluid may seem relatively high; however, these results cannot be compared directly with values 
usually obtained after clinical liver transplantation. First of all, livers were perfused ex vivo in a 
closed circuit and values represent the cumulative release of ALT without any clearance from the 
system. Secondly, the perfusion circuit contained only 2 liters compared to an average of 5 liters 
of blood in vivo.
In addition to bile production alone, good liver function was reflected by a normalization of 
glucose and lactate levels in the perfusion fluid, as well as an increasing production of bicarbonate 
in the livers with high bile output. The latter was reflected by an increasing median concentration 
of bicarbonate in perfusion fluid from 19 mmol/L at baseline to 26 mmol./L after 6 h of NMP in 
the high bile output group. In the low bile output group median bicarbonate concentration in 
the perfusion fluid at 6 h was only 18 mmol/L, despite the addition of a 4-times higher amount 
of sodium bicarbonate 8.4% during perfusion to maintain a physiologic pH. These finding are in 
accordance with a previous animal study that has indicated that autoregulation of the acid-base 
balance is a reflection of a well-functioning liver (16).
In the current study, we did not add bile salts to the perfusion fluid. Hepatocellular secretion of 
bile salts into bile canaliculi is an important driving force of bile flow (17,18). In vivo, bile salts are 
reabsorbed from the gut and transported back to the liver through the enterohepatic circulation. 
Bile salts are subsequently secreted again into the bile, causing a choleretic increase in total bile 
flow. Obviously, this enterohepatic circulation is interrupted during ex vivo NMP and this could 
theoretically lead to bile salt depletion and a subsequent decline in bile production. However, 
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experimental studies using pig livers have shown that bile salt depletion does not occur until 
after 10 hours of NMP (18). In the current study, livers were perfused for 6 hours and we did 
not observe a decline in bile output. Therefore, we do not believe that the addition of bile salts 
is necessary when livers are perfused for less than 10 hours. In fact, hydrophobic bile salts have 
been demonstrated to play a role in bile duct epithelial injury after liver transplantation and this 
could be considered an additional argument not to add bile salts to the perfusion fluid (19-21). 
On the other hand, due to the strong choleric effect of bile salts, bile production during ex vivo 
NMP will be higher when bile salts are added to the perfusion fluid. This should be kept in mind 
when comparing bile output values obtained in different studies.
Bile production is an energy consuming, multi-step process that requires an intact network of 
sinusoidal cells, hepatocytes and cholangiocytes. Therefore, it is intuitive that bile production is 
a strong and reliable indicator of overall liver quality and viability. In clinical liver transplantation, 
poor initial bile production has been associated with poor outcomes. In one study, graft survival 
at one year was only 45% for livers that failed to produce bile in the operating room (14). In 
addition to bile volume, we have shown a higher biliary secretion of bilirubin in grafts with high 
bile output, reflecting better bile quality produced by these livers.
Although some studies on kidney and liver machine perfusion have suggested that a decline in 
arterial flow in a pressure controlled system of machine perfusion can be used as a marker of 
decreasing graft viability (22-24), we found stable flows in both high and low bile output livers. 
Apparently, change in perfusion flow is not a reliable parameter of graft viability in human liver 
machine perfusion. However, in livers with a low bile production we did observe a lower arterial 
flow during the entire 6 h of NMP, compared to the low bile output group, but this did not reach 
statistical significance. In general, we do not advise to use flow values as an indicator of liver 
damage and viability during human liver machine perfusion.
In conclusion, this study provides evidence that the assessment of bile production is a 
discriminative indicator of hepatic function and injury during ex vivo NMP of human donor livers. 
It could potentially be used to identify ECD livers that are declined for transplantation based on 
donor risk factors, but that may still be suitable for transplantation. The next step is to use ex 
vivo bile production as a new critical selection criterion to accept ECD livers that would otherwise 
have been declined for transplantation based on an anticipated poor postoperative function. 
We are currently preparing a clinical trial to implement this novel selection tool based on ex vivo 
assessment of ECD donor livers after cold storage.
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At the time of organ offer for transplantation, donor-related risks such as disease transmission 
and graft failure are weighed against the patient’s risk of remaining on the waiting list. 
The patient’s role in decision-making and the timing and extent of donor-specific risk 
information has been discussed in the medical literature. This is the first study revealing the 
opinion of liver patients on these issues. Forty patients listed for liver transplantation and 
179 transplanted liver patients participated in an anonymous questionnaire-based survey. 
The majority of patients wanted to be informed about donor-related risks (59.8-74.8%). The 
preferred timing of donor-related risk information was for 53.3% of the patients at the time 
of organ allocation. Of these patients, 79.8% wished to be involved in decision-making, 
10.6% wished to make the final decision alone and only 9.6% did not want to be involved 
in the decision-making process. Implementing this knowledge by standardizing the content, 
the manner of transfer, and the amount of information that we provide to our patients 
will improve opportunities for shared decision-making at different time points along the 
transplant allocation process. This will enable us to provide the same opportunities and care 
to every patient on the waiting list.
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Liver transplant waiting lists increase more rapidly than the supply of donor organs, leaving many 
patients stranded, without access to what is often a life-saving therapy. Efforts to increase the 
donor pool are being made by accepting more donors at the expense of diminished quality of 
their organs (i.e. extended criteria donors). An extended criteria donor (ECD) implies a higher 
donor-related risk in comparison with a standard criteria donor (SCD). This risk may manifest 
as increased incidence of poor allograft function, allograft failure, or transmission of a donor-
derived disease (1).
To which extent donor-related risks are discussed with the liver transplant candidate and whether 
or not the transplant candidate is involved in the decision-making process at the time of donor 
offer, varies between countries and hospitals (2-4). In the US, since the 2007 implementation of 
the guidelines from the Department of Health and Human Services, Centers for Medicare and 
Medicaid Services (CMS), consent forms are required for various stages of the transplant process, 
starting with the initial evaluation and ending with the surgery. However, consent for ECD liver 
transplantation is not a requirement of the CMS; it is offered at the discretion of the provider (3). A 
recent study by Bruzzone et al. has provided insight in the European implementation of informed 
consent for ECD liver donation; the majority of transplant centers inform transplant candidates 
about the ECD status of the donor, but great variation was observed in the timing of informing 
(before listing and/or at the time of organ allocation), the topics discussed, and whether a special 
consent form was signed (2).
Standardization for the timing and content of the informed consent and the transplant patient’s 
role in the decision-making process is currently lacking, although both topics receive increasing 
attention in medical literature (5-9). Health researchers and policy-makers increasingly urge 
both patient and clinician engagement in shared decision making (SDM) to facilitate greater 
involvement of patients in their personal healthcare management (10). Paternalistic health care 
has fallen out of favour, replaced by the ‘patient-centered model’, which emphasizes patient 
autonomy, informed consent and empowerment (11). Although SDM has been examined and 
implemented in numerous clinical settings (12,13), it has received little attention in solid organ 
transplantation, especially in the field of (deceased) liver transplantation (8,10). In a transplant 
setting, decisions often have to be made quickly and the risks and benefits are difficult to explain 
fully at the time of an organ offer, complicating patient involvement in SDM. Moreover, medical 
decision making for liver transplantation raises additional challenges for SDM given that liver 
transplant patients have no effective alternative medical options to transplantation, such as 
dialysis in renal patients (10).
Various ideas about the patient’s role in decision-making and the time and extent of informed 
consent have been proposed in medical literature (6,8,14). However, there is a more fundamental 
question to be answered first – what do patients really want? There is very limited information 
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on the donor-related risk information that patients want to receive, the preferred timing of 
ECD informed consent, whether potential transplant candidates want to be involved in decision-
making at the time of organ allocation, and how much risk they are willing to accept. We therefore 
performed an anonymous questionnaire-based survey among patients listed for transplantation 
and transplanted liver patients, addressing these questions.
PaTIEnTS anD METhoDS
Participants and Study Design
All adult liver transplant recipients at the University Medical Center in Groningen (UMCG) 
between 2000 and 2010, who were still receiving post-transplant care at our center, were invited 
to participate. In addition, adult patients that were actively listed for transplantation on the 
1st of February 2013, were invited for participation. All eligible post- and pre-transplant liver 
patients received an information letter and a questionnaire. Questionnaires were coded and 
confidentiality was guaranteed. After 4 weeks, a reminder was sent to non-responders and 
another 4 weeks were allowed for completion. The study met the criteria for an exemption 
from approval (approval letter METc2012.306). The questionnaire was composed for the purpose 
of the study under guidance of an experienced health psychology researcher (AVR). Internal 
validation questions were added to assess the patients’ understanding of the questionnaire 
and demonstrated conformity of 90-96%. The original information letter and questionnaire are 
available upon request.
assessment
All liver patients were approached by mail and asked to complete a 20-30 min questionnaire. 
Patients were first reminded of the distinction between standard criteria donor livers (SCD) and 
donor livers with an increased risk of complications after transplantation; the so-called extended 
criteria (ECD) donor livers. The difference between the general risk of a transplant procedure 
and (specific) donor-related risks was explained. Age >60 yr, steatosis and donation after 
cardiac death (DCD) were described as risk factors for liver failure and bile duct complications, 
respectively. Also, the potential risk of transferring a malignancy or an infectious disease from the 
donor to the recipient was explained. Following this introduction, patients were asked personal 
questions with respect to time on the waiting list, experience with previous liver transplantation 
and experience with complications after liver transplantation (self or an acquaintance).
Patients’ Acceptable Risk of Disease Transmission. Next, patients were informed that the risk 
of transferring a malignancy or infectious disease from the donor in SCD donor livers is generally 
kept below 1%, leading to discard of livers that are otherwise suitable for transplantation. Patients 
then were asked to indicate on a visual proportion scale (1-50%) the risk of disease-transmission 
that they considered a high risk, followed by indicating the risk of disease-transmission that they 
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were willing to accept. The latter two questions were repeated (on the following page) after 
informing the patients about the 15% mortality rate on the waiting list.
Informing Patients About Donor-Related Risks. In the subsequent question, patients were 
asked whether they wished to be informed when a donor liver was offered with: 1) an increased 
risk of transferring an infectious disease such as hepatitis or HIV, 2) an increased risk of transferring 
a malignant disease (tumor), 3) an increased risk of bile duct strictures, 4) an increased risk of 
early graft failure. Early graft failure was explained as requiring re-transplantation within 2 weeks 
after transplantation.
Timing of donor-specific informed consent. Next, it was explained that patients are informed 
(in general terms) about donor-related risks before waiting list registration. It is currently not 
common practice to inform patients about specific donor-related risks at the time of donor offer. 
First, patients were asked to agree or disagree (strongly disagree, disagree, uncertain, agree or 
strongly agree) with four statements in which motives for wanting or not wanting information 
about donor-related risks were explored: 1) It would cause distress (I would worry) if I would 
receive information about donor-related risks at the time of donor offer, 2) I would like to receive 
information about donor-related risks at the time of donor offer, because it will allow me to be 
mentally prepared, 3) I prefer not to receive information about donor-related risks at the time 
of donor offer, because I would be already overwhelmed, 4) I would like to receive information 
about donor-related risks at the time of donor offer, since it will allow me to decide whether I 
do or do not want to receive that donor liver. Subsequently, patients were asked whether they 
wished to be informed about donor-related risks of the liver offered to them for transplantation, 
with the following options for answers: 1) No, I do not want to be informed about the donor-
related risks, 2) I want to be informed at the time of donor offer, even when this is at 3 a.m., 
3) I want to be informed afterwards, when I have recovered from the transplant surgery.
The Patient’s Role in the Decision Process. The patients that wished to be informed at the 
time of donor offer, were asked what they plan to do with the acquired information: a) Just for 
the sake of knowing, the decision on whether or not to accept the liver should be made by my 
physicians; b) I would like to make the decision together with my physician, we should decide 
together on whether or not to accept the liver; c) I would like to make the final decision alone 
(by myself).
Next, patients were explained that in some countries, listed patients are allowed to exclude 
certain groups of (increased risk) donor livers from being offered to them for transplantation, 
such as DCD livers, livers from older donors, or donors with an increased risk of infectious 
disease transmission. They were told that this would decrease the risk of complications after 
transplantation, but it also would increase the waiting time for a donor liver and thereby increase 
the mortality risk while on the waiting list. Patients were asked if they want to be able to exclude 
certain groups of donor livers, before being listed for transplantation.
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Presented Cases. Finally, two cases were presented to the patients, one concerning an 18-year 
old donor acquainted with intra-venous drug use, the second case concerning an 81-year old, 
healthy, donor (Table 3). First, patients were asked to assess the expected risk of infectious 
disease transmission or early graft failure (respectively) in those two cases. Next, the patients 
were asked whether they would accept these livers for transplantation if 1) their personal 
medical situation was stable and if 2) their liver disease was progressively severe and the situation 
therefore unstable.
Information was obtained about patient age, gender, country of origin, civil status, education 
and employment status. Data regarding primary liver disease etiology and time on the waiting 
list were extracted from medical databases.
Statistical analysis
Data were expressed as means and standard deviations, medians or percentage of participants 
with specific responses. Categorical variables were compared with the Pearson Chi-square test 
or Fisher’s Exact test where appropriate. Continuous variables were compared with the Student-T 
test. Repeated measurements of ordinal variables within one group were compared using the 
Wilcoxon Signed Ranks Test. The level of significance was set at a p-value of 0.05. Statistical 
analyses were performed using SPSS software version 16.0 for Windows (SPSS, Inc., Chicago, IL).
RESuLTS
Respondent Characteristics
Patients on the waiting list with status ‘non-active’ (n=18) and age <18 years (n=15) were 
excluded. In total, 243 transplanted patients and 66 patients on the waiting list were invited to 
participate. Overall response was 70.9% (n=219), including 60.6% (n=40) of the approached 
waiting list patients and 73.7% (n=179) of the transplanted patients.
The study population was predominantly middle aged, male, Dutch, married and educated 
at intermediate level (Table 1). The most common indications for transplantation were non-
cholestatic cirrhosis (34.7%), cholestatic cirrhosis (33.3%) and metabolic disease (10.5%). Time 
since (the last) liver transplantation was 6.4±3.1 years (mean±SD) for transplanted patients and 
9.4±4.2 years for patients on the waiting list who had been transplanted before (n=8; 20% of 
all participating listed patients). Of all transplanted patients, 54.4% (n=99) had developed one 
or more complications after transplantation, with biliary complications being the most common 
(n=55; 30.2%). Average time on the waiting list was 34.9 months (median: 26, interquartile 
range 6-49 months) for the waiting list patients. Non-responders did not differ significantly 
from responders with regard to gender, liver disease before transplantation and time since last 
transplantation. However, non-responders were significantly younger (mean and SD 46.7±16.6 vs 
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54.5±13.1; p<0.001). During the study period, two non-responders died and one was admitted 
to the hospital.
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9.4 ± 4.2 (n=8)
34.9 ± 43.2
Values are presented as mean ± SD or N (%)
Patients’ view on acceptable Risk of Disease Transmission
In general, the risk of disease transmission during organ transplantation is kept below 1%. Patients 
reported significantly higher willingness to accept an increased risk of disease transmission after 
having received information about the current 15% waiting list mortality (figure 1). The risk of 
disease transmission that patients were willing to accept was 7±1% (mean±SE), which increased 
to 12±1% after having received information about the current waiting list mortality (p<0.001). 
After providing information about the 15% waiting list mortality, 79.6% of the patients accepted 
a risk of ≥ 5%. No significant differences were found between subgroups based on patient status 
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(transplanted/waiting list), age, gender, level of education (low/intermediate/high), country of 
origin (Netherlands/other) or civil status (living alone/with partner).
figure 1. Acceptable risk of disease transmission. Acceptable risk of disease transmission, according to all 
patients, before (dark grey) and after (light grey) receiving information about the 15% waiting list mortality.
Informing about Different Types of Donor-Related Risks
The vast majority wished to be informed when donor-related risks are increased. In case of 
increased risk of transmission of an infectious disease or a malignant tumor, 73.5% and 74.8% of 
respondents, respectively, wished to be informed (Table 2). In case of increased risk of bile duct 
strictures, 59.8% of respondents wished to be informed. When increased risk of early graft failure 
is present, 70.1% of the patients wished to be informed. Experience with bile duct complications 
or early graft failure after liver transplantation (self or acquaintance) was not associated with an 
increased wish to be informed about an increased risk of bile duct strictures or early graft failure, 
respectively. No significant differences were found between subgroups based on age, gender, 
level of education (low/intermediate/high), country of origin (Netherlands/other) or civil status 
(living alone/with partner). However, compared to transplanted patients, significantly more 
waiting list patients wished to be informed about donor-related risks (Table 2).
Table 2. Number of patients that wish to be informed about donor-related risks
Information about: overall Post-tx Waiting list P-value
Increased risk of infectious disease transmission
Increased risk of malignant tumor transmission
Increased risk of developing bile duct strictures

















* Re-transplantation required within 2 weeks after transplantation
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Preferred Time for Providing Donor-Related Risk Information
The preferred timing of donor-related risk information was for 53.3% of the patients at the 
time of organ allocation, for 18.8% of the patients after the transplant procedure and 27.7% of 
the patients did not wish to be informed. Significantly more waiting list patients wished to be 
informed at the time of organ allocation (71.1%), compared to transplanted patients (49.4%); 
p=0.021 (figure 2). Younger patients (≤40 years) wished to be informed at the time of organ 
allocation more often (70.3%), compared with older patients (55.6% of age 41-60 and 44.0% 
of age 60+). More patients with a lower level of education preferred not to be informed at 
all (43.8%), when compared with intermediate educated (25.5%) or higher educated patients 
(16.9%); p=0.026. No significant differences were found between subgroups based on gender, 
country of origin (Netherlands/other) or civil status (living alone/with partner). When compared 
with waiting list patients, transplanted patients indicated more frequently that they would feel 
worried if donor-related risk information was provided at the time of organ allocation (59.5% 
vs 39.5%) and that they would feel overwhelmed (39.2% vs 18.4%); p=0.048 and p=0.047, 
respectively.
figure 2. Timing and consequence of providing donor-related risk information. The majority of patients 
want to be informed about donor-related risks at the time of organ allocation (pie chart; dark grey) and 
wishes to be involved in the decision-making process (the grey bars on the right).
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The Patient’s Role in the Decision Process
All respondents that wished to be informed about donor-related risk at the time of organ 
allocation, were asked if they wished to be actively involved in the decision-making process for 
accepting or declining the liver for transplantation. Overall, 79.8% of respondents preferred 
shared decision-making, 10.6% wished to make the final decision alone and only 9.6% did 
not want to be involved in the decision-making process. No significant differences were found 
between subgroups based on age, gender, level of education (low/intermediate/high), country 
of origin (Netherlands/other) or civil status (living alone/with partner). As presented in figure 2, 
significantly more waiting list patients wished to be involved in share-decision making (100%), 
when compared to transplanted patients (73.8%); p=0.019).
Patients were asked if they want to be able to exclude certain groups of donor livers, before 
being listed for transplantation. Only 21.6% of transplanted patients and 31.6% of the waiting 
list patients wished to be able to exclude certain groups of donor livers, before being listed for 
transplantation. No differences were found between the above-mentioned subgroups.
Presented Cases
Finally, two potential donor cases were presented; a healthy 18-year-old previous heroin user 
tested negative for HIV and a healthy 81-year-old donor. Of all patients, only 19.4% judged 
the risk of disease transmission associated with accepting the liver from the 18-year-old donor 
as high. Similarly, only 16.5% of the patients judged potential non-function in the 81-year-old 
liver as a high risk. No less than 74.3% of respondents would accept a liver from the 18-year-
old previous heroin user and 73.1% would accept a liver from the healthy 81-year-old donor if 
the respondent’s own condition was deteriorating. If the own condition was moderately stable, 
still 40.7% of the respondents would accept the 18-year-old liver and 39.2% would accept the 
81-year-old liver (Table 3).
In case of the healthy 18-year-old previous heroin user, no significant differences were found 
between subgroups based on patient status (waiting list/transplanted), age, level of education 
(low/intermediate/high), country of origin (Netherlands/other) or civil status (living alone/with 
partner). Male respondents, however, were significantly more often willing to accept this 
18-year-old liver, when compared with female respondents; 50.4% vs 27.5% (p<0.001) when 
the respondent’s condition is moderately stable and 80.5% vs 65.9% (p=0.052) when the 
respondent’s condition is deteriorating. In case of the healthy 81-year-old donor, no significant 
differences were found between the above-mentioned subgroups.
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Table 3. Two cases and situations: Would you accept this liver? 
acceptable?
yes no uncertain
a) An 18-year-old young man died of an acute stroke (brain death). He was 
in good health and his blood liver tests were normal. There is no evidence 
of a (endured) virus infection like Hepatitis B or C virus or HIV. However, the 
donor was acquainted with intravenous heroin use.
Situation 1: You have been listed for transplantation for 8 months and your 
condition is deteriorating, you are admitted to hospital with significant 
jaundice, ascites and fatigue. There are concerns as to whether there will 
be a liver available for transplantation in time.
74% 3% 23%
B) Same donor profile as case A
Situation 2: You have been listed for transplantation for 8 months and your 
condition is fairly stable. You work part-time (half days) because of your liver 
disease and you suffer mild jaundice. arguably, you have some time to 
wait for a suitable organ offer.
41% 17% 43%
C) An 81-year-old woman died of an acute stroke. She lived more or less 
independently, relying only on her neighbours for help with groceries. She 
has been healthy her whole life. Blood liver tests were normal.
Situation 1: You have been listed for transplantation for 8 months and your 
condition is deteriorating, you are admitted to hospital with significant 
jaundice, ascites and fatigue. There are concerns as to whether there will 
be a liver available for transplantation in time.
73% 3% 24%
D) Same donor profile as case C
Situation 2: You have been listed for transplantation for 8 months and your 
condition is fairly stable. You work part-time (half days) because of your liver 
disease and you suffer mild jaundice. arguably, you have some time to 
wait for a suitable organ offer.
39% 15% 46%
DISCuSSIon
Various ideas about the patient’s role in decision-making and the timing and extent of 
informed consent in transplantation have been proposed and discussed in literature by medical 
professionals (5-9,14). This is the first study revealing the opinion of liver patients on these issues. 
The four main findings are: (1) most liver patients want to be informed about donor-related 
risks, (2) half of the liver patients want to be informed at the time of organ allocation, (3) of those 
patients, the majority wishes to participate in the decision making process to accept or decline 
a potential donor liver, and (4) liver patients are willing to accept a relatively high risk of disease 
transmission and graft failure.
The vast majority of patients (60-75%) want to be informed when the donor-related risk of 
infectious disease, a malignant tumor, bile duct strictures or early graft failure is increased. 
The need for a full, clear and frank explanation about general and donor-specific risks of 
transplantation is supported in the literature (7,9). Moreover, better-informed patients may 
establish more realistic expectations, which in turn have shown to improve postsurgical health 
outcomes and decrease legal claims (15,16). This finding also supports the call for standardization 
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of informed consent prior to placement on the waiting list, which would promote the autonomy 
of recipients by helping to ensure that they are informed of all relevant donor risk factors (6).
Interestingly, for more than 50% of the patients the preferred timing of donor-related risk 
information is at the time of organ allocation. Additionally, more than 90% of those patients 
want to be involved in the decision-making process on whether to accept or decline a potential 
donor liver. This confronts medical teams with a dilemma; on one hand, the principles of patient 
autonomy and dignity require nothing less than complete disclosure, especially when potentially 
risky therapies are offered (14), and on the other hand, disclosure of donor-specific risk requires 
extra time precisely when time is at a premium (during organ allocation), which could therefore 
prevent the optimal use of the organ supply (6).
A suggested alternative to shared decision-making at the time of organ allocation, is to give 
patients the opportunity to accept or decline ECD organs as a group before transplantation (6). 
However, a classification of organs into two groups might be inaccurate, since some of the 
standard organs would not be acceptable for certain recipients and not all ECD organs are of 
equal quality and risk (8). It has therefore been suggested to classify ECD organs in several 
groups, but it is still questionable whether the patient can understand the impact of these risks 
and make a good decision, especially since the patients’ own medical condition is a dynamic 
process which will change their willingness to accept ECD livers, as shown in this study. Only a 
quarter of the patients in this study wished to be able to exclude certain groups of donor livers, 
before being listed for transplantation.
There is recognition that shared decision-making may not suit all types of patients. Studies of 
shared decision-making have found that patients with more serious or life-threatening illnesses, 
or those for whom there are no alternative treatments, do not wish to participate in the decision 
making process (17). In contrast to renal patients, patients with end-stage liver disease have no 
effective alternative medical options to transplantation, such as dialysis. Interestingly, this study 
showed that the majority of the liver transplant patients do actually want to be involved in shared 
decision making at the time of organ allocation.
This study also showed that patients are willing to accept a relatively high risk of disease transmission 
and potential graft failure, especially when the patient’s clinical situation is deteriorating. Previous 
studies have shown a similar high willingness of patients to accept donor-related risks, such as 
ECD donor livers or donor kidneys at risk for viral infections (18,19). Interestingly, we noticed 
that informing the patients of the 15% waiting list mortality rate significantly increased the 
willingness to accept more donor-related risk. This suggests that providing information affects 
the decision-making process. Providing standardized information on the risks and benefits of the 
different types of ECD donor transplantation at the time of waiting list registration, potentially in 
combination with comprehension assessment tools and e-health educational tools, might enable 
liver patients to participate in shared decision-making at the time of organ allocation. Decision 
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aids have demonstrated to affect long-term behavior and appear to promote informed decision-
making (20).
A potential bias could reside in the fact that we do not know whether the non-responders 
to this questionnaire would have given the same answers to the questions, when compared 
to the responders. We did, however, compare responder and non-responder characteristics 
and we found no significant differences with regard to gender, liver disease and time since 
transplantation. On the other hand, non-responders were about 8 years younger. During the 
study period, two non-responders died and one was admitted to the hospital. Therefore, we 
think that a part of the non-responders might have been too sick to respond to the questionnaire. 
One might expect that these patients have less interest to participate in shared decision-making 
at the time of organ allocation.
This study is clinically relevant to anyone who is involved in transplantation. Decisions concerning 
the patient’s role in decision-making and the timing and extent of informed consent in 
transplantation need to be made by every transplant centre. Both the physician’s opinion and 
the patient’s opinion on these issues should be taken into consideration. Standardization of the 
information about the different donor types provided before listing the patients and shared 
decision-making at the time of organ allocation is important to provide the same opportunities 
and care to every patient. We are aware that the results of the current study only represent the 
opinion of liver patients in The Netherlands. The opinion of patients elsewhere in the world could 
be different. We hope that this study stimulates other transplant centers to perform a similar 
survey to reveal the local need for information and involvement of patients in the decision-
making process surrounding liver transplantation.
In case of deceased liver transplantation, decisions often have to be made quickly and the risks 
and benefits are difficult to explain fully at the time of an organ offer. The involvement in shared 
decision-making should be consistent with patient preferences; the process of involvement may 
be as important as who eventually makes the decision (21,22). Based on the results of this study 
we suggest that information on risks related to SCD and ECD transplantation is provided in 
detail to all patients listed for transplantation. Moreover, patients who want to be informed and 
involved in SDM at the time of organ allocation should be identified at the time of listing for 
transplantation. Accordingly, these patients should receive additional information and potentially 
decision aids to allow shared decision making at the time of organ allocation.
In conclusion, the questionnaire presented in this paper provides unique information on the 
opinion of liver patients on donor-related risks. The majority of respondents wished to be informed 
about donor-related risks and wanted to be involved with shared decision-making at the time of 
organ allocation. Implementing this knowledge and standardizing the content, the manner of 
transfer and the amount of information we provide to our patients at the different time points 
along the transplant allocation process will be important to provide the same opportunities and 
care to every patient on the waiting list.
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an Ex-vivo oxygenated normothermic 
Machine Perfusion System for Rat Livers
Op den Dries S, Kuipers M, Karimian N, op den Dries GH, Lisman T, Leuvenink HGD, Porte RJ.




An attractive alternative to cold preservation of donor livers before transplantation is ex-
vivo normothermic machine perfusion (NMP) providing oxygen and nutrients at 37°C. To 
allow different NMP protocols to be studied, a normothermic machine perfusion device for 
rat livers, comparable to devices available for human livers, is needed. In this chapter we 
describe the protocol of the ex-vivo oxygenated normothermic machine perfusion system 
for rat livers that we built for the experiment in chapter 9 and for future studies on the 
different aspects of normothermic machine perfusion.
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Ex-vivo machine perfusion of donor organs is receiving increasing attention as an attractive 
alternative to static cold storage (SCS) for preservation of liver grafts before transplantation. 
Contrary to SCS preservation at 4°C, intended to decrease metabolism, normothermic machine 
perfusion at 37°C offers full metabolic support and the possibility to assess graft viability 
prior to transplantation. Moreover, the quality of liver grafts could potentially be improved by 
pharmacological conditioning during ex-vivo normothermic perfusion. Successful normothermic 
machine perfusion requires a device that allows portal and arterial perfusion of the liver, an 
oxygenated perfusion fluid containing nutrients and an oxygen carrier in a temperature- and a 
pressure controlled system in order to protect sinusoids from perfusion pressure-related injury 
(1-3). Such devices for normothermic machine perfusion are available for perfusion of human and 
large animal liver grafts (1,4). However, existing ex-vivo normothermic machine perfusion devices 
for rat livers do not meet the above criteria. In order to study the impact of different aspects 
of normothermic machine perfusion (perfusion fluid, temperature protocol, pharmacological 
agents) on liver function and injury, a normothermic machine perfusion device for rat livers is 
needed. Therefore, we aimed to build a pressure-controlled, ex-vivo oxygenated normothermic 
machine perfusion system for rat livers providing both arterial and portal perfusion.
Previous applications of the protocol
This protocol was used for the study described in chapter 9, in which we determined the impact 
of normothermic machine perfusion on bile duct preservation in rat livers.
overview of the rat liver perfusion system
We developed a normothermic machine perfusion system that enables dual perfusion via both 
the hepatic artery and the portal vein in a closed circuit (figure 1 and 2). Two roller pumps 
provide a pulsating flow to the hepatic artery and a continuous flow to the portal vein. The 
air chamber and the oxygenator minimize pulses caused by the roller pump on the portal side, 
resulting in a continuous portal flow. A physiological arterial flow of 6 mL/min results in a 
physiological arterial pulse of 250/min delivered to the hepatic artery. To minimize loss of pulse 
we used inelastic tubing between the arterial roller pump and the liver. Two tubular membrane 
oxygenators provide oxygenation of the perfusion solution and removal of CO2. The system is 
pressure-controlled, allowing auto regulation of blood flow through the liver, with constant 
pressure at variable flow rates. The Ohm’s formula was used to correct for additional resistance 
caused by the cannulas: Ptotal = Pliver (1+(Rcannula/(Rtotal-Rcannula))). Inline sensors detect flow, pressure 
and temperature, and data are analyzed by and displayed in real-time on a connected laptop. 
Pressure is limited to a mean of 110 mmHg in the hepatic artery and 11 mmHg in the portal 
vein. Two glassware coil type heat exchangers connected to two water baths are used to heat 
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the perfusate to 37°C and the entire perfusion system is placed inside a Perspex climate box 
containing a fan-driven heater regulated by a thermostat to maintain a constant temperature. 
The stainless steel organ chamber allows perfusion fluid to easily return to the circuit. The liver is 
placed in the organ chamber on a metal grid covered with plastic paraffin film to prevent physical 
injury to the bottom of the liver. A transparent plastic cover on the organ chamber maintains a 
moist environment for the perfused rat liver (figure 3).
figure 1. Schematic overview of rat liver perfusion system. Two roller pumps provided a pulsatile flow 
to the hepatic artery (a) and a continuous flow to the portal vein (B), after eliminating pulses with an air 
chamber (C). Two tubular membrane oxygenators provided oxygenation of the perfusion solution, as well 
as removal of CO2 (D). The system was both pressure and temperature controlled. Flow (f), pressure (P) 
and temperature (T) were detected by inline sensors and data were analyzed by and displayed in real-time 
on a connected laptop (E). Heat exchangers (f) and a plexiglass climate box encapsulating the perfusion 
system  (g), ensured temperature control at 37°C. The rat liver was placed into an organ chamber (h), 
protected with a transparent cover to maintain a moist and warm environment. Bile was collected in 
Eppendorf tubes (I). Several three-way connecters were used as bubble traps (J).
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figure 2. Photographic overview of the rat liver perfusion system. The transparent climate box 
containing the perfusion system is flanked by the two water baths. The laptop on the left regulates the 
portal and arterial flows, in a pressure-controlled manner.  
figure 3. Photos during normothermic machine perfusion. The bright red colour of oxygenated blood 
exiting one of the two arterificial lungs (a). The organ chamber with a perfused rat liver (B) and bile 
produced by the liver, collected in an Eppendorf tube (C).






– D-glucose 0.9 g/L
– Human full blood
– William’s Medium E solution with phenol red (Sigma Chemical)
– Human albumin (200g/L Albuman®, Sanquin, Amsterdam, Netherlands)
– Insulin (100 IE/mL Actrapid®, Novo Nordisk, Alphen aan den Rijn, Netherlands)
– Unfractionated heparin (5000 IE/mL)
– Ethanol 70%
– Demineralized water
– Sodium Bicarbonate (8.4% for IV use)




– Syringes 5 mL/10mL/20mL
– Syringe 5 mL with NaCl (0.9%) at 37°C
– Syringe 5 mL with NaCl (0.9%) at 4°C
– Gauzes and cotton buds
– Microsurgery set + vascular clamps
– Surgical microscope
– Silk sutures (6-0 and 4-0)
– Crushed ice + ice container
– Petri dish
– Eppendorf tubes
Ex-vivo Machine Perfusion System
– Roller pump + pump head with 3 rollers for the hepatic artery
(Ismatec ISM404 + ISM719; IDEX Health and Science)
– Roller pump with 6 rollers for the portal vein
(Ismatec MS-2/6-160; IDEX Health and Science)
– Tubing for roller pumps
(Ismatec Pharmed BPT NSF-51; IDEX Health and Science)
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– Porous silicon tubing for the oxygenator
(Rubber BV)
– Glass Büchner flask with rubber bung
(Schott Duran; 500 mL)
– Two inline pressure sensors
(Truwave Tranducer PX600FPR; Edwards Lifesciences Corporation)
– Two inline flow sensors
(Transonic Systems Inc. Type 1PXN)
– Flow measuring device
(Transonic Systems Inc. Model T402; 2 channels)
– Two inline temperature sensors
(MEDOS NTC)
– Two glassware coil type heat exchangers
(Radnoti Heating coil; 5.5 mL)
– Three-way connectors
(Cole-Parmer Y-form Fitting; 35mm by 21 mm)
– Air chamber with membrane
– Digital thermostat
(Lucky Reptile. Thermo Control Pro 2)
– Fan-driven heater
(Euromac bv. Personal Heater 200; 200 Watt)
– Two water baths
 (Julabo Labortechnik GMBH MP-5; 2.1 Kilowatt)
– Custom-made stainless steel organ chamber on a tripod + metal grid
– Extended Clamps (to position portal and arterial cannulas)
– Plastic paraffin film
(Parafilm® Pechiney Plastic Packaging Company, Chicago, US)
– Laptop with software
(Kindly provided by Organ Assist, Groningen, Netherlands)
– Custom-made Perspex climate box
(Research Instrument Manufacturing Department UMCG)
– Portal, arterial and common bile duct cannulas (figure 4)
(Insyte, Becton Dickinson BV. Portal 18 Gauge IV Cathether; Arterial 20 Gauge)
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figure 4. Cannulas. Cannulas for the portal vein (a), celiac trunk (hepatic artery) (B) and common bile 
duct (C). Cannulas are composed of pieces of tubing slid over one another, with a small ring of tubing at the 
tip to prevent them from being pulled out of the blood vessel or bile duct.
Reagent Setup
Red blood cell concentrate
1) Dissolve 0.18 g D-glucose (0.9g/L) in 200 mL NaCl (0.9%). 2) Centrifuge human blood at 
1400 G for 10 min at room temperature, without brake. 3) Pipet plasma + buffy coat from the 
red blood cell concentrate (RBC). 4) Mix the RBC with the glucose/NaCl solution 1:1. Repeat step 
2-3 three times.
Perfusion Fluid
Mix 20 mL human red blood cell concentrate (final hematocrit 15-20%), 59mL William’s Medium 
E solution, 20mL human albumin (200g/L Albuman®, Sanquin, Amsterdam, Netherlands), 1mL 
insulin (100 IE/mL Actrapid®, Novo Nordisk, Alphen aan den Rijn, Netherlands) and 0,1mL 
unfractionated heparin (5000 IE/mL), adding up to a total volume of 100mL.
Equipment Setup to a source of carbogen flow (95% O2 + 5% CO2) with flexible tubing. Insert 
three needles through the rubber bung in the neck of the Büchner flask; two for in- and outflow 
of perfusion fluid and one for the outflow of carbogen. Drape porous tubing over a hook inserted 
into the bottom of the rubber bung in order to increase surface area contact with carbogen and 
connect the tubing to two of the inserted needles (figure 5K).
Ex-vivo machine perfusion system
Connect the different parts of the perfusion system as shown in figure 1 and figure 2.
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figure 5. Photographic details of the rat liver perfusion system. A thermostat was used to maintain a 
constant temperature at 37°C (a), regulated via a fan-driven heater (I) and a heat exchanger (D). An outlet 
(B) for the carbogen used in the two tubular membrane oxygenators (K) on top of the cabinet. An inline 
pressure sensor (C), temperature sensor (E) and flow sensor (f). Cannulas for the hepatic artery and portal 
vein (g). A three-way connector with a small tube inserted, used as a bubble-trap (h) and an air chamber to 
minimize pulses in the portal flow, also functioning as an additional bubble-trap (J).
Procedure
Preparing the ex-vivo machine perfusion system
1. Set the thermostat to 37°C and switch on the connected fan driven heater inside the cabinet. 
Turn on the water baths and set to 37°C.
2. Turn on the laptop, roller pumps and the flow-measuring device. Open the software that 
regulating the pressure-controlled flow in the system.
3. Flush the system with 70% ethanol, unhook the tubing from the roller pumps and dry the 
system using pressurized air.
4. Flush the system with demineralized water and subsequently circulate NaCl 0.9% for 
15 minutes.
5. Fill the system with the prepared perfusion fluid (about 100 mL) and turn on the carbogen 
flow. Use a low flow, as a high flow may cause bubbles to form inside the tubes containing 
perfusion fluid. Check the system for bubbles and use bubble-traps to remove bubbles if 
needed.
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6. Weigh Eppendorf tubes for bile collection and take a perfusate sample for blood gas 
measurement. Correct the pH of the perfusion fluid to 7.35-7.45 by using Sodium Bicarbonate 
and repeat blood gas measurement.
Preparing the hepatectomy
1. Place a 5 mL syringe with NaCl 0.9% in a 37°C stove
2. Place two 5 mL syringes, one 1 mL syringe and one 20 mL syringe with NaCl 0.9% on 
crushed ice in a foam ice container.
3. Fill a Petri dish with crushed ice, cover it with a gauze, the metal grid and a layer of plastic 
paraffin film, to protect the liver from the grid. Place the Petri dish on ice.
4. Prepare a 1 mL syringe with 0.1 mL heparin and 0.9 mL NaCl 0.9%
5. Keep two 20 mL syringes with NaCl 0.9% at room temperature to keep the bowels moist 
during the hepatectomy.
6. Lay out the ligatures and sutures required during the surgery (8x ligature 6/0 and 1x suture 
4/0)
Hepatectomy
1. Initiate anesthesia of the rat with a gas mixture of 5% isoflurane and 100% oxygen, maintain 
anesthesia with 2-3% isolflurane + 100% oxygen.
2. Weigh the rat and place the rat in supine position with the nose pointed into the anesthesia 
nose mask.
3. Shave the incision area and determine the effectiveness of the anesthesia by testing eye 
reflexes and response to pain stimuli.
4. Desinfect the incision area with 70% ethanol and open the abdomen with a transverse 
abdominal incision just below the rib cage. Retract the xiphoid using a suture.
5. Move bowels with a gauze drenched in NaCl 0.9% to the left side of the rat.
6. Cut the falciform ligament and shift the liver towards the diaphragm.
7. Expose the bile duct and place a loose ligature around the bile duct.
8. Incise the bile duct distally from the ligature and cannulate the bile duct. Collect the bile in 
an Eppendorf tube.
9. Expose the portal vein, the splenic vein, the mesenteric vein, the hepatic artery and localize 
the two side branches of the celiac trunk. If possible, place a loose ligature around the 3 side 
branches of the portal vein and the 2 side branches of the celiac trunk. Do not tighten the 
ligatures yet, in order to prevent congestion.
10. Place a loose ligature around the proximal side of the portal vein. Be sure not to accidentally 
ligate the hepatic artery.
11. Expose the distal portal vein (where the portal clamp will be placed for cannulation).
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12. Ligate the branches of the celiac trunk and place 2 loose ligature proximal and distal from the 
celiac trunk.
13. Inject 1 mL of heparin (500 U/mL) via the dorsal vein of the penis.
14. Expose the distal vena cava.
15. Try to dissect the ligaments attaching the liver to the surrounding structures.
16. Ligate the distal celiac trunk, canulate the trunc and fixate the cannula with the proximal 
ligature. Pay attention to face the opening of the canula downwards, with the sharp tip 
facing up.
17. Clamp the distal vena cava and place a clamp on the distal portal vein. From this moment 
onwards the liver has no circulation.
18. Ligate the lienal vein, the mesenteric artery and the mesenteric vein.
19. Insert the cannula into the portal vein, immediately flush 5 mL NaCl 0.9% at 37°C via the 
portal vein. Pay attention to face the opening of the canula downwards, with the sharp 
tip facing up. Dissect the proximal vena cava to prevent backflow of blood, immediately 
followed by 5 mL NaCl 0.9% flush at 4°C via the portal vein. Fixate the portal vein cannula 
using the proximal ligature.
20. Dissect the diaphragm of the rat for easy removal of the liver.
21. Carefully hold the cannulas with tweezers and dissect the liver free. Flush 20 mL NaCl 0.9% 
at 4°C via the portal vein cannula and 3 mL NaCl 0.9% at 4°C via the celiac trunk/hepatic 
artery cannula.
Ex-vivo machine perfusion
1. Before connecting the liver to the system, be sure to recalibrate the system to pressure = zero 
with the spare set of hepatic artery and portal vein cannulas in place and the roller pumps on 
hold.
2. Place the liver in the organ chamber on the convex side (figure 6). Connect the portal vein 
cannula and the celiac trunk (hepatic artery) cannula to the tubes of the perfusion system. 
Make sure there are no bubbles in the cannula or elsewhere in the perfusion system.
3. Set the portal pressure at 11 mmHg and the arterial pressure at 110 mmHg.
4. Direct the bile cannula into an Eppendorf tube that has been weighed before the start of 
the experiment. Attach the Eppendorf tube to the holder on one of the legs of the organ 
chamber.
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figure 6. Normothermic machine perfusion of rat livers. A rat liver just after connecting to the perfusion 
system (a) and the same rat liver after 5 hours of normothermic machine perfusion (B).
Cleaning the ex-vivo machine perfusion system
1. Remove the liver by disconnecting the portal vein cannula and hepatic artery cannula from 
the perfusion system.
2. Flush the system with demineralized water (single-pass) until the water exiting the system is 
clear.
3. Make a Biotex soap solution by passing 500 mL of demineralied water with biotex through a 
filter, heat it in a water bath and flush the system with this warm soap solution.
4. Flush the system with at least 1 L of warm demineralized water (single-pass).
5. Flush the system with 70% alcohol and dry the system with pressured air. Be aware to 
disconnect the tubing from the roller pumps, before drying the system. The tubing should 
remain unhooked from the pumps to prevent stretching and tearing.
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SuMMaRy anD gEnERaL DISCuSSIon
Non-anastomotic biliary strictures (NAS) are a major complication after liver transplantation. 
The development of strictures of the bile ducts inside or more frequently outside the liver 
(extrahepatic) is characteristic of this complication. The aim of this thesis was to gain a better 
understanding of the etiologies underlying NAS and to study the potentially protective role of 
machine perfusion in the prevention of bile duct injury before transplantation. In addition, we 
aimed to investigate how patients want to be informed and involved in the decision to accept a 
liver with increased risk of bile duct complications. In this chapter, the results of this thesis are 
summarized and discussed, followed by a section on future perspectives.
Part a: The Scope of Bile Duct Injury in Liver Transplantation
Chapter 1 provides a general introduction to this thesis, including the aims of each chapter. 
The pathogenesis, clinical presentation, and management of the various types of biliary 
complications that can occur after liver transplantation are discussed in chapter 2. In summary, 
biliary complications are a frequent cause of morbidity after liver transplantation that occur in 
10-40% of the recipients, resulting in mortality rates of 8-15%. Partial liver grafts (e.g. split livers 
and livers from living donors) as well as livers from extended criteria donors (e.g DCD donors) 
are associated with a relatively high risk of biliary complications. Of all biliary complications, 
bile duct strictures and bile leakage are the most common after liver transplantation. While 
bile leakage and anastomotic bile duct strictures can usually be managed successfully without 
long-term sequelae, non-anastomotic biliary strictures are the most troublesome type of biliary 
complication. NAS are often multifocal and can be difficult to treat. When associated with 
recurrent cholangitis, jaundice or even secondary biliary fibrosis, retransplantation may be the 
only treatment option left.
The subsequent chapter 3 focuses on the pathogenesis of NAS, including the lacunae in our 
current knowledge and potential targets to reduce NAS. Not all cases of NAS are equal; the timing, 
localization and severity of strictures varies between patients. Differences in the pathogenesis 
of NAS are thought to, at least partly, explain these variations in presentation. Although NAS 
occurring early after OLT are largely associated with an ischemia-related pathogenesis, NAS 
occurring late after OLT are believed to have a more immune-mediated origin. Endogenous bile 
salts may play an additional role in the pathogenesis of bile duct injury after OLT. Hydrophobic 
bile salts have a direct cytotoxic effect on the cholangiocytes, and this may contribute to the 
post-ischemic injury of the biliary epithelium. Donor surgeons can help prevent NAS by reducing 
warm and cold ischemia time as much as possible, providing adequate flush out of the liver, 
the peribiliary plexus, and the bile ducts. Recipient (transplant) surgeons can help reducing the 
incidence of NAS by keeping the cold ischemia time as short as possible and by performing 
arterial back-table pressure perfusion of the liver graft to ensure adequate perfusion of the 
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peribiliary capillary plexus. More studies are needed to provide better insight in the immune-
mediated mechanisms of NAS that occur late after OLT. Recent advancements in normothermic 
and hypothermic machine perfusion could potentially have an important impact on the incidence 
of NAS through a reduction of preservation injury of the bile ducts and the peribiliary capillary 
plexus of liver grafts.
Part B: Immune and Ischemia-mediated Etiologies of Bile Duct Injury
In chapter 4 we provide evidence that the immune system plays a critical role in the development 
of NAS after OLT. A loss-of-function mutation in the chemokine receptor CCR5 (CCR5-Δ32) 
leads to changes in the immune system, including impaired chemotaxis of regulatory T-cells. 
Patients with CCR5-Δ32 had a 4-fold higher risk of developing NAS, compared with CCR5 Wt 
recipients. This risk was even higher in CCR5-Δ32 carrying patients transplanted for PSC. In 
addition, retransplantation for NAS was seen more frequently in patients with CCR5-Δ32 and 
more late development of NAS occurred in patients with CCR5-Δ32. These data suggest that 
the immune system of the recipient plays a critical role in development of NAS, especially late 
(> 2 years) after liver transplantation, and warrant further experimental studies to unravel the 
mechanism through which CCR5 is involved in the development of bile duct injury.
In chapter 5 we discuss the changing perspective on the pathogenesis of NAS after liver 
transplantation. For decades it was assumed that only few biliary epithelial cells are damaged 
or lost during cold preservation, and that most of the biliary injury occurs after transplantation 
due to reperfusion injury, immunological causes and hydrophobic bile salt toxicity. Two recently 
published studies provided new perspective from which to view biliary injury and the development 
of strictures after transplantation. In both studies major bile duct epithelial loss was observed 
in more than 85% of the common bile duct biopsies collected at the end of static cold storage 
(SCS). If loss of the biliary epithelium and injury of the bile duct wall is so universally present in 
human donor livers, yet only a minority develops biliary strictures after transplantation, this gives 
rise to the important new question as to ‘Why does regeneration of biliary epithelium fail in 
certain livers and how can we stimulate the regenerative capacity of the biliary epithelium after 
OLT?’ It is conceivable that biliary epithelium of the extrahepatic bile duct has an endogenous 
regenerative capacity, which may be impaired when NAS develops after liver transplantation.
The aim of chapter 6 was to identify possible site(s) where epithelial regeneration may be initiated 
in the human extrahepatic bile duct and to study the possible role of local progenitor cells in 
this process. We examined tissue specimens from normal and diseased human extrahepatic bile 
duct varying from mild cellular injury (as in cholangitis/cholecystitis) to severe epithelial injury 
with cholangiocyte loss, as can be seen in NAS after orthotopic liver transplantation. Mild injury 
of the biliary epithelial layer was accompanied with increased cellular proliferation at the luminal 
surface, whereas severe injury was associated with increased cell replication in the peribiliary 
glands. Moreover, the peribiliary glands of large bile ducts were identified as a local niche 
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of biliary progenitor cells that contribute to regeneration of the biliary epithelial lining after 
major injury. Collectively, these data suggest that minor biliary epithelial injury and loss can be 
compensated for by proliferation of mature biliary epithelial cells, and major injury requires the 
mobilization and proliferation of biliary progenitor cells in the peribiliary glands.
In chapter 7 we examined biopsies taken during 140 liver transplant procedures, from the distal 
end of the extrahepatic bile duct. Slides were examined by light microscopy, using a systematic 
injury grading system. This study demonstrates a high incidence of preservation injury of the 
extrahepatic bile ducts of donor livers after cold storage. We identified injury of the peribiliary 
glands and the vascular plexus as significant risk factors for the development of biliary strictures 
after liver transplantation. These findings support our hypothesis that preservation of the 
peribiliary glands and vascular plexus is critical in the timely regeneration of the biliary epithelial 
lining and bile duct wall stroma after liver transplantation. Apparently, the current preservation 
method used in organ transplantation, which is based on flush-out, cooling and static cold 
storage, is insufficient to maintain bile duct viability. It has become clear that we need better 
and probably more sophisticated preservation techniques to protect this delicate part of the liver 
graft. An attractive alternative preservation method is machine perfusion. Machine perfusion 
may not only reduce the incidence of biliary complications by lowering the amount of biliary 
injury prior to transplantation, but also by providing better protection of the peribiliary glands 
and vascular plexus. This, therefore, has been the focus of the third part of this thesis.
Part C: Machine Perfusion: a Potential Strategy to Prevent Bile Duct Injury
During machine preservation livers are perfused with an oxygenated or non-oxygenated 
perfusion fluid at either low temperature or normal body temperature (1-5). Thus far, most 
investigations have focused on hypothermic machine perfusion (HMP; 0-4°C) and studies have 
suggested that HMP results in better preservation of the liver parenchyma, compared to the 
classical method of organ preservation, SCS (3-5). However, it is unknown whether hypothermic 
oxygenated machine perfusion results in better preservation of biliary epithelium and the 
peribiliary vasculature. In chapter 8 we compared oxygenated HMP and SCS in an established 
DCD model of liver donation in pigs. After preservation with either HMP or SCS, liver grafts were 
ex vivo reperfused with autologous whole blood, as a model to simulate transplantation. After 
reperfusion, arterial flow was higher in the HMP group, and histological examination of bile 
ducts revealed significantly less arteriolonecrosis of the peribiliary vascular plexus compared to 
SCS preserved livers. Although we did not observe differences in the degree of biliary epithelial 
cell loss or bile duct stroma necrosis between livers preserved by HMP or SCS, the combination 
of better preservation of the peribiliary plexus and higher arterial flow may contribute to a faster 
recovery of the post ischemic bile ducts. Whether this results in a reduction of the rate of biliary 
complications after transplantation of DCD livers should be answered in clinical trials.
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Alternatively, livers can be perfused at a higher temperature; such as normothermic (37°C) 
or subnormothermic (below 37°C; usually 21°C), An important advantage of normothermic 
machine perfusion (NMP) over conventional SCS is the delivery of oxygen and nutrients at 37°C, 
providing full metabolic support. NMP offers the potential to protect the bile ducts from injury 
caused by the cold ischemia during SCS, and might allow pharmacological preconditioning as 
well as ex vivo testing of hepatic viability and function prior to transplantation. In chapter 9 we 
studied the impact of NMP on bile duct preservation in both DCD and non-DCD rat livers. Livers 
were preserved for 3h using either SCS or NMP, followed by 2h ex-vivo reperfusion. Compared 
with conventional SCS, NMP provided superior preservation of bile duct epithelial cell function 
and morphology. This beneficial effect of NMP was most pronounced in DCD livers. By reducing 
biliary injury, NMP could have an important impact on the utilization of DCD livers and may 
improve outcome after transplantation. These findings provide a strong stimulus for a clinical trial 
of NMP in human DCD liver transplantation.
Successful normothermic perfusion of livers has been reported only in animal models (6-10). In 
chapter 10 we demonstrate that normothermic machine perfusion of human donor livers is 
technically feasible. Four discarded human livers were perfused successfully ex vivo at 37oC for 
6 hours. Oxygenated, normothermic machine perfusion consisted of pressure and temperature 
controlled pulsatile perfusion of the hepatic artery and continuous portal perfusion. Biochemical 
markers in the perfusion fluid reflected minimal hepatic injury and improving function during 
perfusion. Lactate levels decreased to normal values, reflecting active metabolism by the liver. 
Bile production was observed throughout the 6 h perfusion period (mean rate 8.16±0.65 g/h 
after the first hour). Histological examination before and after 6 h of perfusion showed well-
preserved liver morphology without signs of additional hepatocellular ischemia, biliary injury, or 
sinusoidal damage. This study is the first study to show that NMP is of human livers technically 
feasible.
One of the advantages of NMP is the ex vivo testing of suboptimal liver grafts that, based on 
conventional clinical criteria, are considered not suitable for transplantation because of a too 
high early failure rate. In order to move forward to clinical use of machine perfusion for selecting 
transplantable organs, it is necessary to identify markers during machine perfusion that can 
predict adequate liver function after transplantation. In case of end-ischemic NMP, we should 
ideally be able to assess and predict liver quality within 1-3 hours of perfusion to allow time for 
selection and preparation of a patient from the waiting list for liver transplantation. In chapter 11 
we evaluated 12 discarded human livers for graft function at 6h of NMP. Six livers demonstrated 
excellent graft function at 6 h of NMP and 6 livers demonstrated clear signs of injury and 
nonfunction. Bile production at 2.5 h of NMP was identified as the only 100% discriminating 
predictor of graft function at 6 hours of NMP. From this study we concluded that normothermic 
perfusion of ECD livers allows assessment of graft viability prior to transplantation, which opens 
new avenues for donor organ selection, therapeutic interventions and preconditioning. This may 
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not only improve organ quality and function, but will also lead to a considerable expansion of the 
number of organs available for transplantation.
Part D: addendum
DCD and other ECD donor grafts are increasingly used for transplantation, resulting in an 
increased risk of bile duct complications. At the time of organ offer for transplantation, donor-
related risks such as disease transmission and graft failure are weighed against the patient’s risk 
of remaining on the waiting list. The patient’s role in decision-making and the timing and extent 
of donor-specific risk information has been discussed in the medical literature; however it has 
not been documented what patients themselves think of this. In chapter 12 we describe the 
first study revealing the opinion of liver patients on these issues. Forty patients listed for liver 
transplantation and 179 transplanted liver patients participated in an anonymous questionnaire-
based survey. The majority of respondents wished to be informed about donor-related risks 
and wanted to be involved with shared decision-making at the time of organ allocation. 
Implementing this knowledge and standardizing the content, the manner of transfer, and 
the amount of information we provide to our patients at the different time points along the 
transplant allocation process will be important to provide the same opportunities and care to 
every patient on the waiting list.
The rat liver perfusion system, used for our study in chapter 9, is described in detail in chapter 13. 
The system allows NMP in a pressure- and temperature controlled manner. Two artificial lungs 
provide oxygenation, the arterial flow is pulsatile and the portal flow continuous.
In chapter 14, the current chapter, the results of this thesis are summarized and discussed, 
followed by a section on future perspectives.
ConCLuSIonS anD fuTuRE PERSPECTIvES
The studies described in this thesis have resulted in a better understanding of the etiologies 
underlying bile duct injury and the subsequent formation of NAS after liver transplantation. 
Moreover, they have provided first evidence that machine preservation provides superior 
protection of the bile ducts of liver grafts, compared to conventional SCS.
The most important findings and conclusions of this thesis are:
1)  Injury of the biliary epithelial lining of the large bile ducts, characterized by detachment and 
loss of epithelial cells as well as reduced epithelial cell function, is almost universally present 
in donor livers prior to transplantation. However, this type of injury does not correlate with 
the development of NAS after transplantation. Nevertheless, this unexpected new finding 
has totally changed our view on the pathogenesis of NAS. If biliary injury is universally 
present, yet only a minority of livers grafts develop biliary strictures, this suggests that lack of 
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regeneration of bile duct epithelium, rather than the amount of injury determines whether a 
transplant will be complicated by biliary strictures or not.
2)  Peribiliary glands are a niche of biliary progenitor cells and these glands play a critical role in 
regeneration of the bile duct epithelium after severe injury.
3)  In addition to damage of the epithelial lining of bile duct lumen, injury of the peribiliary glands 
and peribiliary vasculature plexus can be found in some of the livers prior to transplantation. 
Injury to these components of the bile duct wall is strongly related to the development of NAS 
early after transplantation, supporting the novel concept of insufficient biliary regeneration 
as the main determinant of NAS.
4)  Machine perfusion provides better preservation of the bile ducts of donor livers, compared 
to SCS. Injury to the peribiliary vasculature can be reduced by HMP (in a porcine model of 
DCD donation). Bile duct epithelial cell loss and dysfunction can be prevented by NMP (in a 
rat model of DCD donation).
5)  NMP of human livers is technically feasible and this new technique may allow us to provide 
better protection of the bile ducts prior to transplantation. In addition, NMP provides a novel 
tool to improve the selection of donor livers for transplantation. Bile production during NMP 
is likely to be a good predictive parameter for ex vivo viability testing of ECD donor livers prior 
to transplantation.
6)  In addition to biliary injury that occurs during cold preservation, immune mediated biliary 
injury may occur after transplantation and this plays a significant role in the development of 
NAS that occur late (>2 years) after transplantation.
7)  Finally, we should reconsider the way we allow patients to be involved in the decision-making 
process when an ECD donor liver is offered for transplantation. Patients have a strong wish to 
participate in this complex process and we should develop protocols to inform them better.
Although the studies described in this thesis have provided important answers to the clinical 
questions that were raised at the start of this PhD research project, new challenges and questions 
have subsequently arisen. In this last paragraph of this thesis, I would like to spend a few words 
on the issues that have emerged and are still unanswered and to describe some of the new 
directions and opportunities for future research.
Concerning the etiology of NAS, we have demonstrated a significantly higher incidence of 
late NAS in recipients with CCR5-Δ32 (chapter 4). This observation may be explained by an 
immunological imbalance caused by the lack of a functional CCR5 in these patients. CCR5 
deficiency in humans, as well as in experimental animal models of inflammation and infection, 
is associated with significant increases of tissue levels of CCR5 ligand CCL5, which promotes 
enhanced influx of T-cells into tissues by binding to one of its alternative receptors, CCR1 (11-14). 
Moreover, the CCR5-Δ32 mutation has been associated with impaired attraction of regulatory 
T cells to the site of tissue injury (15-17). Regulatory T-cells reduce inflammation and suppress 
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activation of potentially harmful, self-reactive lymphocytes. The strong association between 
CCR5-Δ32 and late NAS observed in the study described in chapter 4 could therefore possibly 
be explained by an increased inflammatory response of the host towards the biliary epithelium 
of the liver graft and a lack of regulatory T cells at the place of injury. However, this clinical, 
observational study did not allow us to define the underlying mechanisms as to why CCR5-Δ32 
leads to the development of biliary strictures. Better understanding of the mechanisms underlying 
this clinical observation could be derived from an experimental animal study. One option would 
be to study bile duct injury and proliferation after bile duct ligation in CCR5 knockout mice. Influx 
of immune cells into the liver in response to bile duct injury caused by bile duct ligation could be 
quantified by flowcytometry and immunohistochemistry. Recognizing the difference in immune 
response between CCR5 wildtype and knockout mice would create a greater understanding of 
the pathophysiology of (late) NAS and therefore bring us closer to potential therapeutic strategies 
for this subtype of NAS.
Concerning the prevention of NAS, it has become evident that the current clinical practice of a 
single flush out and cooling of donor livers, followed by static cold storage is not sufficient to 
protect and preserve the bile ducts prior to transplantation. Machine perfusion of donor livers 
is an attractive alternative to SCS, as it provides a promising new strategy to prevent bile duct 
injury. The technical advances made in this field, in combination with the increasing shortage of 
donor livers, provide an exciting new avenue of research opportunities and clinical challenges. 
After a time period of more than 40 years in which static cold preservation and storage of donor 
organs has been the gold standard in clinical transplantation, we may see a great change in 
clinical practice with the introduction of machine perfusion. Although the animal models and 
the studies using human donor livers described in this thesis have demonstrated the technical 
feasibility of machine perfusion systems, as well as their protective effects on bile ducts, several 
questions remain unanswered.
To answer these new questions, future studies should focus on the following aspects and 
questions:
1) What is the optimal temperature for bile duct preservation during machine perfusion? It is 
unclear whether 37oC is the optimal temperature or whether perfusion at lower temperatures 
(e.g. between 4-10 oC or at room temperature) is equally effective, yet cheaper and possibly 
safer.
2) As long as the surgical technique of a multi-organ donation procedure is not changed, organs 
will be flushed out initially with cold preservations fluid. If organs are subsequently preserved 
by machine perfusion, what is the best strategy to increase the temperature? Should 
this de done gradually and if so, at what speed?
3) When and how long should machine perfusion best be used? Should static cold 
preservation completely be replaced by machine perfusion, or is it sufficient to combine SCS 
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with a period of machine perfusion? If so, should machine perfusion be performed before 
SCS (immediately after organ retrieval in the donor hospital) or at the end of SCS upon arrival 
at the transplant center?
4) Can we improve the quality of donor livers and their bile ducts by using machine perfusion 
prior to transplantation? Preconditioning could focus on the stimulation of natural defense 
mechanisms or the enhancement of endogenous repair processes. Alternatively, machine 
perfusion could enable us to improve the quality of a donor liver by reducing a preexisting 
pathological condition, such as steatosis.
5) Another important question that needs to be addressed is: What is the best type of 
perfusion fluid?
6) Finally, future research should aim to identify specific biomarkers or to develop molecular 
imaging tools that allow adequate assessment of bile duct viability prior to transplantation.
ad 1 – The optimal temperature
During machine preservation livers can be perfused with an oxygenated or non-oxygenated 
perfusion fluid at either low temperature or normal body temperature (2-4,18,19). A relatively 
simple and safe option is hypothermic machine perfusion (0-4°C), which allows the removal of 
waste products while perfusing with a preservation solution and at a temperature similar to the 
conventional SCS. The first clinical study on machine perfusion of human livers was performed 
by Guarrera et al., using HMP without oxygenation (1). Although a reduction in delayed graft 
function was demonstrated in this study, long-term benefits have not been described. Recent 
studies in animal models have demonstrated the beneficial effects of oxygenation during cold 
machine perfusion, resulting in improved protection of mitochondrial function, lower markers 
of hepatocellular injury and stress, and enhanced functional recovery after reperfusion (19,20). 
Moreover, in chapter 8 of this thesis we have demonstrated improved preservation of the 
peribiliary vascular plexus in oxygenated HMP preserved porcine livers. However, it remains 
unknown to which extend the peribiliary glands are preserved during oxygenated HMP, and 
whether this in combination with better preservation of the peribiliary vasculature also results in 
a reduction of biliary strictures after transplantation of human livers. The answer to this question 
should come from a clinical study and the time has come to initiate a randomized clinical trial 
comparing SCS with oxygenated HMP in liver transplantation. Based on the high incidence of 
NAS after DCD liver transplantation, such a trial should best be performed in DCD livers grafts.
ad 2 – The best strategy to increase temperature
An alternative to choosing one temperature for perfusion is to combine different temperatures 
in a protocol that covers transport, assessment and preconditioning of the liver. In a recent study 
by Minor et al. 90 minutes of controlled oxygenated rewarming by machine perfusion up to 
20°C significantly reduced cellular enzyme loss and more bile production, when compared to 
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90 minutes of SCS or subnormothermic machine perfusion (21). More research in this area will 
be needed to define the best clinical protocol.
ad 3 – Timing and duration of machine perfusion
Machine perfusion can be used to replace cold storage entirely or in combination with a 
period of cold storage. A strategy to replace cold storage entirely is followed by the group 
of Friend in Oxford, UK, using NMP. This method may be most successful, but also requires 
exceptional organizational planning and caries a higher risk of failure. Accidental disconnection 
of a liver from the perfusion device at 37°C poses great risk to the graft as it immediately 
results in deleterious warm ischemia. Safer and possibly still effective may be a short period 
of oxygenated hypothermic perfusion either before or after conventional cold storage during 
transportation. While the latter option is actively investigated by the group of Dutkowski in 
Zurich, Switzerland  (19,22), a Japanese group recently presented very promising preliminary 
results of a short period of oxygenated normothermic perfusion before SCS in an animal model 
of DCD liver transplantation (23). Which option is most effective and the safest in clinical practice 
will be investigated in clinical trials in the coming years.
ad 4 – Improving donor organ quality
In contrast to HMP, NMP enables restoration of normal physiology and metabolic function. 
This creates a unique opportunity to improve organ quality and biliary integrity by activation of 
endogenous or exogenous repair mechanisms. Potentially interesting topics that deserve further 
exploration are, for example, the addition of mesenchymal stem cells (24) or growth factors (25) 
to the perfusion fluid. Especially humoral factors that have been identified to stimulate 
proliferation of biliary epithelial cells, such as vascular endothelial growth factor, glucagon-like 
peptide-1, insulin-like growth factor-1 are interesting targets during NMP (25). Alternatively, it 
is worthwhile to explore the potentially protective effects of ex vivo stimulation of bicarbonate 
secretion by biliary epithelial cells, as this has been described as a critical endogenous protection 
mechanism of biliary epithelial cells against bile salt mediated toxicity and cell death  (26). 
Finally, NMP could be used to improve bile duct preservation and function by the addition of 
cytoprotective, anti-inflammatory and antifibrotic hydrophilic bile salts or their derivatives, such 
as tauroursodeoxycholic acid, nor-ursodesoxycholic acid, or 6alpha-ethyl-chenodeoxycholic 
acid (27-29)
ad 5 – The best perfusion fluid
In our NMP experiments (chapter 9-11) we used a perfusion fluid that would mimic physiology, 
with exception of the potentially harmful leukocytes and thrombocytes, based on human blood 
products such as red blood cells (RBC), fresh frozen plasma (FFP) and albumin. Since blood 
products are sparse and rely on donation, it is worthwhile to evaluate artificial oxygen carriers 
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and plasma replacements as alternative components of a perfusion fluid. Moreover, protocols 
involving machine perfusion at different temperatures will require an alternative to RBCs, since 
they loose their flexibility and oxygen-binding capacity at lower temperatures.
ad 6 – Bile duct viability assessment ex vivo
Although we have shown the ability to asses viability of the hepatic parenchyma during ex 
vivo machine perfusion (chapter 10 and 11), we have not yet been able to access bile duct 
viability other than by taking biopsies from the distal end of the common bile duct (chapter 7). 
In the experiments focusing on NMP of human donor livers, we have used biliary secretion 
of bicarbonate as a biomarker of biliary epithelial function. Biliary epithelial cells contribute 
significantly to bile volume and flow by active secretion of bicarbonate and we have observed a 
recovery of biliary bicarbonate secretion during machine perfusion. The amount of bicarbonate 
secretion in the bile, however, is the result of all biliary epithelial cells present in the intra- and 
extrahepatic bile ducts and it does not necessarily reflect function of the epithelium of the 
larger bile ducts, which are most prone for the development of strictures after transplantation. 
Therefore, we need to identify better biomarkers of biliary epithelial cell injury and function. 
The group of van der Laan in Rotterdam has recently identified miRNA’s as an attractive new 
biomarker for hepatobiliary injury (30). It needs to be demonstrated whether measurement of 
biliary epithelial cell specific miRNA’s in bile can be used as a maker to predict bile duct viability 
during NMP. Alternatively, an attractive option could be the development of molecular imaging 
techniques using near-infrared fluorescence that allow a non-invasive assessment of the biliary 
epithelium. If such molecular imaging techniques are combined with visible light cholangioscopy 
this could provide an intraoperative tool for surgeons to judge viability of the biliary tree prior to 
transplantation (31).
In summary, the studies described in this thesis have contributed significantly to a better 
understanding of the etiologies underlying biliary injury during and after liver transplantation. 
Moreover, they have provided the first evidence that machine preservation is a feasible and 
very attractive alternative to static cold storage of donor livers prior to transplantation. Machine 
perfusion was shown to provide better protection of the bile ducts of liver grafts, compared to 
conventional SCS. It is expected that this novel technique will change the surgical practice of liver 
transplantation. It is my hope and expectation that machine perfusion of donor livers may not 
only reduce the amount of biliary complications after transplantation, but will also increase the 
number of organs that are suitable for transplantation, providing a greater chance for patients 
suffering from end-stage acute or chronic liver disease to receive this life-saving therapy.
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Het ontstaan van non-anastomotische galwegstricturen (NAS) is een veel voorkomend en moeilijk 
behandelbaar probleem na levertransplantatie. Kenmerkend voor deze complicatie is het ontstaan 
van vernauwingen (stricturen) van de galwegen in of vaker net buiten de lever (extrahepatisch). 
De doelstelling van dit proefschrift is om de onderliggende etiologie (oorzaken) van NAS beter 
te begrijpen en aan de hand hiervan de potentieel beschermende rol van machineperfusie in het 
voorkomen van galwegschade te onderzoeken. Daarnaast wordt beschreven hoe leverpatiënten 
geïnformeerd willen worden en betrokken willen zijn bij het besluit om een donorlever te 
accepteren, indien deze lever een verhoogd risico heeft op galwegcomplicaties. In dit hoofdstuk 
worden de resultaten van dit proefschrift samengevat en besproken, gevolgd door een paragraaf 
met toekomstperspectieven.
Deel a: omvang en oorzaken van galwegschade tijdens levertransplantatie
hoofdstuk 1 is een algemene inleiding tot dit proefschrift, inclusief de doelstellingen van 
ieder hoofdstuk. De pathogenese, het klinische beeld en de behandelmogelijkheden van 
verschillende types galwegcomplicaties die na levertransplantatie kunnen optreden, worden 
besproken in hoofdstuk 2. Samengevat zijn galwegcomplicaties een frequente oorzaak van 
ziekte na levertransplantatie. Het komt voor in 10-40% van de ontvangers, resulterend in een 
sterftepercentage van 8-15%. Zowel partiële levertransplantaten (zoals splitlevers en donorlevers 
afkomstig van levende donoren) als levers van zogenaamde ‘extended criteria donoren’ (ECD), 
in het bijzonder de ‘donation after cardiac death’ (DCD) donoren, zijn geassocieerd met een 
relatief groot risico op galwegcomplicaties. Van alle galwegcomplicaties zijn galwegstricturen 
en gallekkage de meest voorkomende complicaties na levertransplantatie. Hoewel gallekkage 
en een strictuur van de anastomose gewoonlijk succesvol behandeld kunnen worden, is dit bij 
non-anastomotische galwegstricturen helaas niet het geval. NAS zit vaak op meerdere plekken 
tegelijk, is erg therapie-resistent en meestal is re-transplantatie de enige effectieve behandeling.
In hoofdstuk 3 wordt de pathogenese van NAS beschreven, inclusief de lacunes in onze 
huidige kennis en de potentiële aangrijpingspunten om NAS te kunnen voorkomen of 
verminderen. Niet iedere manifestatie van NAS is identiek; de timing, de lokalisatie en de 
ernst van de galwegstricturen verschillen tussen patiënten. Gedacht wordt dat deze variaties 
in manifestatie (in elk geval deels) te verklaren zijn door verschillen in etiologie. Hoewel NAS 
vroeg na levertransplantatie grotendeels geassocieerd wordt met een ischemie-gerelateerde 
pathogenese, wordt NAS laat na levertransplantatie toegeschreven aan een immuun-gemedieerde 
oorzaak. Endogene galzouten spelen waarschijnlijk een additionele rol in de pathogenese van 
galwegschade na levertransplantatie. Hydrofobe galzouten hebben een direct cytotoxisch effect 
op de cholangiocyten (galwegepitheelcellen) en dit kan bijdragen aan de post-ischemische 
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schade van het galwegepitheel. Donorchirurgen kunnen NAS proberen te voorkomen door de 
warme en koude ischemietijden zo kort mogelijk te maken en daarbij de lever, de peribiliaire 
vasculaire plexus (de kleine bloedvaten die de galwegen van zuurstof voorzien) en de galwegen 
adequaat te doorspoelen met koude preservatievloeistof. Transplantatiechirurgen kunnen de 
incidentie van NAS proberen te verlagen door de koude ischemietijd zo kort mogelijk te houden 
en een arteriele back-table druk-perfusie van het transplantaat uit te voeren, zodat de peribiliaire 
vasculaire plexus adequaat wordt geperfuseerd. Meer studies zijn nodig om beter inzicht te 
leveren in de immuun-gemedieerde mechanismen van NAS die pas laat na OLT optreden. De 
recente ontwikkelingen in normotherme en hypotherme machineperfusie kunnen potentieel een 
belangrijke impact hebben op de incidentie van NAS door een reductie van preservatieschade 
van de galwegen en de peribiliaire vasculaire plexus van de donorlevers.
Deel B: Immuun- en ischemiegerelateerde etiologieën van galwegschade
In hoofdstuk 4 tonen we aan dat het immuunsysteem een belangrijke rol speelt in de ontwikkeling 
van NAS na levertransplantatie. Een verlies-van-functie mutatie in de chemokine receptor CCR5 
(CCR5-Δ32) leidt tot veranderingen in het immuunsysteem, inclusief een gestoorde chemotaxis 
van regulatoire T-cellen. Leverpatiënten met CCR5-Δ32 hebben, vergeleken CCR5 wildtype 
leverpatiënten, een viervoudig verhoogd risico op het ontwikkelen van NAS. Dit risico is nog 
hoger in CCR5-Δ32 dragers die getransplanteerd werden voor de ziekte primaire scleroserende 
cholangitis (PSC). Daarnaast is er bij patiënten met CCR5-Δ32 vaker sprake van re-transplantatie 
ten gevolge van NAS en treedt de ontwikkeling van NAS vaak laat op (>2 jaar na transplantatie). 
Deze resultaten suggereren dat het immuunsysteem van de ontvanger een belangrijke rol speelt 
in het ontwikkelen van NAS, in het bijzonder van de NAS die pas laat (>2 jaar) na transplantatie 
ontstaat. Experimentele studies zijn nodig om te ontrafelen op welke manier CCR5 exact 
betrokken is bij de ontwikkeling van galwegschade.
In hoofdstuk 5 wordt een nieuwe visie op de pathogenese van NAS besproken. Jarenlang werd 
er verondersteld dat slechts enkele galwegepitheelcellen beschadigd raken of verloren gaan 
tijdens de koude preservatietijd, en dat de meeste galwegschade ontstaat na levertransplantatie 
als gevolg van reperfusieschade, immunologische oorzaken en hydrofobe galzouttoxiciteit. 
Twee recent gepubliceerde studies wierpen nieuw licht op het ontstaan van galwegschade 
en het ontwikkelen van galwegstricturen na transplantatie. In beide studies werd uitgebreide 
galwegepitheelschade gezien in meer dan 85% van de extrahepatische galwegbiopten 
die verzameld waren aan het einde van de koude preservatietijd. Blijkbaar is verlies van 
galwegepitheel zeer frequent aanwezig in humane donorlevers, maar slechts een minderheid 
ontwikkelt galwegstricturen na levertransplantie. Deze bevinding leidt tot de belangrijke vraag 
‘Waarom faalt de regeneratie van het galwegepitheel in sommige levers, en hoe kunnen we 
de regeneratieve capaciteit van het galwegepitheel na lever transplantatie stimuleren?’ Het is 
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denkbaar dat het galwegepitheel van de extrahepatische galweg een endogene regeneratieve 
capaciteit heeft, welke afwijkend is in de levers die NAS ontwikkelen na levertransplantatie.
Het doel van hoofdstuk 6 is tweeledig. Het eerste doel is het identificeren van mogelijke locaties 
rondom de humane extrahepatische galweg waar regeneratie van het galwegepitheel wordt 
geïnitieerd. Het tweede doel is het bestuderen van de mogelijke rol van lokale voorlopercellen 
(progenitorcellen) in dit regeneratieproces. Weefsel van gezonde en zieke humane extrahepatische 
galwegen werd bestudeerd, variërend van milde schade (zoals bij cholangitis/cholecystitis) tot 
ernstige schade met verlies van galwegepitheel, zoals wordt gezien bij NAS na levertransplantatie. 
Milde schade van het galwegepitheel ging gepaard met een verhoogde cellulaire proliferatie aan 
de luminale zijde van de galweg, terwijl ernstige schade geassocieerd was met een verhoogde 
celdeling in de peribiliaire klieren. Daarnaast werden de peribiliaire klieren van de grote 
galwegen geïdentificeerd als een lokale nis voor biliaire progenitorcellen. Deze data suggereert 
dat milde schade aan het galwegepitheel hersteld kan worden door proliferatie van volgroeide 
galwegepitheelcellen in het lumen. Ernstige galwegschade daarentegen, vereist proliferatie en 
mobilisatie van biliaire progenitorcellen vanuit de biliaire klieren.
In hoofdstuk 7 onderzochten we galwegbiopten van het distale uiteinde van de extrahepatische 
galweg, afkomstig van 140 transplantatieprocedures. De biopten werden lichtmicroscopisch 
bestudeerd aan de hand van een systematisch scoringssysteem. Deze studie demonstreert een 
hoge incidentie van galwegschade van de extrahepatische galwegen van donorlevers na koude 
preservatie. We identificeerden schade aan de peribiliaire klieren en de peribiliaire vasculaire 
plexus als significante risicofactoren voor het ontwikkelen van NAS na levertransplantatie. Deze 
bevindingen ondersteunen onze hypothese dat preservatie van de peribiliaire klieren en vasculaire 
plexus van de extrahepatische galwegen cruciaal is voor tijdige regeneratie van het galwegepitheel 
en de galwegwand na levertransplantatie. Blijkbaar geeft de huidige preservatiemethode van 
donororganen, welke gebaseerd is op doorspoelen, koelen en koud preserveren, onvoldoende 
bescherming om de levensvatbaarheid van het galwegepitheel te behouden. Het is duidelijk 
geworden dat we betere en waarschijnlijk meer geavanceerde preservatietechnieken nodig 
hebben om dit kwetsbare onderdeel van de donorlever te kunnen beschermen. Een aantrekkelijke 
alternatieve preservatiemethode is machineperfusie. Deze techniek biedt de mogelijkheid om 
niet alleen de hoeveelheid galwegschade vóór levertransplantatie te verminderen, maar ook een 
betere bescherming te bieden van de peribiliaire klieren en peribiliaire vasculaire plexus. Om deze 
reden staat machineperfusie centraal in het derde deel van dit proefschrift.
Deel C: Machineperfusie: Een potentiële strategie om galwegschade te voorkomen
Tijdens machineperfusie worden donorlevers doorspoeld (geperfuseerd) met een geoxygeneerde 
of niet-geoxygeneerde perfusievloeistof bij lichaamstemperatuur of kouder (1-5). Tot nu 
toe hebben de meeste studies zich geconcentreerd op hypotherme machineperfusie (HMP; 
0-4°C) en onderzoek heeft uitgewezen dat HMP resulteert in een betere preservatie van het 
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leverparenchym, vergeleken met de klassieke methode van orgaanpreservatie ‘static cold 
storage’ (SCS) (3-5). Echter, het is onbekend of hypotherme geoxygeneerde machineperfusie 
resulteert in een betere preservatie van het galwegepitheel en de peribiliaire vasculaire plexus. In 
hoofdstuk 8 vergeleken we geoxygeneerde HMP met SCS in varkenslevers afkomstig van een 
‘donation after cardiac death’ (DCD) donatieprocedure. Om een transplantatie na te bootsen 
werden de levers, na preservatie met HMP of SCS, ex vivo met autoloog volbloed gereperfuseerd. 
Na reperfusie was de arteriële doorstroming beter in de HMP groep en histologisch onderzoek 
van de galwegen onthulde significant minder arteriolonecrose (afsterven van bloedvaten) in de 
peribiliaire vasculaire plexus vergeleken met SCS gepreserveerde levers. Hoewel er geen verschil 
werd gezien in de mate van galwegepitheelverlies of galwegwandnecrose tussen de HMP en 
SCS gepreserveerde levers, draagt de combinatie van een gespaarde peribiliaire vasculaire 
plexus en een betere arteriële doorstroming daarentegen waarschijnlijk wel bij aan een sneller 
herstel van de post-ischemische galwegen. Of dit resulteert in een verminderde incidentie van 
galwegcomplicaties na transplantatie van NHB levers zal moeten blijken uit klinische studies.
Machineperfusie kan ook op een hogere temperatuur worden uitgevoerd; zoals normotherme 
(37°C) of subnormotherme (<37°C; meestal 21°C) machineperfusie. Een groot voordeel 
van normotherme machineperfusie (NMP) boven de klassieke SCS is de afgifte van zuurstof 
en voedingstoffen op lichaamstemperatuur, waarbij de lever wordt voorzien van complete 
metabole ondersteuning. NMP heeft de potentie om galwegen te beschermen tegen schade 
veroorzaakt door koude ischemie tijdens SCS, daarnaast biedt het de potentiële mogelijkheid tot 
farmacologische preconditionering en het ex vivo testen van de leverfunctie vóór transplantatie. 
In hoofdstuk 9 bestudeerden we de impact van NMP op galwegpreservatie in zowel DCD 
(donation after cardiac death) als non-DCD (donatie zonder voorafgaande circulatiestilstand) 
rattenlevers. Levers werden 3 uren gepreserveerd met SCS of NMP, gevolgd door 2 uren ex 
vivo reperfusie. Vergeleken met de klassieke SCS, resulteerde NMP in superieure preservatie van 
galwegepitheel morfologie en -functie. Dit gunstige effect was met name uitgesproken in de 
DCD donorlevers. Door het verminderen van galwegschade kan NMP een grote impact hebben 
op het gebruik van DCD donorlevers en zodoende de uitkomsten na transplantatie verbeteren. 
Deze bevindingen zijn een belangrijke stimulans om een klinische studie naar NMP in humane 
DCD levertransplantatie op te zetten.
Succesvolle NMP is tot op heden alleen gerapporteerd in levers afkomstig van proefdieren (6-10). 
In hoofdstuk 10 demonstreren we in een unieke studie dat ook NMP van humane levers technisch 
mogelijk is. Vier humane levers (afgekeurd voor transplantatie) werden 6 uur lang succesvol 
ex vivo geperfuseerd. De geoxygeneerde, normotherme machineperfusie bestond uit druk- en 
temperatuurgereguleerde pulserende doorbloeding van de arterie hepatica en een continue 
doorbloeding van de vena porta. De biochemie van de perfusievloeistof reflecteerde minimale 
leverschade en een verbetering in leverfunctie tijdens de 6 uur durende perfusieperiode. De 
levers waren metabool actief; lactaatwaarden daalden tot een normaal (fysiologisch) niveau en 
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een continue galproductie werd waargenomen tijdens de perfusieperiode (gemiddeld 8.16±0.65 
g/h na het eerste uur). Histologisch onderzoek voor en na 6 uur NMP liet goed-gepreserveerde 
levermorfologie zien, zonder tekenen van extra hepatocellulaire ischemie, galwegschade of 
sinusoïdale schade. Deze studie was de allereerste studie waarin werd aangetoond dat NMP van 
humane levers technisch haalbaar is.
Één van de grote voordelen van NMP is de mogelijkheid tot het ex vivo testen van suboptimale 
donorlevers die, gebaseerd op de huidige klinische criteria, niet in aanmerking komen 
voor transplantatie (in verband met een te groot risico op vroeg transplantaatfalen). Om 
machineperfusie klinisch te kunnen gebruiken voor het selecteren van transplanteerbare 
organen, is het noodzakelijk dat er markers worden geïdentificeerd die tijdens machineperfusie 
adequaat de leverfunctie na transplantatie kunnen voorspellen. Wanneer NMP aan het einde 
van een periode van koude ischemie (SCS) wordt uitgevoerd, zou het idealiter mogelijk moeten 
zijn om de leverkwaliteit te onderzoeken en te voorspellen binnen 1-3 uur perfusietijd. Op deze 
manier zal er voldoende tijd overblijven voor het selecteren en voorbereiden van een ontvanger. 
In hoofdstuk  11 hebben we 12 afgekeurde levers geëvalueerd voor transplantaatfunctie 
na 6 uur NMP. Zes levers vertoonden excellente leverfunctie en de andere zes levers lieten 
duidelijke tekenen van schade en disfunctie zien. Galproductie na 2,5 uur NMP werd in deze 
studie geïdentificeerd als de enige 100% discriminerende voorspeller van transplantaatfunctie 
na 6 uur NMP. Concluderend kan gezegd worden dat normotherme machineperfusie van 
‘extended criteria donor’ (ECD) levers de mogelijkheid biedt om donorlevers te testen vóór 
transplantatie. Dit creëert nieuwe kansen voor donororgaan selectie, therapeutische interventies 
en preconditionering. Naast het verbeteren van donororgaankwaliteit en functie kan dit leiden 
tot een uitbreiding van het aantal voor transplantatie beschikbare donororganen.
Deel D: addendum
‘Donation after cardiac death’ (DCD) en andere ‘extended criteria donor’ (ECD) donororganen 
worden steeds vaker gebruikt voor transplantatie, resulterend in een verhoogd risico op 
galwegcomplicaties. Ten tijde van het donoraanbod worden donorgerelateerde risico’s zoals 
ziekteoverdracht en transplantaatfalen afgewogen tegen het (overlijdens)risico van de patiënt 
indien hij/zij op de wachtlijst blijft staan. De rol van de patiënt in het beslissingsproces, het 
tijdstip waarop en de mate waarin informatie over donorspecifieke risico’s zou moeten worden 
gegeven, wordt besproken in de medische literatuur. Echter de mening van de patiënten zelf is 
niet eerder gedocumenteerd. hoofdstuk 12 beschrijft een eerste onderzoek naar de mening 
van leverpatiënten met betrekking tot deze zaken. Veertig leverpatiënten op de wachtlijst voor 
transplantatie en 179 reeds getransplanteerde leverpatiënten namen deel aan een anonieme 
vragenlijststudie. De meerderheid van de deelnemers wenste geïnformeerd te worden over 
donorgerelateerde risico’s en daarnaast willen ze ook betrokken worden bij de besluitvorming 
ten tijde van het donoraanbod. Door het standaardiseren van de inhoud, de overdrachtswijze en 
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de hoeveelheid informatie die we onze patiënten geven op verschillende tijdstippen tijdens het 
transplantatie toekenningsproces, zouden we iedere patiënt op de wachtlijst dezelfde kansen en 
zorg kunnen bieden.
Het rattenleverperfusiesyteem dat we hebben gemaakt voor onze studie in hoofdstuk 9, 
beschrijven we in detail in hoofdstuk 13. Het is een druk- en temperatuurgereguleerd systeem 
dat geschikt is voor NMP van rattenlevers. Twee kunstmatige longen voorzien de perfusievloeistof 
van zuurstof, de arteriële doorbloeding van de lever is pulserend en de portale doorbloeding is 
continu. Dit rattenleverperfusiesysteem lijkt veel op het perfusiesysteem dat we gebuiken voor 
humane levers en was in staat om gezonde rattenlevers in ieder geval 5 uur lang in leven te 
houden.
In hoofdstuk 14, het huidige hoofdstuk, worden de resultaten van dit proefschrift samengevat 
en bediscussieerd, gevolgd door een paragraaf met toekomstperspectieven.
ConCLuSIES En ToEKoMSTPERSPECTIEf
De studies beschreven in dit proefschrift hebben geresulteerd in het beter begrijpen van de 
onderliggende etiologieën van galwegschade en het daaropvolgende ontstaan van NAS 
na levertransplantatie. Daarnaast wordt het eerste bewijs geleverd dat machinepreservatie, 
vergeleken met klassieke SCS preservatie, superieure bescherming van de galwegen van 
donorlevers geeft.
De belangrijkste bevindingen en conclusies van dit proefschrift:
1)  Schade aan het galwegepitheel van de grote galwegen, gekenmerkt door loslating en verlies 
van galwegepitheelcellen en verminderde galwegepitheelfunctie, komt vrijwel universeel 
voor in alle donorlevers voor transplantatie. Echter, dit type schade is niet geassocieerd met 
het ontwikkelen van NAS na transplantatie. Deze onverwachte bevinding heeft onze kijk op 
de pathogenese van NAS compleet veranderd. Dat galwegschade universeel aanwezig is, 
maar slechts een deel van de donorlevers galwegstricturen ontwikkelt, geeft aan dat niet 
zozeer de hoeveelheid schade maar juist de afwezigheid van regeneratie bepalend is voor het 
ontwikkelen van NAS.
2)  De peribiliaire klieren zijn holtes (nissen) met galwegepitheelvoorlopercellen (progenitorcellen) 
die in contact staan met het lumen van grotere galwegen. Deze klieren spelen een belangrijke 
rol in de regeneratie van het galwegepitheel na ernstige schade.
3)  Naast de schade aan het galwegepitheel, wordt ook schade in de peribiliaire klieren en de 
peribiliaire vasculaire plexus gevonden in een aantal levers na SCS en voor transplantatie. 
Schade aan deze componenten van de galwegwand is sterk geassocieerd met het ontwikkelen 
van NAS vroeg na transplantatie. Dit ondersteunt onze hypothese dat een onvermogen tot 
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regeneratie van het galwegepitheel de belangrijkste voorspeller is voor het ontwikkelen van 
NAS.
4)  Vergeleken met de klassieke preservatiemethode SCS biedt machineperfusie een betere 
bescherming aan de galwegen van donorlevers. Schade aan de peribiliaire vasculaire plexus 
kan worden voorkomen door preservatie met hypotherme machineperfusie (HMP), zoals 
aangetoond in een model van NHB donorlevers afkomstig van varkens. Galwegepitheelverlies 
en disfunctie kan worden voorkomen door normotherme machineperfusie (NMP), zoals 
gedemonstreerd in een rattenmodel van DCD donatie.
5)  NMP van humane levers is technisch haalbaar en deze nieuwe techniek biedt de mogelijkheid 
om galwegen beter te beschermen tussen uitname en transplantatie. Daarnaast kan NMP 
worden gebruikt om geschikte donorlevers voor transplantatie te selecteren. Galproductie 
tijdens NMP lijkt een goede voorspellende parameter te zijn voor het ex vivo testen van ECD 
donor levers voor transplantatie.
6)  Naast de galwegschade die ontstaat tijdens de koude preservatieperiode, kan immuun-
gemedieerde schade optreden na transplantatie, dit is een belangrijke oorzaak van NAS dat 
later (>2 jaar) na transplantatie ontstaat.
7)  Ten slotte zouden we de manier waarop we patiënten betrekken bij het besluit om een 
ECD donorlever al dan niet te accepteren, moeten herzien. Patiënten willen graag betrokken 
worden bij dit ingewikkelde proces en we zouden protocollen moeten ontwikkelen om hen 
beter te informeren.
Hoewel er in dit proefschrift antwoorden zijn gegeven op een aantal belangrijke klinische 
vraagstellingen, zijn hieruit nieuwe vragen en uitdagingen ontstaan. In deze laatste paragraaf 
van dit proefschrift wijd ik graag een aantal woorden aan de vragen die zijn ontstaan of nog 
steeds onbeantwoord zijn, alsmede suggesties voor onderzoek in de (nabije) toekomst.
Met betrekking tot de etiologie van NAS hebben we gedemonstreerd dat late NAS veel vaker 
optreedt in ontvangers met CCR5-Δ32 (hoofdstuk 4). Dit kan worden verklaard door een 
immunologische disbalans die veroorzaakt wordt door een tekort aan functioneel CCR5 in 
deze patiënten. CCR5 deficiëntie is zowel in mensen als in proefdiermodellen geassocieerd met 
significant grotere hoeveelheden CCR5 ligand CCL5 in weefsel waarin een ontstekingsproces 
gaande is. Doordat het CCL5 zich kan binden aan zowel CCR5 als een alternatieve receptor, 
CCR1, worden er bij CCR5 deficiëntie mogelijk meer T-cellen aangetrokken (11-14). Daarnaast 
is de CCR5-Δ32 mutatie geassocieerd met verminderde influx van regulatoire T-cellen naar de 
plek van beschadiging (15-17). Regulatoire T-cellen spelen een immunomodulerende rol door 
het verminderen van ontsteking en het onderdrukken van potentieel schadelijke lymfocyten. 
De sterke associatie tussen CCR5-Δ32 en late NAS zoals beschreven in de studie in hoofdstuk 
4 kan dus mogelijk worden verklaard door een verhoogde immuunrespons ten opzichte van 
het galwegepitheel van de donorlever en/of door een tekort aan regulatoire T-cellen op de 
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plek van beschadiging. Echter, de huidige klinische observatiestudie stelt ons niet in staat om 
uit te kunnen zoeken waarom CCR5-Δ32 tot het ontwikkelen van NAS leidt. Een beter begrip 
van de onderliggende mechanismen zou moeten worden verkregen in een dierexperimentele 
studie. Het bestuderen van galwegschade en proliferatie na galwegligatie in CCR5 knock-out 
muizen zou hieraan kunnen bijdragen. De influx van immuuncellen in de lever als reactie op de 
galwegschade veroorzaakt door galwegligatie kan worden gekwantificeerd door flowcytometrie 
en immunohistochemie. Het verschil in immuunrespons tussen CCR5 wildtype en CCR5 knock-
out muizen kan leiden tot een beter begrip van de onderliggende pathofysiologie van (late) NAS 
en ons daarmee dichter bij een potentiële therapeutische strategie brengen voor dit subtype van 
NAS.
Met betrekking tot het voorkomen van NAS kunnen we stellen dat de huidige methode van 
eenmalig koud spoelen en koud bewaren van levers op ijs (SCS) onvoldoende bescherming van 
de galwegen biedt. Machineperfusie van donorlevers is een aantrekkelijk alternatief voor SCS, 
met potentie om galwegschade te voorkomen. De technische vooruitgangen op dit gebied, in 
combinatie met het alsmaar groeiende donortekort, bieden ons nieuwe onderzoeksmogelijkheden 
en klinische uitdagingen. Na een periode van meer dan 40 jaar waarin koude preservatie op ijs 
(SCS) van donororganen de gouden standaard is geweest, zien we nu een mogelijke verandering 
in de klinische transplantatiepraktijk door de introductie van machineperfusie. Hoewel een 
aantal studies in dit proefschrift zowel de technische mogelijkheden als het beschermende effect 
van machineperfusie op de galwegen hebben gedemonstreerd, blijven verschillende vragen 
onbeantwoord.
Om deze nieuwe vragen te kunnen beantwoorden, zullen toekomstige studies zich moeten 
richten op de volgende aspecten:
1) Wat is de optimale temperatuur voor galwegpreservatie tijdens machineperfusie? Het is 
nog onduidelijk of 37oC de optimale temperatuur is, of dat perfusie op een lagere temperatuur 
(bijvoorbeeld tussen 4-10 oC of op kamertemperatuur) net zo effectief, maar goedkoper en 
wellicht veiliger is.
2) Zolang de chirurgische techniek en de protocollen van een multi-orgaan donatieprocedure 
niet verandert, worden alle organen in het donorlichaam doorspoeld met een koude 
preservatievloeistof, voordat de organen worden uitgenomen. Als organen na deze koude 
flush op een apparaat worden aangesloten voor normotherme machineperfusie, wat is 
dan de beste strategie om de temperatuur te verhogen? Het is nog onbekend of dit 
langzaam en/of stapsgewijs moet gebeuren en zo ja, hoe langzaam.
3) Wanneer en voor hoe lang kunnen we machineperfusie het beste gebruiken? 
Moet de standaard koude ischemie (SCS) geheel worden vervangen door machineperfusie, 
of is het voldoende om SCS te combineren met een periode van machineperfusie? In het 
tweede geval zou machineperfusie moeten plaatsvinden voor SCS (direct na uitname van 
opdendries.indd   232 11-10-2013   9:50:48
Nederlandse samenvatting
233
de donororganen in het donorziekenhuis) of aan het einde van de SCS bij aankomst in het 
transplantatiecentrum?
4) Zijn we in staat de kwaliteit te verbeteren van de donorlevers en de galwegen 
door het gebruik van machineperfusie voor transplantatie? Zijn we in staat om levers te 
preconditioneren door het stimuleren van natuurlijke verdedigingsmechanismen of het 
stimuleren van endogene reparatieprocessen? Anderzijds kan machineperfusie ons wellicht 
in staat stellen om de kwaliteit van een donorlever te verbeteren door het verminderen van 
een bestaande pathologische conditie, zoals steatose (leververvetting).
5) Een andere belangrijke vraag die behandeld moet worden is: Wat is de beste soort 
perfusievloeistof?
6) Ten slotte, toekomstig onderzoek zou zich moeten richten op het identificeren van specifieke 
biomarkers of het ontwikkelen van moleculaire imaging tools ter beoordeling van de 
levensvatbaarheid van de galwegen voor transplantatie.
ad 1 - De optimale temperatuur
Tijdens machineperfusie kunnen levers worden geperfuseerd met een geoxygeneerde of niet-
geoxygeneerde perfusievloeistof op verschillende temperaturen (2-4,18,19). Een relatief simpele 
en veilige optie is hypotherme machineperfusie (HMP; 0-4°C), waarbij het voordeel ten opzichte 
van SCS wordt behaald uit het verwijderen van afvalproducten tijdens het perfuseren. De eerste 
klinische studie naar machineperfusie van humane levers werd uitgevoerd door Guarrera et 
al., gebruik makende van HMP zonder zuurstof (1). Hoewel in deze studie een vermindering 
in vertraagde transplantaatfunctie werd gedemonstreerd, zijn langetermijn voordelen niet 
beschreven. Recente studies in proefdiermodellen hebben de voordelige effecten van oxygenatie 
aangetoond tijdens HMP, resulterend in verbeterde bescherming van mitochondriële functie, 
minder hepatocellulaire schade en een verbeterd functioneel herstel na reperfusie (19,20). 
Daarnaast demonstreren wij zelf in hoofdstuk 8 van dit proefschrift dat geoxygeneerde HMP 
van varkenslevers resulteert in verbeterde preservatie van de peribiliaire vasculaire plexus 
van de galwegen. Echter, het is onbekend of peribiliaire klieren beter bewaard blijven tijdens 
geoxygeneerde HMP, en of dit in combinatie met verbeterde preservatie van de peribiliaire 
vasculaire plexus ook resulteert in een vermindering van galwegstricturen na transplantatie 
van humane levers. Het antwoord op deze vraag zal moeten komen van een gerandomiseerde 
klinische studie. In een dergelijke studie kan SCS worden vergelijken met geoxygeneerde HMP, 
waarbij DCD donorlevers, gezien de hoge incidentie van NAS in deze levers, de meest geschikte 
onderzoeksgroep zullen zijn.
ad 2 – De beste strategie om de temperatuur te verhogen
Een alternatief voor het kiezen van één temperatuur is het combineren van verschillende 
temperaturen in een protocol dat zowel het transport, het testen en het preconditioneren van 
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de lever omvat. In een recente studie door Minor et al. zorgde 90 minuten gecontroleerde 
geoxygeneerde opwarming tot 20°C door machineperfusie voor een significante reductie 
in verlies van leverenzymen en verbeterde galproductie, vergeleken met 90 minuten SCS of 
subnormotherme machineperfusie (21). Toekomstig onderzoek is nodig om te onderzoeken wat 
in dit geval het beste klinische protocol is.
ad 3 – Tijdstip en duur van machineperfusie
Machineperfusie kan de klassieke koude preservatie (SCS) geheel vervangen of in combinatie 
met SCS worden ingezet. De strategie om SCS geheel buiten spel te zetten wordt momenteel 
gevolgd door de onderzoeksgroep van Dr. Friend in Oxford, UK, gebruikmakende van NMP. 
Deze methode is potentieel het meest succesvol, maar het vereist uitzonderlijke organisatorische 
planning en het draagt een relatief hoog mislukkingsrisico. Indien een lever tijdens NMP op 
37°C per ongeluk ontkoppeld van het perfusieapparaat, dan resulteert dit onmiddellijk in warme 
ischemie wat een groot risico is voor het donororgaan. Een veiliger, maar mogelijk nog steeds 
effectief, alternatief is een korte periode van geoxygeneerde hypotherme machineperfusie (HMP) 
voor of na het transport waarin de klassieke SCS wordt gebruikt. De laatste optie wordt actief 
onderzocht door de groep van Dr. Dutkowski in Zurich, Zwitserland (19,22) en een Japanse groep 
presenteerde recent veelbelovende preliminaire resultaten van een korte periode geoxygeneerde 
NMP voorafgaande aan SCS in een rattenmodel van DCD levertransplantatie (23). Welke optie 
het meest effectief is en veilig genoeg voor klinische toepassing, zal worden onderzocht in 
klinische studies in de komende jaren.
ad 4 – Kwaliteitsverbetering donorlevers
In tegenstelling tot HMP, is NMP potentieel in staat om de normale fysiologie en metabole 
activiteit van de lever te herstellen. Dit creëert een unieke kans om zowel orgaankwaliteit als 
galwegintegriteit te verbeteren door activering van endogene of exogene reparatiemechanismen. 
Potentieel interessante onderwerpen die verder onderzocht dienen te worden zijn bijvoorbeeld 
het toevoegen van mesenchymale stamcellen (24) of groeifactoren (25) aan de perfusievloeistof. 
Met name humorale factoren die de proliferatie van galwegepitheelcellen kunnen stimuleren, 
zoals ‘vascular endothelial growth factor, ‘glucagon-like peptide-1’ en ‘insulin-like growth 
factor-1’ zijn interessante toevoegingen tijdens NMP (25). Daarnaast is het de moeite waard 
om de potentieel beschermende effecten van ex vivo stimulatie van bicarbonaatexcretie door 
galwegepitheelcellen te bestuderen, aangezien dit is beschreven als een belangrijk endogeen 
beschermingsmechanisme van het galwegepitheel tegen galzout-gemedieerde toxiciteit 
en celdood (26). Tenslotte zou NMP gebruikt kunnen worden om galwegpreservatie en 
functie te verbeteren door het toevoegen van de beschermende, ontstekingsremmende en 
fibroseremmende hydrofiele galzouten of afgeleiden hiervan, zoals tauroursodeoxycholic acid, 
of 6alpha-ethyl-chenodeoxycholic acid (27-29).
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ad 5 – De beste perfusievloeistof
In onze eigen NMP experimenten (hoofdstuk 9-11) gebruiken we een perfusievloeistof die zoveel 
mogelijk op ‘normaal’ bloed lijkt, omdat we de fysiologische omgeving van de lever willen 
nabootsen. De belangrijkste componenten van deze perfusievloeistof zijn rode bloedcellen 
(RBC), ‘fresh frozen plasma’ (FFP) en albumine. Het grootste verschil met ‘normaal’ bloed is 
de afwezigheid van potentieel schadelijke leukocyten en thrombocyten, en de toevoeging van 
antibiotica. Omdat bloedproducten schaars zijn en afhankelijk zijn van donatie, is het verstandig 
om kunstmatige zuurstofdrager en plasmavervangers te evalueren als mogelijk alternatieve 
componenten van de perfusievloeistof. Daarnaast zal kunstmatige zuurstofdrager noodzakelijk 
zijn indien een machineperfusie protocol met verschillende temperaturen wordt gebruikt, RBC’s 
verliezen namelijk hun flexibiliteit en zuurstofbindende capaciteit bij lagere temperaturen.
ad 6 – Beoordeling levensvatbaarheid galwegen ex vivo
Hoewel we lieten zien dat de levensvatbaarheid van de levercellen tijdens machineperfusie 
testbaar is (hoofdstuk 10 en 11), we hebben de levensvatbaarheid van de galwegen nog niet 
kunnen aantonen, afgezien van de biopten die we hebben genomen van de ductus choledochus 
van donorlevers in hoofdstuk 7. In onze NMP experimenten hebben we biliaire secretie van 
bicarbonaat gebruikt als biomarker van de galwegepitheelfunctie. Galwegepitheelcellen dragen 
significant bij aan het volume en de flow van de gal door actieve secretie van bicarbonaat. 
Tijdens de NMP van humane levers zagen we herstel van de bicarbonaatsecretie tijdens 
machineperfusie. De hoeveelheid bicarbonaatsecretie in de gal is echter het resultaat van alle 
galwegepitheelcellen in de intra- en extrahepatische galwegen en reflecteert daardoor niet 
persé de functie van het galwegepitheel in de grotere galwegen, welke het meest gevoelig 
zijn voor het ontwikkelen van stricturen na transplantatie. Om deze reden is het van belang om 
betere biomarkers van galwegepitheelschade en –functie te identificeren. De onderzoeksgroep 
van Dr. Van der Laan in Rotterdam heeft recent miRNA’s geidentificeerd als een veelbelovende 
nieuwe biomarker voor hepatocellulaire schade (30). Of het meten van galwegspecifieke miRNA’s 
in de gal gebruikt kan worden om de levensvatbaarheid van het galwegepitheel tijdens NMP te 
voorspellen, zal moeten worden uitgewezen. Een alternatief is het ontwikkelen van moleculaire 
beeldvormingstechnieken met near-infrarood fluorescentie waarmee het galwegepitheel non-
invasief kan worden beoordeeld. Als dergelijke beeldvormingstechnieken gecombineerd worden 
met cholangioscopie, dan zou dit een intraoperatief hulpmiddel kunnen zijn om chirurgen het 
galwegepitheel te laten beoordelen, voorafgaande aan de transplantatie (31).
Samengevat, de studies in dit proefschrift hebben significant bijgedragen aan een beter 
begrip van de onderliggende oorzaken van galwegschade tijdens en na levertransplantatie. 
Machineperfusie blijkt een uitvoerbaar en veelbelovende alternatief te zijn voor de klassieke 
koude preservatie van donorlevers voor transplantatie. Er is aangetoond dat machineperfusie 
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de galwegen beter beschermd dan de klassieke koude preservatie. De verwachting is dat 
deze nieuwe techniek de dagelijkse praktijk van levertransplantatie zal veranderen. Ik hoop en 
verwacht dat machineperfusie van donorlevers niet alleen de hoeveelheid galwegcomplicaties na 
levertransplantatie zal verminderen, maar ook een toename in het aantal getransplanteerde levers 
teweeg zal brengen, waardoor leverpatiënten een grotere kans krijgen op deze levensreddende 
therapie.
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